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SUMMARY
Summary
DNA methylation and histone modifications play a central role in the epigenetic regu-
lation of gene expression and cell differentiation. DNA methyltransferase 1 (Dnmt1) is
the most ubiquitously expressed DNA methyltransferase and is essential for maintaining
DNA methylation patterns during semi-conservative DNA replication and DNA repair.
The fidelity and processivity of this process is crucial for genome stability and is based
on the specific recognition of hemimethylated CpG sites emerging at the replication
forks. Remarkably, a variety of proteins have been reported to interact with Dnmt1,
regulating the activation, stabilization and recruitment of Dnmt1 to specific sites and
regions. Recently, Uhrf1 has been found to interact with Dnmt1, indicating together
with genetic studies a central role in the maintenance of DNA methylation. However,
the exact mechanism how Uhrf1 plays a role in DNA methylation remains elusive.
Uhrf1 is a multi-domain protein harbouring distinct functional domains, which specifi-
cally recognize epigenetic marks such as DNA methylation and histone modifications.
To investigate the histone-tail binding specificities of Uhrf1, we developed an in vitro
histone-tail peptide binding assay using GFP-fusion proteins. Moreover, we expanded
this assay to 96-well micro plates, allowing high-throughput screening for histone-tail
peptide binding, DNA binding, protein-protein interactions, detection of endogenous
binding partners and quantification of post-translational modifications. Using this as-
say, we demonstrated that Uhrf1 preferentially binds to H3K9me3 via a tandem Tudor
domain. The binding is mediated by three highly conserved aromatic amino acids
that form an aromatic cage similar to the chromodomain of HP1b.
Furthermore, we characterized the second member of the Uhrf family, Uhrf2. Binding
assays demonstrate a cooperative interplay of Uhrf2 domains that induces preference
for hemimethylated DNA and enhances binding to H3K9me3 heterochromatin marks.
Localization and binding dynamics of Uhrf2 in vivo require an intact tandem Tudor do-
main and depend on H3K9 trimethylation but not on DNA methylation. Remarkably,
both genes showed an opposite expression pattern and ectopic expression of Uhrf2 in
uhrf1-/- ESCs did not restore DNA methylation at major satellites indicating functional
differences.
Finally, we used a combination of SILAC and mass spectrometry to quantify protein
interactions of Dnmt1 over the cell cycle. Therefore, we immunoprecipitated endoge-
nous Dnmt1 from HeLa cells cultured in "light" or "heavy" media synchronized in either
G1, early S or late S phase of the cell cycle. With this approach, we could accurately
identify interactions of endogenous Dnmt1 and characterize the cell cycle-dependent
dynamics.
In conclusion, this work contributes to the further elucidation of the complex and dy-
namic mechanisms of Dnmt1 regulation by interacting factors and demonstrates the
role of Uhrf proteins in mediating epigenetic crosstalk.
1
INTRODUCTION
1 Introduction
1.1 Epigenetic Gene Regulation
Multicellular organisms comprise a variety of highly specialized cells that contain the
same genetic information, the DNA sequence, but differ dramatically in morphology
and function. In simple terms, large ranges of different phenotypes arise from the
same genotype. The formation of organs and tissues of morphological and functional
distinct cell types throughout development are controlled by spatial and temporal
changes of gene activation and repression. One of the most important control mech-
anisms to ensure proper development is transcriptional regulation by a complex pro-
tein network that results in gene transcription by the RNA polymerase II. Basically, the
regulation of transcription initiation is accomplished by three different mechanisms: (i)
Architecture of the core promoter including regulatory elements, multiple start sites
and alternative promoter usage (ii) control of DNA accessibility by altering the chro-
matin structure (Berger, 2007) and (iii) general and sequence-specific transcription fac-
tors (Malik and Roeder, 2005).
Transcription factors are crucial determinants for the regulation of gene expression that
activate or repress specific genes through sequence-specific interactions with their
promoters. Interaction of transcription factors with their cognate DNA sequence trig-
gers a chain of events, often involving changes in the structure of chromatin, leading
to the assembly of an active transcription complex. However, due to the complexity
of genomic functions in eukaryotes, transcription factors are not sufficient for full es-
tablishment and long-term stability of transcriptional states. This probably accounts
for the very low efficiency of cloning animals from the nuclei of differentiated cells
and that cloned animals generated from the same donor DNA are not identical to
their donor. Even more drastically, cloned animals by nuclear transfer often develop
diseases with various defects (Rideout et al., 2001). It became clear that stable cell-
type specific gene expression pattern are established and maintained by a complex
interplay between transcription factors and epigenetic regulators. In particular, epi-
genetic processes like DNA methylation, post-translational histone modifications and
nucleosome positioning play an essential role in the regulation of gene expression (Fig-
ure 1). These modifications are by definition epigenetic, since epigenetics in its classic
definitions describes heritable modifications of DNA or chromatin that do not alter the
primary nucleotide sequence (Bird, 2002; Jaenisch and Bird, 2003). These epigenetic
processes control the composition, structure and dynamics of chromatin and thereby
regulate gene expression by regulating the condensation and accessibility of genomic
DNA (Bird, 2002; Kouzarides, 2007; Reik, 2007).
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Figure 1: Three levels of epigenetic regulation
Epigenetic regulation depends on the interplay of DNA methylation (PDB ID code: 3BSE), histone modi-
fications (PDB ID code: 1AOI) and nucleosome positioning. Figure is adapted from (Portela and Esteller,
2010)
1.1.1 DNA Methylation
DNA methylation was the first epigenetic modification to be identified and has been
intensively studied for half a century. DNA methylation is the post-replicative addition
of methyl groups to the C5 position of cytosines catalysed by a family of DNA methyl-
transferases (Dnmt). Methylation of cytosines within DNA is found in most eukaryotes,
including plants, animals and fungi (Goll and Bestor, 2005; Chan et al., 2005; Klose and
Bird, 2006), but, it has been lost from some species including budding yeast Saccha-
romyces cerevisae and Caenorhabditis elegans (Feng et al., 2010). DNA methylation
occurs almost exclusively in the context of CpG dinucleotides that tend to cluster in
regions called CpG islands, which constitute about 1 %-2 % of the genome. In general,
CpG islands are DNA stretches of more than 200 base pairs in length (0.2-3 kb) char-
acterized by an elevated C/G content (at least 50 %) and a ratio of observed to statis-
tically expected CpG frequencies of a least 0.6 (Illingworth and Bird, 2009). About the
half of CpG islands are associated with transcription start sites (Deaton and Bird, 2011)
and many are linked to housekeeping genes and developmental regulators (Meissner,
2011). Studies estimated that about 60 % of human genes are associated with CpG is-
lands that are usually unmethylated at all stages of development and in all tissue types
(Antequera and Bird, 1993), although some of them ( ~6 %) become methylated in a
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tissue-specific manner during early development or in differentiated tissues (Straussman
et al., 2009). Comprehensive microarray analyses showed that unmethylated regions
seem to be established during early embryogenesis, not as a result of CpG-ness, but
rather through the recognition of specific sequence motifs closely associated with tran-
scription start sites (TSS) (Straussman et al., 2009). In general, CpG island methylation
is associated with transcriptional silencing and genomic imprinting, resulting in mono-
allelic, parent-of-origin-specific expression (Kacem and Feil, 2009), and X-chromosome
inactivation in females (Reik and Lewis, 2005). However, DNA methylation does not ex-
clusively correlate with transcriptional silencing. A recent publication reported that
gene body methylation positively correlates with active transcription of genes on the
active X chromosome while their promoter remains unmethylated (Hellman and Chess,
2007). Also, DNA methylation does not occur exclusively in CpG islands but also in so-
called CpG island shores, that are closely associated with transcriptional repression
(Irizarry et al., 2009). A comprehensive DNA methylation map of haematopoietic pro-
genitors revealed that differential DNA methylation correlates with gene expression
more strongly at CpG shores than CpG islands and ~70 % of the differentially methy-
lated regions in reprogramming are associated with CpG shores (Doi et al., 2009; Ji et
al., 2010).
Although DNA methylation occurs mainly in the context of CpG sites, non-CG methy-
lation, which is well characterized in plants, has recently been described in humans at
CHG and CHH sites (where H is A, C or T) (Lister et al., 2009). In plant cells non-CG sites
are methylated de novo by the Chromomethylase CMT3 responsible for maintaining
epigenetic gene silencing (Lindroth et al., 2001). Genome-wide, single-base-resolution
maps of methylated cytosines in mammalian genome (human embryonic stem cells as
well as fetal fibroblasts) revealed that nearly one-quarter of all methylation identified
in embryonic stem cells (ESCs) was in a non-CG context (Lister et al., 2009). Methy-
lation in non-CG context is enriched in gene bodies and depleted in protein binding
sites and enhancers. The level of non-CpG methylation decreases upon differentiation
and is restored in induced pluripotent stem cells, suggesting that ESCs may use a differ-
ent methylation mechanism to affect gene regulation (Lister et al., 2009; Laurent et al.,
2010). However, the role and origin of non-CpG methylation remains unclear (Laurent
et al., 2010).
It has become clear that the regulation of DNA methylation is crucial for normal devel-
opment. For example, knockout mutations of any of the three mouse genes encod-
ing DNA methyltransferases (Dnmt1, Dnmt3a and Dnmt3b) are lethal (Okano et al.,
1999; Lei et al., 1996), demonstrating that aberrant DNA methylation impair normal de-
velopment. Loss-of-function mutations in MET1, the homolog of Dnmt1 in Arabidopsis
thaliana, and CMT3 impair the normal development of Arabidopsis embryos, display-
ing altered planes and numbers of cell divisions and reduced cell viability (Xiao et al.,
4
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2006). Knockdown of dnmt1 in zebra fish embryos caused defects in terminal differen-
tiation of the intestine, exocrine pancreas, and retina (Rai et al., 2006).
Recently, additional DNA modifications have been identified. Besides the fifth base
5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC) and
5-carboxylcytosine (5caC) have been identified (Ito et al., 2011) (Figure 2). 5hmC is
abundant 5fC and 5caC are detectable in genomic DNA of mouse ESCs and organs
and can be increased or decreased by overexpression or depletion of Tet proteins
(Ito et al., 2011). In tumour cells, the DNA methylation pattern is altered, resulting in
global hypomethylation of the genome and hypermethylation at CpG sites of tumor-
suppressor genes (Esteller, 2008). Interestingly, hemizygous deletions and mutations of
TET2 were found in a wide range of myeloid malignancies, including myelodysplas-
tic syndrome (MDS) and myeloproliferative disorders (Langemeijer et al., 2009; Del-
hommeau et al., 2009). Furthermore, genomic 5hmC levels correlate with TET2 muta-
tions and with a distinct global gene expression pattern in secondary acute myeloid
leukemia (Konstandin et al., 2011). The presence of 5hmC (or 5fc and 5caC) may con-
tribute to both passive and active demethylation in the genome. The maintenance
of DNA methylation during DNA replication by Dnmt1 may be inhibited by the inabil-
ity of Dnmt1 to recognize 5hmC (Lao et al., 2010), leading to the passive loss of DNA
methylation during cell division. However, the rapid loss of DNA methylation during
mammalian development shortly after fertilization (Hajkova et al., 2010; Mayer et al.,
2000; Oswald et al., 2000) and again in primordial germ cells (Hajkova et al., 2002;
Lee et al., 2002) within one single cell cycle, suggest the presence of enzymes that
can actively remove 5mC independently of DNA replication. In plants, methylated
cytosines are excised by the DNA glycosylase DEMETER and replaced with C leading
to active genomic demethylation (Kinoshita et al., 2004). However, DNA glycosylases
that recognize 5mC have not been identified in mammals until now (Cimmino et al.,
2011).
H ON
O
O
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N
NH2
3H  C
H ON
O
O
OH
N
NH2
HO
C
H2
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  O
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5-methylcytosine (5mC) 5-hydroxymethylcytosine (5hmC) 5-formylcytosine (5fC) 5-carboxylcytosine (5caC)
Figure 2: Overview of DNA modifications
Stepwise oxidation starting from 5-methylcytosine (5mC) results in 5-hydroxymethylcytosine (5hmC), 5-
formylcytosine (5fC) and finally in 5-carboxylcytosine (5caC).
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Instead, the mammalian DNA glycosylase TDG, analogous to plant demethylases, has
been shown to possess weak 5mC glycosylase activity, although it is unclear whether
TDG is indeed responsible for the active DNA demethylation observed in vivo (Zhu et
al., 2000; Hardeland et al., 2003). Other studies have shown that active TET hydroxylases
may catalyse active DNA demethylation by oxidizing 5mC followed by subsequent
deamination and replacement via BER pathway (Guo et al., 2011).
1.1.2 Histone Modifications
The straightened DNA from a single human cell would have a length of ~2 metres
and taken into account that the average diameter of a human cell nuclei is ~6 mi-
crometres, eukaryotic organisms are faced with an information storage and packag-
ing problem (Radman-Livaja and Rando, 2010). To overcome these problems, DNA
has to be folded in a hierarchy of different levels into higher order chromatin consisting
of DNA, histone proteins and non-histone proteins in a way that permits the transcrip-
tional machinery access to enable gene expression. The first level is accomplished by
wrapping 147 base pairs (bp) of DNA in 1.65 turns around an histone octamer, consist-
ing of two H2A/H2B and H3/H4 heterodimers (Luger et al., 1997). A DNA linker, with a
length of ~50 bp on average, connects these core units of chromatin and thousand of
nucleosomes end up looking like "beads on a string" in electron microscopy. Nucleo-
somes are then further condensed into a shorter, thicker filament, the so-called 30-nm
fibre. Finally, nucleosomes are folded into various higher order structures that can be
unwrapped as needed (Luger and Hansen, 2005). Importantly, the core histones are
predominantly globular except for their N-terminal tails that are unstructured. These
histone-tails protrude out of the histone octamer and are mostly subjected to a large
variety of post-translational modifications with different impact on chromatin accessi-
bility and stability (Kouzarides, 2007). Histones are modified at about 150 different sites
and several different types of post-translational modifications have been reported. It
was proposed that distinct histone modifications, on one or more histone tails, act se-
quentially or in combination to form a "histone code" that is read by other proteins to
bring about distinct downstream events (Strahl and Allis, 2000).
In the last 20 years a large variety of enzymes has been identified for acetylation
(Sterner and Berger, 2000), methylation (Zhang and Reinberg, 2001), phosphorylation
(Nowak and Corces, 2004), ubiquitination (Shilatifard, 2006), sumoylation (Nathan et
al., 2003), ADP-ribosylation (Hassa et al., 2006), deimination (Cuthbert et al., 2004), pro-
line isomerization (Nelson et al., 2006) and crotonylation (Tan et al., 2011). Some of
the best-characterized histone modifying enzymes are the protein complexes of the
polycomb (PcG) and trithorax (trxG) groups (Francis and Kingston, 2001; Campos and
6
INTRODUCTION
Reinberg, 2009; Bernstein et al., 2007). PcG proteins catalyse two distinct histone mod-
ifications: H3K27me3 is catalysed by the polycomb repressive complex (Prc) 2 (Cao et
al., 2002) and mono-ubiquitination of lysine 119 of H2A by Prc1 (Campos and Reinberg,
2009). Loss of any of the Prc2 subunits results in severe gastrulation defects, highlighting
its essential role in normal development (Faust et al., 1998; O’Carroll et al., 2001; Pasini
et al., 2004).
In general, post-translational histone modifications can function via two different mech-
anisms. Firstly, the disruption of contacts between nucleosomes can disturb the chro-
matin structure. Of all known modifications, acetylation of lysine residues has the high-
est potential to decondense chromatin since it neutralizes the basic charge of histones.
Another striking example is the phosphorylation of histone residues. Phosphorylation
has important consequences on chromatin compactness via charge change and has
been shown to play an important role in mitosis, apoptosis and gametogenesis (Ahn
et al., 2005; Fischle et al., 2005; Krishnamoorthy et al., 2006). Secondly, the compo-
sition of histone modifications can encourage or abolish the binding of non-histone
proteins to chromatin. One example is the heterochromatin-associated protein HP1b
that specifically binds to the predominant heterochromatin mark H3K9me3 (Jacobs
and Khorasanizadeh, 2002; Jacobs et al., 2001) and is released upon phosphorylation
of the adjacent serine 10 during M phase of the cell cycle (Fischle et al., 2005).
In the last years structural and functional studies revealed how chromatin effector
modules target their respective covalent histone modification (reviewed by (Taverna
et al., 2007) (Figure 3). Besides the already mentioned HP1b, which specifically recog-
nizes H3K9me3 by its chromodomain, many other protein domains are known to recog-
nize methylated lysine residues. The so-called Royal superfamily comprises chromod-
omains, double chromodomains, chromo barrels, Tudor domains, double/tandem Tu-
dor domains and MBT (malignant brain tumor) domains, and readout higher lysine
methylation. In contrast, members of the PHD-finger (Plant Homeo Domain) fam-
ily can target both, methylated and unmodified lysine residues. On one hand, the
BPTF PHD finger, the largest subunit of the nucleosomal remodelling factor (NURF) ATP-
dependent chromatin remodelling complex, targets di- and trimethyllysine in H3K4
context (Wysocka et al., 2006). On the other hand, the PHD finger of BHC80, a part
of the Lsd1 co-repressor complex, binds unmethylated H3K4 and discriminates strongly
against its methylated counterparts (Lan et al., 2007). Interestingly, it has been shown
that the ADD (ATRX-Dnmt-Dnmt3L) domain of Dnmt3L, that is structurally very similar to
PHD finger, targets unmethylated lysine in H3K4 context (Ooi et al., 2007). The reader
modules for acetylated histone residues are bromodomains. For example, the pro-
totypical bromodomain of the transcriptional coactivator "p300/CBP-associated fac-
tor" (P/CAF, the homolog of S. cerevisiae Gcn5p) targets acetyllysine in H4K16 context
(Dhalluin et al., 1999). Other reader modules are WD40 repeats (Ruthenburg et al.,
7
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2006), 14-3-3 (Macdonald et al., 2005) and BRCT domains (Stucki et al., 2005) recogniz-
ing unmethylated arginine residues, phosphoserine marks and phosphoserine marks in
H2A.X context, respectively. In addition, there are many examples of proteins carrying
two or more putative histone-binding modules allowing for combinatorial readout of
multivalent post-translational modifications at the histone or nucleosome level (Ruthen-
burg et al., 2007).
MBT
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(BHC80; 2PUY)
WD40
(WDR5; 2H6N)
14-3-3
(14-3-3; 2C1J)
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Figure 3: Histone post-translational modifications and their binding partners
A) Reading modules of histone post-translational modifications. Shown grouped by domain family are
known chromatin-associated modules and the histone marks they have been reported to bind (Taverna
et al., 2007). B) Solved structures of histone-binding modules. Protein names and PDB ID code are written
in brackets. Figure is adapted from (Taverna et al., 2007).
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One functional consequence of histone modifications is the establishment of global
chromatin environments (Kouzarides, 2007). In relation to its transcriptional state, the
human genome can be roughly divided into actively transcribed euchromatin and
transcriptional inactive heterochromatin. Euchromatic regions are associated with
acetylation of histone H3 and H4 and trimethylation of H3K4, H3K36 and H3K79. Modifi-
cations that are localized to heterochromatic regions are methylated H3K9, H3K27 and
H4K20 (Li et al., 2007). In addition, bivalent domains have been found in mouse ESCs
consisting of large regions of H3K27 methylation, implicated in silent chromatin. These
domains harbour smaller regions of H3K4 methylation, an euchromatic mark, that tend
to coincide with transcription factors at genes expressed at low levels (Bernstein et al.,
2006). The bivalent domains allow ESCs to keep transcription factors in a poised, low-
expressed level, which can be activated during differentiation.
Besides post-translational modifications, also histone H3 tail clipping regulates gene
expression. An endopeptidase, which shows a preference for histone tail carrying re-
pressive modifications, cleaves H3 after Ala21, generating a histone that lacks the first
21 residues (Santos-Rosa et al., 2009). Histones can also be modified at different sites
simultaneously, leading to crosstalk between several different marks. The communica-
tion among histone modifications can occur within the same site (Wang et al., 2008),
in the same histone tail (Duan et al., 2008) and among different histone tails (Nakanishi
et al., 2009). Thus, a single histone mark does not determine the outcome alone. In-
stead, the cooperative interplay of several different histone marks or the combination
of all modifications existing in nucleosomes specify the biological outcome (Portela
and Esteller, 2010).
1.1.3 Nucleosome Positioning
In addition to DNA methylation and histone modifications, nucleosome positioning
plays a role in the epigenetic regulation of gene expression. Nucleosomes are a barrier
to transcription since they block the accession of the transcription machinery to DNA.
The packaging of DNA into nucleosomes appears to affect all stages of transcription,
thereby regulating gene expression (Portela and Esteller, 2010). In particular, the pre-
cise position of the nucleosome around the transcription start site (TSS) influences the
initiation of transcription. Genome-wide studies provide a view of the nucleosome
positions of a typical cell (Radman-Livaja and Rando, 2010). The promoter regions
are overall depleted of nucleosomes relative to transcribed regions and the so-called
nucleosome free regions (NFRs) are located just upstream of the TSS. In general, NFRs
directly upstream of the TSS correlate with gene activation, whereas the occupancy of
the TSS by a nucleosome correlates with gene repression (Schones et al., 2008; Cairns,
9
INTRODUCTION
2009). The function and positioning of nucleosomes can also be influenced by histone
variants. Histone variants differ in sequence and expression timing from the canoni-
cal counterparts and are enriched in chromatin of specific functional states, ranging
from DNA repair and centromere determination to the regulation of gene expression
(Wiedemann et al., 2010). For example, the incorporation of the histone variant H2A.Z
changes the nucleosome positioning in comparison to canonical nucleosomes (Fan et
al., 2002). Also, the incorporation of H2A.Z destabilizes the nucleosomes in comparison
to canonical histones (Abbott et al., 2001).
The position of nucleosomes can also be changed by the sliding and eviction of nu-
cleosomes by ATP-dependent chromatin remodelling machines (Clapier and Cairns,
2009). Chromatin modellers can be grouped into four families (SWI/SNF, ISWI, CHD and
INO80) all containing a SWI2/SNF2-family ATPase subunit characterized by an ATPase
domain and differ in their unique subunits (Clapier and Cairns, 2009; Korber and Becker,
2010).
1.1.4 Crosstalk between Epigenetic Modifications
Early studies have demonstrated a link between DNA methylation and histone modifi-
cations mediated by a group of proteins that specifically recognize methylated CpG
sites (mCpG). The family of the methyl-CpG binding proteins (MBPs) consist of at least
three protein families: the methyl-CpG binding domain (MBD), the Kaiso and the UHRF
protein family (Rottach et al., 2009). These proteins bind to methylated DNA and recruit
a protein complex that contains HDACs and histone methyltransferases, demonstrating
a change of the chromatin structure induced by DNA methylation (Nan et al., 1998;
Rottach et al., 2009; Hendrich and Tweedie, 2003; Bird, 2002). In addition, it is known
that DNA methylation inhibits methylation of H3K4 and vice versa (Weber et al., 2007;
Okitsu and Hsieh, 2007). On the one hand, H3K4 methylation is depleted from regions
with DNA methylation (Okitsu and Hsieh, 2007), on the other hand early studies in Neu-
rospora crassa demonstrate that mutations of histone H3K9 methyltransferase reduced
DNA methylation, suggesting that DNA methylation depends on histone methylation
(Tamaru and Selker, 2001). Moreover, genome-scale DNA methylation studies demon-
strate a correlation between DNA methylation and histone modifications. In particu-
lar, DNA methylation correlates with the absence of H3K4 methylation and presence of
H3K9 methylation (Meissner et al., 2008). This correlation may in part be caused by DNA
methyltransferases specifically recognizing histone modifications. For instance, the de
novo DNA methyltransferase Dnmt3a and its cofactor Dnmt3L specifically recognize
unmethylated H3K4 via an ADD domain (Ooi et al., 2007; Otani et al., 2009). Also,
a link between DNA methylation and nucleosome positioning has been shown in A.
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thaliana (Zilberman et al., 2008). Exclusion of H2A.Z correlates with sites of DNA methy-
lation in bodies of actively transcribed genes in methylated transposons. Interestingly,
mutations in the MET1, which cause both loss and gain of DNA methylation leads to
opposite changes (gains and losses) in H2A.Z deposition (Zilberman et al., 2008).
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1.2 DNA Methyltransferases
DNA methylation is the post-replicative addition of methyl groups to the C5 position
of cytosines catalysed by a family of DNA methyltransferases (Dnmt). All C5 cytosine
Dnmts share the same conserved motifs involved in the complex molecular mecha-
nism of methyl group transfer best studied in the prokaryotic DNA methyltransferases
M. HhaI (Klimasauskas et al., 1994). This mechanism involves DNA methyltransferase
binding to the DNA, flipping the target cytosine out of the DNA double helix, cova-
lent bond formation between a conserved cysteine nucleophile and the cytosine C6,
transfer of a methyl group from S-adenosyl-L-methionine to the activated cytosine C5
and DNA methyltransferase release by β -elimination (Klimasauskas et al., 1994; Cheng
and Blumenthal, 2008).
In vertebrates, there are five known members of the Dnmt family that differ in struc-
ture and function and apart from Dnmt2, all Dnmts comprise an N-terminal regulatory
domain in addition to the C-terminal catalytic domain (Figure 4)
I IV VI VIII IX X
BAH1 BAH2 TS
CXXC
PBD
1620
N-terminal regulatory region
391
Dnmt1
Dnmt2
PWWP PHD 912Dnmt3a
PWWP PHD 853Dnmt3b
PHD 386
I IVVI X
Dnmt3L
M.HhaI 327
I IVVI VIII IX X
IV VIII IX X
I IV VIII IX X
MET1
840BAH
Chromo
BAH TS  TS BAH
CMT3
1554
C-terminal catalytic domain
Figure 4: Schematic outline of DNA Methyltransferases
Schematic outline of the domain architecture of mammalian Dnmts and the A. thaliana Methyltrans-
ferase MET3 and Chromomethylase3 CMT3 in comparison to the prokaryotic DNA methyltransferases
M.HhaI. All DNA methyltransferases harbour highly conserved motifs (I-X) in the C-terminal catalytic do-
main but differ in their N-terminal regulatory domain. Figure is adapted from (Qin et al., 2011b).
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The Dnmt3 subfamily, comprising Dnmt3a and Dnmt3b, possesses activity towards un-
methylated DNA and establishes de novo DNA methylation patterns during gameto-
genesis and embryogenesis (Kaneda et al., 2004; Okano et al., 1999; 1998). The de
novo Dnmts are highly expressed in ESCs and down regulated in differentiated cells
(Watanabe et al., 2002; Esteller, 2007). The Dnmt3 family contains a third member
Dnmt3L, which is required for establishing maternal genomic imprinting (Bourc’his et
al., 2001). The cofactor Dnmt3L (Aapola et al., 2000) specifically recognizes unmethy-
lated histone H3K4 (Ooi et al., 2007; Otani et al., 2009) stimulates the activity of Dnmt3a
and Dnmt3b (Suetake et al., 2004), but by itself lacks enzymatic activity (Hata et al.,
2002). Established DNA methylation patterns are maintained during DNA replication
and DNA repair by the ubiquitously expressed Dnmt1 (Leonhardt et al., 1992; Mor-
tusewicz et al., 2005), which displays a strong preference for hemimethylated CpG
sites, the substrate of maintenance DNA methylation (Bestor and Ingram, 1983). The
fifth member of the Dnmt family, Dnmt2, shows very weak activity toward DNA and
was instead shown to methylate cytoplasmic tRNAAsp (Goll et al., 2006; Hermann et
al., 2004).
Despite their common catalytic mechanism, all three active eukaryotic Dnmts have
distinct and non-redundant functions, which are likely mediated by their diverse regu-
latory domains (Figure 4). In contrast to prokaryotic Dnmts, the tissue-specific de novo
Dnmts, Dnmt3a and Dnmt3b, are only active on a subset of target CpG sites (Hsieh,
1999), reflecting a selective control imposed by the N-terminal regulatory domain. The
ubiquitously expressed Dnmt1 preferentially methylates hemimethylated CpG sites and
thereby maintains DNA methylation patterns after DNA replication and DNA repair
(Leonhardt et al., 1992; Mortusewicz et al., 2005; Bestor and Ingram, 1983). Remark-
ably, the catalytic domain of Dnmt1 -although possessing all conserved motifs- is not
catalytically active by itself and requires allosteric activation by the N-terminal regula-
tory domain (Margot et al., 2000; Zimmermann et al., 1997; Fatemi et al., 2001).
However, none of the three catalytically active Dnmts shows a particular target prefer-
ence that could explain cell-type-specific methylation patterns, suggesting that alter-
native mechanism must be in place to either direct or inhibit their recruitment (Meiss-
ner, 2011). A recent study investigated the role of the underlying genome sequence in
guiding DNA methylation (Lienert et al., 2011). Small methylation-determining regions
(MDRs) within gene promoters were identified which mediate both hypomethylation
and de novo methylation in cis, and their activity depends on developmental state,
motifs for DNA-binding factors and a critical CpG density (Lienert et al., 2011).
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1.2.1 Structure and Function Dnmt1
Bioinformatics suggested that the mammalian Dnmt1 evolved by fusion of at least
three ancestral genes (Margot et al., 2000). The N-terminal regulatory domain of
Dnmt1 occupies 2/3 of the whole enzyme and harbours several functional distinct do-
mains. It harbours a proliferating cell nuclear antigen (PCNA) binding domain (PBD),
a targeting sequence (TS domain), a zinc finger domain (CXXC) and two bromo-
adjacent homology domains (BAH1/2) and is connected to the C-terminal catalytic
domain by seven lysyl-glycyl dipeptide repeats (Goll and Bestor, 2005; Rottach et al.,
2009). The PBD domain has been shown to mediate the interaction with PCNA leading
to the association of Dnmt1 with the replication machinery (Leonhardt et al., 1992;
Chuang et al., 1997; Easwaran et al., 2004). The TS domain mediates association
with heterochromatin and may lead to dimerization of Dnmt1 (Leonhardt et al., 1992;
Easwaran et al., 2004; Fellinger et al., 2009). Recently, it has been shown that mutations
in DNMT1 cause both central and peripheral neurodegeneration in one form of hered-
itary sensory and autonomic neuropathy with dementia and hearing loss (Klein et al.,
2011). Exome sequencing revealed two mutations within the TS domain that cause
premature degradation of mutant proteins, reduced methyltransferase activity and
impaired heterochromatin binding during the G2 cell cycle phase leading to global
hypomethylation and site-specific hypermethylation (Klein et al., 2011). The CXXC do-
main of Dnmt1 binds to unmethylated DNA but its deletion does not alter the activity
and specificity of Dnmt1 (Frauer et al., 2011). Interestingly, the isolated C-terminal cat-
alytic domain of Dnmt1, although harbouring all conserved Dnmt motifs, requires an
additional, large part of the N-terminal domain for enzymatic activity. Fusion of this
N-terminal region of Dnmt1 to the prokaryotic Dnmt, M.HhaI, induced a preference
for hemimethylated DNA (Pradhan and Roberts, 2000). Cleavage between the reg-
ulatory and the catalytic domain stimulated the initial velocity of methylation of un-
methylated DNA without substantial change in the rate of methylation of hemimethy-
lated DNA (Bestor, 1992). These findings illustrate the role of the N-terminal domain in
the selective activation of the catalytic domain to ensure faithful maintenance of DNA
methylation patterns.
First insights into the molecular mechanism of Dnmt1 regulation were provided by
two recently published crystal structures comprising either a large fragment of mouse
Dnmt1 (aa 291-1620) (PDB ID code 3AV4) or a shorter fragment (aa 650-1,602) in com-
plex with unmethylated DNA (PDB ID code 3PT6) (Takeshita et al., 2011; Song et al.,
2011b). Notably, the overall structure of the eukaryotic catalytic domain is highly similar
to the prokaryotic M.HhaI (PDB ID code 5mht) (Figure 5). In addition, both structures
showed an interaction of the N-terminal regulatory domain with the C-terminal cat-
alytic domain, which is consistent with prior genetic and biochemical studies (Fatemi
14
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et al., 2001; Margot et al., 2003). Remarkably, the TS domain was found deeply inserted
into the catalytic pocket and would in this conformation prevent Dnmt1 binding to
hemimethylated DNA, the substrate for maintenance DNA methylation (Takeshita et
al., 2011).
Figure 5: Structural insights into the DNA methyltransferases 1
Left: Crystal structure of the prokaryotic cytosine- (C5) methyltransferases M.HhaI in complex with
hemimethylated DNA (PDB code 5MHT). Right: Crystal structure of the large fragment (291‚Äì1620) of
mouse Dnmt1 (PDB code 3AV4) in superimposition with the prokaryotic structure (left) showing the ex-
pected steric clash between the TS domain and DNA binding in the catalytic pocket. The single domains
are color-coded: TS domain: black; Catalytic domain: green; BAH1: orange; BAH2: red; CXXC domain:
blue. Figure is adapted from (Qin et al., 2011b).
These structural insights indicate that Dnmt1 most likely undergoes several conforma-
tional changes during the methylation reaction. Activation of Dnmt1 requires displace-
ment of the TS domain from the DNA binding pocket to allow substrate binding. In-
deed, deletion of the TS domain lowered the activation energy (O’Gara et al., 1996)
and addition of purified TS domains inhibited Dnmt1 methylation activity in vitro (Syeda
et al., 2011), clearly pointing to an auto-inhibitory function of the TS domain. These find-
ings suggest that interacting proteins may modulate the interactions of the N-terminal
15
INTRODUCTION
domain with the catalytic domain and thereby regulate the activity of Dnmt1 in vivo.
1.2.2 Regulation of Dnmt1 by Interactions
Over the last two decades, a large variety of proteins were reported to interact with
Dnmt1, ranging from DNA methyltransferases, DNA binding proteins, chromatin mod-
ifiers and chromatin binding proteins to tumor suppressors, cell-cycle regulators and
transcriptional regulators. Notably, many of these proteins also interact with each
other, leading to a complex epigenetic network (Figure 6).
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Figure 6: Interactom of Dnmt1.
Protein-Protein interactions were drawn in Cytoscape (Edge Weighted Spring Embedded Layout) and
the proteins were grouped into the following functional classes: Light green: DNA methyltransferases;
Blue: DNA binding proteins; Red: Chromatin modifiers; Yellow: Chromatin binding proteins; Green Yellow:
Tumor suppressors; Blue: cell-cycle regulators; Dark green: Transcriptional regulators; Grey: Others
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As mentioned before, Dnmt1 interacts with PCNA via its PBD domain and thereby lo-
cates to site of DNA replication during S phase. The transient association of Dnmt1
with PCNA (Chuang et al., 1997) could be an efficient mechanism to bridge the dis-
crepancy between the high processivity of DNA replication (~0.035 seconds per nu-
cleotide) (Jackson and Pombo, 1998) and the low turnover rates (70-450 seconds per
methyl group) of recombinant Dnmt1 (Pradhan et al., 1999). Importantly, although be-
ing very transient and not strictly required for maintaining DNA methylation in vivo, the
binding of Dnmt1 to PCNA enhances the methylation activity about twofold (Scher-
melleh et al., 2007; Spada et al., 2007). The reason for the enhancement of activity
is still unclear and may result either from local enrichment of Dnmt1 concentration at
the site of replication or from conformational changes induced by the Dnmt1-PNCA
interaction and thus allosteric activation.
Although Dnmt1 can bind hemimethylated CpG sites by itself, it also interacts with
methyl-CpG binding proteins like MeCP2 (Kimura and Shiota, 2003), Mbd2/3/4 (Tatem-
atsu et al., 2000; Ruzov et al., 2009) and the Uhrf family of proteins (Bostick et al., 2007;
Sharif et al., 2007; Arita et al., 2008; Avvakumov et al., 2008; Qian et al., 2008; Achour
et al., 2009; Pichler et al., 2011; Meilinger et al., 2009). MeCP2 binds DNA, induces
chromatin compaction (Brero, 2005; Georgel et al., 2003) and interacts with Dnmt1
via its transcription repressor domain (TRD) (Kimura and Shiota, 2003). MeCP2 and
Mbd2, which specifically recognize fully methylated CpG sites and Mbd3 also form
complexes with histone deacetylases HDAC1 and HDAC2, which in turn interact with
Dnmt1 (Kimura and Shiota, 2003; Achour et al., 2007; Fuks et al., 2000; Robertson et al.,
2000; Rountree et al., 2000). This set of interactions can explain the correlation between
DNA hypermethylation and histone hypoacetylation at transcriptional inactive regions
(Eden et al., 1998), suggesting a role in transcriptional repression (Wade, 2001). This
complex may also comprise the Dnmt1 association protein (Dmap1) (Rountree et al.,
2000; Mohan et al., 2011) and the transcriptional co-regulator Daxx (Muromoto et al.,
2004) mediating repression in an HDAC-independent manner (Rountree et al., 2000;
Mohan et al., 2011). In addition, the interaction with methyl-CpG binding proteins and
HDACs may enrich Dnmt1 in highly methylated heterochromatic regions to increase lo-
cal methylation efficiency and/or enhance heterochromatin formation at these highly
methylated regions (Qin et al., 2011b). Dnmt1 also interacts with Mbd4, the only mem-
ber of the MBD family of proteins that does not appear to be involved in transcriptional
repression (Ruzov et al., 2009; Hendrich and Tweedie, 2003). Mbd4 directly interacts
with Dnmt1 and Mlh1, leading to recruitment of Mlh1 to heterochromatic sites (Ruzov
et al., 2009). Recently, Uhrf1 has emerged as an essential co-factor for maintenance
DNA methylation. The genetic ablation of uhrf1 in ESCs leads to genomic hypomethy-
lation similar to dnmt1-/- ESCs (Bostick et al., 2007; Sharif et al., 2007). In addition Uhrf1
as well as Dnmt1 interacts with the de novo Dnmts, Dnmt3a and Dnmt3b (Fatemi et
17
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al., 2002; Kim et al., 2002; Lehnertz et al., 2003; Meilinger et al., 2009; Rhee et al., 2002).
These results demonstrate a complex interplay between methyl-CpG binding proteins
and Dnmts in establishing genomic DNA methylation patterns.
Besides the interaction with methyl-CpG binding proteins, Dnmt1 also associates with
a number of proteins involved in the establishment and maintenance of heterochro-
matin structure. Dnmt1 interacts with the major eukaryotic histone methyltransferases
Suv39H1 (Fuks et al., 2003) and Ehmt2 (also known as G9a) (Estève et al., 2006; Kim et
al., 2009; Peters et al., 2003; Tachibana et al., 2002), which are essential for H3K9 methy-
lation (Lehnertz et al., 2003; Ikegami et al., 2007). Genetic ablation of ehmt2 (Dong et
al., 2008; Ikegami et al., 2007) and suv39h (Lehnertz et al., 2003) in mouse ESCs leads to
DNA hypomethylation at specific loci in genomic DNA and altered DNA methylation
of pericentric satellite repeats, respectively. Interestingly, also the H3K9me3 binding
heterochromatin protein HP1b was shown to interact with Dnmt1 (Fuks et al., 2003), but
localization of Dnmt1 at late replicating chromocenters seemed to be independent
of Suv39h1/2 and HP1b (Easwaran et al., 2004). In addition, Dnmt1 interacts with Poly-
comb group (PcG) proteins Ezh2 (Vire et al., 2006; Xu et al., 2011) and Eed (Vire et al.,
2006), which are subunits of the Prc2/Eed-Ezh2 complex that methylates H3K27. Ezh2
was shown to recruit Dnm1 to target genes and thereby mediate promoter methyla-
tion (Vire et al., 2006). A recent study showed that Dnmt1 inhibition decreased the
expression levels of PcG proteins and induced cellular senescence, providing a possi-
ble link between DNA methylation, maintenance of stem cell self-renewal and multi-
potency (So et al., 2011).
In addition to the histone modifying enzymes, also chromatin remodelling ATPases
like Lsh are required for maintaining DNA methylation in mammals. Lsh is related to
the SNF2 family of chromatin-remodelling ATPases and forms a complex with Dnmt1,
Dnmt3b and HDACs, suggesting a role in transcriptional repression (Jeddeloh et al.,
1999; Myant and Stancheva, 2008). Similarly, Baz2a (also known as Tip5), the large
subunit of the nucleolar remodelling complex (NoRC), forms a complex with Dnmt1,
Dnmt3s, HDACs and hSNF2H, mediating recruitment to rDNA (Zhou and Grummt, 2005).
One component of this complex, the chromatin remodelled hSNF2H, increases the
binding affinity of Dnmt1 to mononucleosomes (Robertson et al., 2004). The interac-
tion with these chromatin-remodelling factors may help Dnmt1 to access substrate sites
in heterochromatic regions. Besides indirect connections to transcriptional regulation,
also direct interactions of Dnmt1 with transcription regulators and factors have been
described. Cxxc1 (Cfp1), a component of the SetD1A/B methyltransferase complex,
binds to Dnmt1, and Cxxc1-deficient ESCs display reduced levels of global DNA methy-
lation (Butler et al., 2008). Moreover, Dnmt1 was shown to interact with the transcription
factors Sp1/3 (Estève et al., 2007) and Stat3 (Zhang et al., 2005). A Stat3-Dnmt1-HDAC1
complex binds to the promoter of shp1, encoding a negative regulator of cell sig-
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nalling, inducing cell transformation (Zhang et al., 2005). Also Nrip1, a co-repressor
for nuclear receptors, interacts with Dnmt1 and Dnmt3s in gene repression (Kiskinis et
al., 2007). Additional Dnmt1 interactions have been reported with various tumor sup-
pressor genes including Wt1 (Xu et al., 2011), Rb (Robertson et al., 2000; Pradhan and
Kim, 2002), p53 (Estève et al., 2005) and hNaa10p (Lee et al., 2010). The Wilms tumor
suppressor protein (Wt1) recruits Dnmt1 to the pax2 promoter resulting in DNA hyper-
methylation (Xu et al., 2011). The retinoblastoma (Rb) tumor suppressor gene product
associates with Dnmt1 and the transcription factor, E2f1, resulting in transcriptional re-
pression of E2f1- responsive promoters (Robertson et al., 2000). The interaction with p53
stimulates Dnmt1 activity, leading to hypermethylation (Estève et al., 2005). Finally, the
tumor suppressor, hNaa10p, recruits Dnmt1 to promoters of tumor suppressor genes
and increases the DNA binding affinity of Dnmt1 (Lee et al., 2010). Besides a role in nor-
mal gene regulation, connections with deregulated gene expression in cancer were
also reported. The leukemia-promoting PML-RAR fusion recruits Dnmt1 to target pro-
moters, inducing gene hypermethylation, an early step of carcinogenesis (Di Croce et
al., 2002).
1.2.3 Regulation of Dnmt1 by Post-translational Modifications
While most of the interacting factors regulate Dnmt1 activity by recruitment to spe-
cific DNA sequences and target genes, some of them have been described to mod-
ulate Dnmt1 activity by post-translational modifications (Figure 7). Recent publica-
tions have described several different post-translational modifications that influence
the stability, abundance and activity of Dnmt1. Dnmt1 was shown to undergo cell
cycle-dependent changes in acetylation and ubiquitination (Bronner, 2011; Du et al.,
2010; Qin et al., 2011a). On the one hand, Dnmt1 is acetylated by Kat5 subsequently
ubiquitinated by the E3 ubiquitin ligase, Uhrf1, marking Dnmt1 for proteolytic degrada-
tion. The abundance of Dnmt1 increases in early S phase and starts to decrease during
late S or G phase, a pattern which inversely correlates with the abundance of Kat5,
suggesting that Kat5-mediated Dnmt1 acetylation triggers Dnmt1 degradation (Du et
al., 2010). On the other hand, Dnmt1 is deubiquitinated by Usp7 (also known as Her-
pes virus-associated ubiquitin-specific protease HAUSP) and deacetylated by HDAC1,
protecting Dnmt1 from proteolytic degradation (Du et al., 2010; Qin et al., 2011a). The
interaction between Dnmt1 and Usp7 is disrupted during mid-late S phase, showing
that a physical interaction is required for the stabilization of Dnmt1. Furthermore, the
interaction of Uhrf1 and Dnmt1 increases during late S phase leading to destabilization
of Dnmt1 (Du et al., 2010)
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Figure 7: Regulation of Dnmt1 by post-translational modifications
Crosstalk between Dnmt1 and interacting proteins, leading to post-translational modifications of Dnmt1.
The following abbreviations are used: Ac = Acetylation; Ub = Ubiquitination; SUMO = Sumoylation; p =
Phosphorylation; Me = Methylation. The dotted line indicates a hypothetical dephosphorylation. Figure is
adapted from (Qin et al., 2011b).
In fact, the first post-translational modification to be described was the phosphoryla-
tion of Dnmt1 at Ser515 (DNMT1 Ser509) (Glickman et al., 1997), which was suggested
to modulate the interaction between the regulatory and catalytic domain (Goyal et
al., 2007). In addition, Dnmt1 is phosphorylated at Ser146 (in mice only) by the casein
kinase 1d/e, decreasing the DNA binding affinity (Sugiyama et al., 2010), and at sites in
the regulatory domain, which have yet to be mapped, by members of the PKC family
(Lavoie et al., 2011). Notably, it has been reported that the phosphorylation of Dnmt1
disrupts the Dnmt1/PCNA/Uhrf1 interaction, promoting global DNA hypomethylation in
human gliomas (Hervouet et al., 2010). Phosphorylation of Ser143 by Akt1 during early
and mid-S phase has been described to stabilize Dnmt1 (Estève et al., 2011). S143
phosphorylation in turn blocks methylation of the adjacent Lys142 by Setd7, which
marks Dnmt1 for proteolytic degradation during late S phase and G2 (Estève et al.,
2011; 2009) . Besides Lys142, Set7/9 can also methylate the Lys1096 residue of Dnmt1
(Lys1094 of DNMT1), which destabilizes the enzyme. The corresponding demethyla-
tion by Kdm1A (also known as lysine-specific demethylase Lsd1 and Aof2) in turn in-
creases the stability of Dnmt1 (Wang et al., 2009). Consistently, the genetic ablation
of kdm1a in ESCs led to a progressive loss of DNA methylation (Wang et al., 2009)
and caused cellular differentiation (Adamo et al., 2011). Finally, Dnmt1 is also sumoy-
lated by the ubiquitin-conjugating enzyme, Ubc9, leading to the increased catalytic
activity of Dnmt1 on genomic DNA in vitro (Lee and Muller, 2009). In summary, post-
translational modifications influence the abundance and activity of Dnmt1, and may
thus play a role during normal development and disease.
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1.3 The Uhrf Family of Proteins
As mentioned above, epigenetic memory of a cell involves DNA methylation, histone
modifications and nucleosome positioning (Figure 1). There is a tight link between
the histone code and DNA methylation, as modifications of histones contribute to the
establishment of DNA methylation patterns and vice versa (Bronner et al., 2010). Inter-
estingly, the family of Uhrf proteins has recently been identified to simultaneously read
both methylated DNA and the histone code.
1.3.1 Phylogenetic Tree of Evolution
Uhrf1 (Ubiquitin-like-containing PHD and RING finger domains protein 1) also known
as Np95 (nuclear protein of 95 kDa) or ICBP90 (inverted CCAAT box binding protein
of 90 kDa) has initially been identified using a monoclonal antibody against murine
thymic lymphoma, (Muto et al., 1995). The other member of the Uhrf family of pro-
teins, Uhrf2, has been identified in a yeast two-hybrid screen for interacting factors for
a novel PEST-containing nuclear protein (PCNP) (Mori et al., 2002). Uhrf1 and Uhrf2
are highly conserved in vertebrates ranging from humans to fish and are also found
in invertebrates like ants and bees similar to the phylogenetic occurrence of Dnmts
(Figure 8). Notably, the phylogenetic tree of the SRA superfamily (the SRA domain
is unique for Uhrf proteins) (Figure 8) does not show any Uhrf1 or Uhrf2 equivalent
in flies like Drosophila melanogaster, in worms like Caenorhabditis elegans or in the
Saccharomyces genome. Dnmts show a similar pattern of evolution in the phyloge-
netic tree since they are also absent in C. elegans and S. cerevisiae. Notably, the
Drosophila genome contains a single candidate DNA methyltransferases gene simi-
lar to Dnmt2 (Kunert et al., 2003) but no Dnmt1 or Dnmt3 equivalents. In contrast to D.
melanogaster, other related insects such as the honeybee have functional Uhrf, Dnmt1
and Dnmt3 homologues (Honeybee Genome Sequencing Consortium, 2006). In gen-
eral, the presence of Uhrf proteins correlates with DNA methylation. Although DNA
methylation is conserved in most eukaryotic groups, including many plants, animals,
and fungi, it has been lost from certain model organisms such as the mentioned bud-
ding yeast S. cerevisae, and C. elegans (Feng et al., 2010). The insect D. melanogaster
is reported to contain low levels of 5mC (Lyko et al., 2000) although mostly in the CpT
rather than in CpG context.
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Figure 8: Phylogenetic Tree of Life for Dnmts and Uhrf proteins
Tree of life (Letunic and Bork, 2007; 2011) annotated with Dnmts (Dnmt1, Dnmt2, Dnmt3a and Dnmt3b)
and the SRA superfamily. Note that the SRA domain is unique for Uhrf protein. Organism containing
Dnmts are coloured in green, organism containing the SRA superfamily in red and those having both are
coloured in yellow.
Recently, DNA methylation analyses revealed that the honeybee genome contains
very low levels of CHG or CHH methylation and only ~1 % CG methylation (Feng et
al., 2010). In addition to vertebrates, Uhrf and Dnmt homologues can also be found
in Ciona intestinalis, a primitive chordate that is distantly related to vertebrates (De-
hal et al., 2002). DNA methylation in C. intestinalis is nearly exclusively in CG context
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and increases sharply in the body of protein-coding genes (Feng et al., 2010). Taken
together, Uhrf homologues are mostly found in species with detectable DNA methyla-
tion and Dnmt homologues, suggesting a conserved role of UHRF proteins in eukaryotic
methylation.
1.3.2 Structure and Function of Uhrf Proteins
The Uhrf family of proteins, comprising the multi-domain proteins Uhrf1 and Uhrf1, har-
bour an ubiquitin-like domain (Ubl), a tandem Tudor domain, a plant homeo domain
(PHD), a SET-and-RING associated domain and a RING domain (Figure 9). In contrast,
the Uhrf1 homologues in Arabidopsis thaliana, VIM1-3, are lacking the Ubl domain and
carry a RING finger domain between the PHD and SRA domain (Bronner et al., 2007).
Ubl tandem Tudor PHD SRA RING
PDB: 1WY8 PDB: 3DB3 PDB: 3SOX PDB: 2ZOI PDB: 1Z6U
Figure 9: Multi-domain proteins Uhrf1 and Uhrf2
Schematic outline of the multi-domain architecture of Uhrf1 and Uhrf2. An N-terminal ubiquitin-like do-
main (Ubl; PDB code 1WY8) is followed by a tandem Tudor domain (TTD; PDB ID code 3DB3)), a plant
homeo domain (PHD; PDB ID code: 3SOCX), a SET and RING associated (SRA; PDB ID code: 2ZKE) do-
main and a C-terminal really interesting new gene (RING; PDB ID code: 1Z6U) domain. The figure is
adapted from (Hashimoto et al., 2009).
Studies revealed a co-localization of Uhrf1 with PCNA during S phase (Uemura et al.,
2000), indicating a function of Uhrf1 in cell cycle progression, DNA replication (Fujimori
et al., 1998) and DNA damage repair (Muto et al., 2002). The expression of Uhrf1 is
essential for entry from G1/G0 phase into S phase in NIH-3T3 cells (Bonapace, 2002),
but not in ESCs (Muto et al., 2002). Uhrf1 binds preferentially to histone H3 and displays
E3 ubiquitin ligase activity for histone H3 (Citterio et al., 2004). Moreover, Uhrf1 has
been shown to be involved in large scale reorganization of chromocenters (Papait et
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al., 2007). It has been shown to bind to methylated DNA (Unoki et al., 2004) and to
the methylated promoter of RB1 (Jeanblanc et al., 2005). In addition, Uhrf1 interacts
with Dnmt3a and Dnmt3b and with histone modifying enzymes like HDAC1, G9a and
Tip60 (Achour et al., 2009; Kim et al., 2009; Meilinger et al., 2009; Unoki et al., 2004).
Uhrf1 binds hemimethylated DNA via a SET and RING associated (SRA) domain and
likely targets Dnmt1 to its substrate of maintenance DNA methylation (Arita et al., 2008;
Avvakumov et al., 2008; Bostick et al., 2007; Hashimoto et al., 2008; Sharif et al., 2007;
Qian et al., 2008). In vertebrates, the SRA domain has only been observed in this family,
demonstrating its unique function for the Uhrf family. However, the SRA domain is also
present in histone methyltransferases in A. thaliana such as SUVH1 and SUVH2 (Bronner
et al., 2007) and has been shown to be involved in directing DNA methylation to tar-
get sequences (Naumann et al., 2005). The second member of the Uhrf family, Uhrf2,
harbours similar domains (Bronner et al., 2007). Until now, the only known function of
Uhrf2 is a role in intranuclear degradation of polyglutamine aggregates (Iwata et al.,
2009) and in cell cycle arrest (Mori et al., 2011).
Strikingly, genetic ablation of uhrf1 leads to remarkable genomic hypomethylation,
similar to the genetic ablation of dnmt1 in ESCs (Bostick et al., 2007; Sharif et al., 2007)
and uhrf1-/- null mice died in midgestation (Muto et al., 2002). Additional studies in
tissue cultures cells demonstrate that Uhrf1 depletion causes cell cycle arrest (Bona-
pace, 2002; Jenkins et al., 2005; Tien et al., 2011), hypersensitivity to DNA damage and
chemotherapeutic agents (Muto et al., 2002; Arima et al., 2004), or apoptosis (Abbady
et al., 2003; Tien et al., 2011). Moreover, zebra fish mutants in uhrf1, and also dnmt1,
have defects in lens development and maintenance and lens epithelial cells lacking
uhrf1 have altered gene expression and reduced proliferation (Tittle et al., 2011). Con-
versely, high levels of Uhrf1 are found in a number of human cancer cell lines (Mousli
et al., 2003; Jenkins et al., 2005) and primary tumours (Hopfner et al., 2000; Crnogorac-
Jurcevic et al., 2005). In some cells, overexpression of Uhrf1 increases cell-proliferation
(Hopfner et al., 2002; Jenkins et al., 2005). The loss of the UHRF2 gene was found at
statistically significant levels in diverse tumours in the Oncomine database and a re-
current micro deletion at 9p24 targeting UHRF2 was observed in small lung carcinoma
(Mori et al., 2011). In contrast to Uhrf1, overexpression of Uhrf2 induced an increase
in G1 phase cells, cell cycle regulation by Uhrf2 appears to be executed through the
mechanism regulating Cdk2 activity (Li et al., 2004).
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1.3.3 Regulation of Uhrf Proteins
Despite the emerging understanding how and where Uhrf proteins function, little is
known how they are regulated. Basically, Uhrf proteins can be regulated at the tran-
scriptional level and recent studies revealed regulation by post-translational modifica-
tions (reviewed in Qin et al., 2011b).
The dynamic expression pattern of uhrf1 mRNA during embryonic development (Sadler
et al., 2007; Tittle et al., 2011) points to transcriptional control as a regulatory mecha-
nism (Chu et al., 2011). Changes in uhrf1 mRNA (Sadler et al., 2007), protein (Bona-
pace, 2002; Arima et al., 2004; Kim et al., 2009) and localization (Uemura et al., 2000;
Miura et al., 2001; Kim et al., 2009) occur during different phases of the cell cycle. Also,
both mRNA and protein levels of Uhrf1 are downregulated in response to DNA dam-
age in human tumor cell lines controlled by p53/p21Cip1 (Arima et al., 2004). Notably,
in cancer cells the level of Uhrf1 does not change dramatically during the cell cycle
and the expression is continuously at a high level (Mousli et al., 2003; Arima et al., 2004;
Bronner et al., 2007). In addition to regulation by p53/p21Cip1, Uhrf1 expression is con-
trolled by cell cycle regulators such as the Rb/E2f complex (Abbady et al., 2003) and
the E1a transcription factor (Bonapace, 2002). As mentioned before, overexpression
of Uhrf1 increases cell-proliferation (Hopfner et al., 2002; Jenkins et al., 2005) and the
S and G2/M phase cell fractions of serum-starved lung fibroblasts (Jeanblanc et al.,
2005). Contrary to Uhrf1, overexpression of Uhrf2 induced an increase in G1 phase cells
and Uhrf2 is regulated by Cdk2 (Li et al., 2004), pointing to a role in G1/S transition.
Uhrf2 expression is growth dependent in normal fibroblasts, whereas in serum-starved
cancerous cells the expression is consistently high (Mori et al., 2002). Notably, Uhrf2 was
shown to interact with some cell cycle proteins including cyclins (A2, B1, D1 and E1),
p53 and Rb and ubiquitinates cyclins D1 and E1 (Mori et al., 2011).
In addition to the regulation on the transcription level, recent studies demonstrated the
regulation of Uhrf1 by post-translational modifications. Recently, the auto-ubiquitination
of Uhrf1 has been demonstrated (Qin et al., 2011a) that is most likely mediated by the
RING finder domain, which was also shown to ubiquitinate histone H3 (Citterio et al.,
2004). Moreover, Uhrf1 interacts with the deubiquitinase Usp7 (Qin et al., 2011a; Felle et
al., 2011). Usp7 was shown to interact and deubiquitinate Dnmt1, which leads to an in-
creased protein stability of Dnmt1 and protects it from proteolytic degradation (Qin et
al., 2011a; Du et al., 2010). In addition, Uhrf1 is phosphorylated in the region between
the SRA and RING domain by Cdk2. Uhrf1 phosphorylation is required for gastrulation
in zebra fish and phosphorylated Uhrf1 can be detected in human cancer cells and
in non-transformed zebra fish cells (Chu et al., 2011). So far, these post-translational
modifications have not been tested for Uhrf2.
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2 Aims of this work
The role of Dnmt1 in maintenance DNA methylation and its role in the epigenetic net-
work, controlling gene expression and genome stability during development, is well
established. In the last decades, many protein interactions and post-translational mod-
ifications of Dnmt1 have been reported. These data clearly demonstrate that Dnmt1,
and by extension also DNA methylation in general, are functionally linked with several
other epigenetic pathways and cellular processes. General themes of these interac-
tions and modifications include the activation, stabilization and recruitment of Dnmt1
at specific sites and heterochromatin regions. However, the molecular mechanisms
that ultimately control DNA methylation still remain elusive.
During this thesis, I focus on the Dnmt1-interacting proteins Uhrf1 and Uhrf2 and de-
velop methods to study the functional characteristics of these factors and their role in
maintaining DNA methylation. At first I aimed at elucidating the histone-tail peptide
binding specificities of Uhrf1, an essential co-factor for maintaining DNA methylation.
Uhrf1 interacts with Dnmt1 and harbours several functional domains including DNA
and putative histone binding domains. Although Uhrf1 has been reported to bind to
histones, nothing is known about its histone-tail peptide binding specificities. To ad-
dress this question, I developed an in vitro histone-tail peptide binding assay (Chapter
3.1) and I expanded the assay to 96-well micro plates (Chapter 3.2). This versatile high-
throughput assay allows for determining the in vitro binding specificities of GFP-fusion
proteins to histone-tail peptides, DNA substrates and RFP-fusions. Moreover, it allows for
measuring DNA binding specificity in dependence on histone binding and vice versa.
Using this assay, I measured the histone-tail binding specificities of Uhrf1 and identified
highly conserved amino acid residues responsible for its specificity (Chapter 3.3).
Interestingly, a second member of the Uhrf family, Uhrf2, harbours similar domains. How-
ever, until now, the only known function of Uhrf2 is a role in intranuclear degradation
of polyglutamine aggregates. To investigate the function of Uhrf2 in DNA methylation,
I tested the in vitro binding specificities of Uhrf2, various single domains, hybrids and
point mutants. Moreover, I tested the crosstalk between different repressive epige-
netic marks such as methylated DNA and H3K9me3 (Chapter 3.4).
For a comprehensive understanding of the regulation of DNA methylation it is neces-
sary to systematically quantify the interactions and modifications of Dnmt1, to eluci-
date their function at the molecular level and to integrate these data at the cellular
level. To quantify the interactions of Dnmt1 over the cell cycle, I used a combination of
SILAC and mass spectrometry. At the beginning of this project, I initially tested different
Dnmt1 binding proteins and optimized the synchronization protocol (Chapter 3.6).
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3 Results
3.1 Fluorescent protein specific Nanotraps to study protein-protein
interactions and histone tail peptide binding
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Summary 
Fluorescent proteins are widely used to study protein localization and protein dynamics in 
living cells. Additional information on peptide binding, DNA binding, enzymatic activity and 
complex formation can be obtained with various methods including chromatin 
immunoprecipitation (ChIP) and affinity purification. Here we describe two specific GFP- and 
RFP binding proteins based on antibody fragments derived from llama single chain 
antibodies. The binding proteins can be produced in bacteria and coupled to monovalent 
matrixes generating so called Nanotraps. Both Traps allow a fast and efficient (one-step) 
isolation of fluorescent fusion proteins and their interacting factors for biochemical analyses 
including mass spectroscopy and enzyme activity measurements. Here we provide protocols 
for precipitation of fluorescent fusion proteins from crude cell extracts to identify and map 
protein-protein interactions as well as specific histone tail peptide binding in an easy and 
reliable manner. 
 
 
Key words:  
green fluorescent protein (GFP), red fluorescent protein (RFP), immunoprecipitation, mass 
spectrometry, peptide binding, protein-interactions 
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Introduction 
Fluorescent proteins (FP) are widely used to study protein localization and dynamics in living 
cells (1, 2). The validation and interpretation of these data, however, require additional 
information on biochemical properties of the investigated fluorescent fusion proteins e.g. 
enzymatic activity, DNA binding and interaction with other cellular components. For these 
biochemical analyses proteins are mostly fused with a small epitope tag (e.g. Histidine-tag, c-
Myc, FLAG or hemaglutinin). Monomeric derivates of the green fluorescent protein (GFP) 
and the red fluorescent protein (RFP) are the most widely used labelling tags in cell biology 
but are rarely used for biochemical analyses although various mono- and polyclonal 
antibodies are available (3, 4) (Abcam, Cambridge, UK; Sigma, St. Louis, USA.; Roche, 
Mannheim, Germany, ChromoTek, Martinsried, Germany). 
We recently generated specific GFP- and RFP binding proteins (GFP-Trap, RFP-Trap) 
based on single domain antibodies derived from Lama alpaca (5). Those binding proteins are 
characterized by a small barrel shaped structure (~ 13 kDa, 2.5 nm X 4.5 nm) and very high 
stability (stable up to 70°C, functional in 2 M NaCl or 0.5% SDS). From detailed in vitro 
binding analysis we determined that one molecule of the GFP- or RFP-Trap binds one 
molecule GFP or RFP respectively in stable stoichiometric complexes. The dissociation 
constants (KD) of both binding molecules are in the sub-nanomolar range comparable to 
conventional antibodies. Our binding analysis showed that the GFP-Trap exclusively binds to 
wtGFP, eGFP and GFPS65T as well as to YFP and eYFP while no binding to red fluorescent 
proteins derived from DsRed was detectable. Those red fluorescent protein derivates 
including mRFP, mCherry or mOrange are recognized exclusively by the RFP-Trap without 
any crossreaction to GFP derivates.  
Here we demonstrate the application of both FP-Traps to investigate interacting factors as 
well as histone-tail peptide binding of fluorescent fusion proteins. For immunoprecipitations of 
FP fusion proteins we coupled the GFP- or RFP-binding proteins covalently to monovalent 
matrices (e.g. agarose beads or magnetic particles).  
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A direct comparison of the FP-Trap with conventional antibodies for immunoprecipitation of 
FP from crude cell lysates reveal that the FP-Traps allow a very fast (~ 5 – 30 min) depletion 
of fluorescent fusion proteins from tested samples, which cannot be achieved with 
conventional antibodies even after 12 h of incubation. Moreover, after precipitation with the 
FP-Traps only the antigen (FP) was detectable on a coomassie gel whereas the typical 
antibody fragments (light chain, 25 kDa; heavy chain, 50 kDa) could be detected in the 
bound fraction after precipitation with conventional mono- and polyclonal antibodies (5).  
The lack of unspecific binding or contaminating antibody fragments is one major advantage 
of the FP-Traps, because unspecific protein fragments in the bound fraction often interfere 
with subsequent mass spectrometry analysis of interacting complex partners. For the FP-
Traps we demonstrated that they are versatile tools to purify FP-fusions and their interacting 
factors for biochemical studies including mass spectrometry and enzyme activity assays (6-
9). Moreover, the FP-Traps are also suitable for chromatin immunoprecipitations (ChIPs) (5, 
10, 11) in cells expressing fluorescent DNA binding proteins. In conclusion the protocol 
below can be used to perform immunoprecipitation of fluorescent fusion proteins from crude 
cell extracts to identify and map protein-protein interactions as well as specific peptide 
binding in an easy and reliable manner.  
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2. Materials 
Prepare all solutions using ultrapure water (prepared by purifying deionized water to attain a 
resistance of 18 MΩ cm at 25°C) and analytical grade reagents. Prepare and store all 
reagents at room temperature (unless indicated otherwise). Ready to use buffers once 
prepared should be stored at 4°C. Diligently follow all applicable waste disposal regulations 
when disposing waste materials.  
 
2.1. Immunoprecipiation of FP 
Phosphate buffer saline (PBS): 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4, 
pH 7.4 
Cell Lysis Buffer: 10 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.5 mM EDTA, 0.5% Non-Ident 40 
(NP 40), 1 mM PMSF, Protease Inhibitor cocktail (e.g. provided by Roche, Mannheim, 
Germany).  
optional for nuclear proteins / chromatin proteins: DNaseI (f.c) 1 µg/ µl, 2.5 mM MgCl2 
RIPA Buffer: 10 mM Tris-HCl pH 7.5, 150 mM NaCl, 5 mM EDTA, 0.1 % SDS, 1% Triton X-
100, 1% Deoxycholate, 1 mM PMSF, Protease Inhibitor cocktail (e.g. provided by Roche, 
Mannheim, Germany) 
Dilution Buffer: 10 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.5 mM EDTA, 1 mM PMSF, 
Protease Inhibitor cocktail (e.g. provided by Roche, Mannheim, Germany) 
Wash Buffer 1: 10 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.5 mM EDTA, 1 mM PMSF, 
Protease Inhibitor cocktail (e.g. provided by Roche, Mannheim, Germany) 
Wash Buffer 2: 10 mM Tris-HCl pH 7.5, 0.5 M NaCl, 0.5 mM EDTA, 1 mM PMSF, Protease 
Inhibitor cocktail (e.g. provided by Roche, Mannheim, Germany) 
Elution Buffer: 0.2 M glycine-HCl pH 2.5 
Neutralization Buffer: 1 M Tris-base (pH 10.4) 
SDS-PAGE Sample Buffer (3x): 150 mM Tris-HCl pH 6.8, 300 mM DTT, 6% SDS, 0.3% 
Bromphenol blue, 30% Glycerol 
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Coomassie Solution: 50% Methanol, 40% H2O, 10% acetic acid, 0.25% Coomassie Blue R-
250 
 
FP-Trap 
gta-20 (agarose coupled), gtm-20 (magnetic particles) (ChromoTek, Martinsried, Germany) 
rta-20 (agarose coupled), rtm-20 (magnetic particles) (ChromoTek, Martinsried, Germany) 
Nanotraps based on specific binding proteins as provided by ChromoTek are most 
consistently effective; however, Nanotraps can be generated and used from other sources. 
 
2.2. Histone-tail peptide binding assay 
Dilution Buffer: 10 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.5 mM EDTA, 1 mM PMSF, 
Protease Inhibitor cocktail (e.g. provided by Roche, Mannheim, Germany) 
Wash Buffer 3: 10 mM Tris-HCl pH 7.5, 300 mM NaCl, 0.5 mM EDTA, 1 mM PMSF, 
Protease Inhibitor cocktail (e.g. provided by Roche, Mannheim, Germany) 
Histone-tail peptides 
All histone-tail peptides are C-terminal labeled with fluorescent carboxytetramethylrhodamine 
succininmidyl ester (TAMRA) or Biotin. Absorptions- and emission wavelengths of TAMRA 
are 544 nm and 570 nm, respectively. 
H3(1-20)K9me3-TAMRA, H3(1-20)K9me3-Biotin, H3(1-20)K9ac-Biotin were purchased from 
Peptide Specialty Laboratories (PSL, Heidelberg, Germany) 
Microplate 96-well (e.g. Greiner Bio-One GmbH, Frickenhausen, Germany) 
 
2.3. Evaluation of binding ratios 
Microplate reader (e.g. Tecan Infinite M1000 (TECAN, Männedorf, Switzerland) 
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3. Methods 
Carry out all procedures at 4°C unless otherwise specified. 
 
3.1. Immunoprecipitation of FP 
The following step by step immunoprecipitation protocol is based on about 1 x 107 cells 
(HEK293T or HeLa) transiently transfected with expression vectors coding for fluorescent 
fusion proteins of interest. The transfection efficiency should be in the range of 60-90% 
determined by fluorescence microscopy. 
1. Wash the cells 2 times with 5 mL of PBS on ice. Scrape cells off. Transfer cells to a tube 
and centrifuge at 800 g and 4°C for 3 min. 
2. Wash cells with 1 mL of PBS and centrifuge again (see Subheading 3.1., item 1). 
3. Resuspend cell pellet in 200 µL of Cell Lysis Buffer (see Note 1). 
4. For lysis incubate cells on ice for 30 min. Resuspend cells every 10 min by gently 
pipetting.  
5. Clear lysate by centrifugation at 20,000 g and 4°C for 10 min (see Note 2). 
6. Adjust volume to 500 µL with Dilution Buffer (see Note 3). 
7. Take an aliquot which corresponds to 5% to 10% of your diluted sample (referred to as 
input fraction (IP)) and add SDS-PAGE sample buffer. 
8. Add 20 µL to 40 µL of GFP-Trap or RFP-Trap (gta-20, gtm-20 or rta-20, rtm-20) and 
incubate for 10 min to 2 h at 4°C with constant mixing. Binding reaction can also be 
performed on a micro column (see notes 4 and 5). 
9. Harvest immunocomplexes bound to the monovalent matrix by centrifugation for 2 min at 
5,000 g and 4°C or magnetic separation using a specially designed rack (e.g. from 
Chemicell, Berlin, Germany). 
MANUSCRIPT IN PRINT
34
10. Collect an aliquot of the supernatant or flow through (referred to as non-bound fraction 
(NB)) and add SDS-PAGE sample buffer. 
11. Wash beads with 1 mL of Wash Buffer 1. 
12. Repeat washing step with 1 mL of Wash Buffer 2 (see Note 6). 
13. Resuspend beads in 50 to 100 µL of SDS-PAGE sample buffer (referred to as bound 
(B)). 
14. Elute proteins by boiling at 95°C for 10 min (see Note 7). 
15. For immunoblot analysis subject 1% of input and e.g. 20% of bound fractions to SDS-
PAGE. Transfer to a nitrocellulose or PVDF membrane. 
16. Detect precipitated GFP- or RFP-fusion proteins with an anti-GFP or anti-RFP antibody 
(e.g. from Roche, Mannheim, Germany, ChromoTek, Martinsried, Germany) and interacting 
proteins with the respective antibodies.  
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3.2. Histone-tail peptide binding assay 
The following step-by-step histone-tail peptide binding protocol for FP-fusions continues after 
the washing step of the immunoprecipitation with the FP-Traps (see Subheading 3.1, item 
11). 
 
1. Equilibrate beads with 1 ml of Dilution Buffer. 
2. Add TAMRA-labeled histone-tail peptide to a final concentration of 0.15 µM (see Note 8). 
3. Incubate for 15 min at room temperature with constant mixing (see Note 9). 
4. Harvest beads by centrifugation for 2 min at 5,000g and 4°C. 
5. Wash beads 2 times with 1 mL of Wash Buffer 3 (see Note 9). 
6. Resuspend beads in 100 µL of Dilution Buffer. 
7. Transfer beads in a 96-well plate. 
 
3.3. Evaluation of binding ratios 
For quantification, fluorescence intensity measurements are adjusted using standard curves 
from labelled probes with known concentrations. Fluorescence intensities (FI) were 
measured with a microplate reader Tecan Infinite M1000 (TECAN, Männedorf, Switzerland) 
(12). Following settings were used: 
• GFP: 490±10 nm and 511±10 nm 
• TAMRA: 560±5 nm and 586±5 nm 
 
1. Measure fluorescence intensities (see Note 10). 
2. Calculate GFP- and TAMRA concentration using standard curves (see Note 10). 
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3. Calculate relative binding ratio histone-tail peptide/protein. 
4. Notes 
1. The given example of buffer recipes can be modified according to the experimental needs. 
One can use different buffer recipes (e.g. phosphate buffered saline or HEPES) comprising 
higher salt concentrations or containing DNase I (AppliChem, Darmstadt, Germany) or 
MNase S7 (Roche, Mannheim, Germany) to release chromatin proteins or RIPA buffer to 
release chromatin or membrane bound fluorescent fusion proteins.  
2. The centrifugation step to clarify the lysate can be shortened up the 2 to 5 min for highly 
soluble proteins. Such proteins will be transferred to the supernatant after 2 to 5 min of 
centrifugation. 
3. If necessary the protein sample can be diluted in larger volumes. Accordingly, one should 
elongate the incubation time with the FP-Traps up to 12 h over night incubation at 4°C. 
Alternatively, one can increase the amount of GFP- or RFP-Trap in the pulldown reaction.  
4. In some case it was observed that N-terminal GFP-tagged proteins were better recognized 
as C-terminal tagged ones. If that is the case you can achieve a comparable efficiency with a 
prolonged incubation time. 
5. As an alternative to batch purification the pulldown reaction can be carried out on columns 
like micro columns (e.g. 1 mL column, MoBiTec GmbH, Göttingen, Germany). 
6. Depending on the nature of the protein complexes one can increase the salt concentration 
(e.g. up to 500 mM NaCl to get rid of unspecific binding). Alternatively if transient interactoms 
characterized by hydrophilic interactions have to be analyzed one can lower the salt 
concentration in the Wash Buffer 2. 
7. The interaction between the FP-Traps and the fluorescent epitope can be released by 
acidic elution. It is recommended to elute bound proteins by adding 100 µL of 0.2 M glycine-
HCL pH 2.5 for 1 min. Acidic eluate should be immediately neutralized by adding  
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5 to 10 µL of 1 M Tris-base (pH 10.4). 
8. As an alternative to TAMRA conjugates one can use every fluorescent label whose 
specific fluorescence characteristics do not interfere with GFP or RFP.  
9. Depending on the nature of the protein and the histone-tail peptide one can vary the 
incubation time, temperature and salt concentrations for washing. In this case best results 
were observed at room temperature for 15 min and washing with 300 mM NaCl. 
10. Calibration curves for the fluorescent DNA substrates and proteins were determined by 
measuring the fluorescence signal of known concentrations of the TAMRA-coupled histone-
tail peptides and purified GFP and calculated by linear regression. 
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Figure legends 
 
	  
Figure 1 Immunoprecipiation of fluorescent fusion proteins (FP). (A) Schematic drawing of 
Nanotrap derived from Camelidae antibody. (B) Immunoprecipation of GFP- or RFP-PCNA 
with the GFP- or RFP-Trap. 1% of input and 20% of bound fractions were subjected to a 
SDS PAGE and detected by coomassie staining. The molecular size of the proteins (kDa) is 
indicated.  
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Figure 2 Immunoblots after co-immunoprecipitations illustrate the interaction between GFP-
Dnmt1 and endogenous DNMT1, whereas precipitation of GFP alone was used as negative 
control. 1% of input and 30% of bound fractions were subjected to immunoblot analysis. The 
molecular size of the proteins (kDa) and the antibodies used are indicated. Mapping the 
Dnmt1 dimerization region to the TS domain of Dnmt1: Immunoblot after co-
immunoprecipitation showing that the N-terminal TS domain of Dnmt1 can co-precipitate 
endogenous DNMT1 (Data taken from Dimerization of DNA methyltransferase 1 is mediated 
by its regulatory domain, Fellinger et al., J. Cell. Biochem. Vol 106(4) p.521-28, Copyright 
2009© Wiley-Blackwell) 
 
 
  
Figure 3. Histone-tail binding properties of mouse Cbx1 (Drosophila HP1 beta). GFP-Cbx1 
was purified with the GFP-Trap and incubated with TAMRA-labeled H3(1-20)K9me3 histone-
tail peptide in competition with either biotinylated H3K9me3 or H3K9ac in different molar 
ratios. 
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Abstract
Fluorescent fusion proteins are widely used to study protein localization and interaction dynamics in living cells. However,
to fully characterize proteins and to understand their function it is crucial to determine biochemical characteristics such as
enzymatic activity and binding specificity. Here we demonstrate an easy, reliable and versatile medium/high-throughput
method to study biochemical and functional characteristics of fluorescent fusion proteins. Using a new system based on 96-
well micro plates comprising an immobilized GFP-binding protein (GFP-mulitTrap), we performed fast and efficient one-step
purification of different GFP- and YFP-fusion proteins from crude cell lysate. After immobilization we determined highly
reproducible binding ratios of cellular expressed GFP-fusion proteins to histone-tail peptides, DNA or selected RFP-fusion
proteins. In particular, we found Cbx1 preferentially binding to di-and trimethylated H3K9 that is abolished by
phosphorylation of the adjacent serine. DNA binding assays showed, that the MBD domain of MeCP2 discriminates between
fully methylated over unmethylated DNA and protein-protein interactions studies demonstrate, that the PBD domain of
Dnmt1 is essential for binding to PCNA. Moreover, using an ELISA-based approach, we detected endogenous PCNA and
histone H3 bound at GFP-fusions. In addition, we quantified the level of H3K4me2 on nucleosomes containing different
histone variants. In summary, we present an innovative medium/high-throughput approach to analyse binding specificities
of fluroescently labeled fusion proteins and to detect endogenous interacting factors in a fast and reliable manner in vitro.
Citation: Pichler G, Jack A, Wolf P, Hake SB (2012) Versatile Toolbox for High Throughput Biochemical and Functional Studies with Fluorescent Fusion
Proteins. PLoS ONE 7(5): e36967. doi:10.1371/journal.pone.0036967
Editor: Pierre-Antoine Defossez, Universite´ Paris-Diderot, France
Received January 12, 2012; Accepted April 10, 2012; Published May 11, 2012
Copyright:  2012 Pichler et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: GP was supported by the International Doctorate Program NanoBioTechnology (IDK-NBT, http://www.cens.de/doctorate-program/) and GP and AJ by
the International Max Planck Research School for Molecular and Cellular Life Sciences (IMPRS-LS, https://www.imprs-ls.de/). PW is a fellow of the Graduate School
Life Science Munich (LSM, http://www.lsm.bio.lmu.de/). SBH was supported by CIPSM (http://www.cipsm.de/en/index.html) and the DFG (http://www.dfg.de/
index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: pichler@bio.lmu.de
Introduction
Over the past decade a variety of proteomic approaches have
been used to identify cellular components in order to understand
the mechanism and inner workings of cells [1]. For example, mass
spectrometry-based proteomics uncovered the proteome of many
different organisms as well as cell-type specific differences in
protein expression. However, to understand and characterize the
function of single proteins, as well as the interplay between
different factors, it is essential to gain further insights into their
abundance, localization, dynamic interactions and substrate
specificities.
Fluorescent proteins like the green fluorescent proteins (GFP)
[2] and spectral variants have become popular tools to study the
localization and dynamic interactions of proteins in vivo. Despite,
the availability of a variety of commercial mono- and polyclonal
antibodies against GFP and other fluorescent proteins [3,4] (e.g.
Abcam, UK; Sigma, USA; Roche, Germany, ChromoTek,
Germany), proteins are mostly fused to a small epitope tag such
as FLAG or c-Myc to analyze biochemical characteristics like
enzymatic activities and/or binding specificities. Thus, integration
of such in vitro data with in vivo data obtained with fluorescently
labeled proteins has, in part, been impeded by the simple fact that
different protein tags are used for different applications. The gold
standard to examine binding affinities is surface plasmon
resonance (SPR) [5]. One drawback of this method is the need
of large amount of proteins. Such proteins have to be expressed
and purified from bacterial systems (e.g. E.coli) or lower eukaryotes
such as yeast (e.g. S. cerevisiae). Thus, the recombinant proteins lack
essential post-translational modifications or are not folded properly
possibly leading to different binding properties and inaccurate
results. In addition with SPR measurements one can only
determine the binding affinity to one substrate. This does not
reflect the in vivo situation where most proteins have the choice
between many different binding substrates in parallel.
Protein microarrays are an alternative to study protein-protein
interactions in high-throughput manner [6]. Once more the
drawback of this in vitro method is the laborative and time-
consuming preparation of recombinant proteins or protein
domains. Therefore protein microarrays are limited to domains
that can be produced as soluble, well-folded proteins [6].
Recently, specific GFP binding proteins based on single domain
antibodies derived from Lama alpaca have been described [7]
(GFP-Trap ChromoTek, Germany). The GFP-Trap exclusively
binds to wtGFP, eGFP and GFPS65T as well as to YFP and eYFP.
Coupling to matrices including agarose beads or magnetic
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particles the GFP-Trap allows for one-step purification of GFP-
fusion proteins. Previous studies made use of the GFP-Trap to
perform a broad range of different methods including mass
spectrometry analysis [8], DNA binding, DNA methyltransferase
activity assays [9], as-well-as histone-tail peptide binding assays
[10]. One mayor disadvantage of the GFP-Trap is, that batch
purification of GFP-fusions is very laborious and time-consuming
and one cannot test different GFP-fusion and/or assay conditions
in parallel. Here, we present an innovative and versatile high-
throughput method to quantitatively measure binding specificities
and to detect endogenous interacting factors in a fast and reliable
manner in vitro: 96-well micro plates coated with immobilized
GFP-Trap (GFP-multiTrap). To demonstrate the general suitabil-
ity of our assays, we choose already known binding partners and
compared our results with previous publications. Using this
method, we could confirm that Cbx1 preferentially binds to di-
and trimethylated histone H3 lysine 9 and that this binding is
abolished by phosphorylation of the adjacent serine 10 [11–13]. In
addition, we determined a 4-fold preference of the MBD domain
of MeCP2 for fully over unmethylated DNA in accordance to [14–
16]. Furthermore, we performed protein-protein interaction assays
and found that the Dnmt1 binds to PCNA in a PBD domain-
dependent manner consistent to [17,18]. In contrast, LigaseIII
binds Xrcc1 but does not interact with PCNA [19,20]. Using an
ELISA-based assay, we were able to detect endogenous PCNA
bound to immunoprecipiated Dnmt1, Fen1 and PCNA itself. In
accordance with our protein-protein interaction data, Dnmt1
lacking the PBD domain (Dnmt1DPBD) could not co-immuno-
precipate with PCNA. Consistent with our histone-tail peptide
binding data, we could detect endogenous histone H3 bound to
Cbx1. Finally, we quantified specific histone modifcations on
nucleosomes comprising different histone variants. All of these
data clearly demonstrate the versatility and easy handling of this
high-troughput approach and its immense benefit to many
researchers.
Results
One-step Purification of GFP-fusion Proteins
In a first step, we tested the efficiency of the GFP-multiTrap to
purify GFP-fusion proteins from cellular extracts. First, we
examined the pull-down efficiency of a GFP-tagged protein and
chose GFP-Cbx1 as a model protein. Cbx1 is a chromodomain-
containing protein related to the Drosophila HP1b, a well-studied
heterochromatin-associated protein [11]. We used cell extracts
from HEK293T cells transiently expressing GFP-Cbx1 or GFP,
purified the GFP-fusions using the GFP-multiTrap, eluted the
bound fractions, separated them by SDS-PAGE and visualized the
bound proteins by coomassie staining. The bound fractions
displayed mainly GFP as well as GFP-Cbx1 with only minor
impurities (Figure 1A), providing therefore a reliable tool for
downstream biochemical analyses. Notably, the washing condi-
tions can be varied according to the downstream applications. In
addition to these qualitative results, we performed experiments to
quantify the pull-down efficiency. For this purpose we quantified
the amount of bound GFP with varying concentrations of input
GFP from cellular extracts. After binding, the single wells were
subjected to several washing steps and bound GFP was analyzed
by fluorescent read-out using a micro plate reader. Notably, the
input amount of protein/substrate was measured in solution,
whereas the bound fraction represents one value on the 96-well
surface. We measured the fluorescence intensities of bound GFP
and plotted the amount of bound GFP as a function of total GFP
(Figure 1B). The amount of bound GFP increased linearly from 10
to 130 nM of total input and saturated between 130 and 400 nM.
Next, we quantified the amount of bound GFP by immunoblot-
ting. Therefore, we eluted the bound GFP fractions, separated
them by SDS-PAGE, visualized the bound proteins by immuno-
blot analysis (Figure 1C) and quantified the GFP signal by
measuring the mean intensity via Image J (Figure 1D). Similar to
the quantifcation by fluorescent read out using a micro plate
reader, the amount of bound GFP increases linearly from 10 to
130 nM of total input and saturates between 130 and 400 nM.
In summary, we demonstrated that the GFP-multiTrap allows
for fast and efficient one-step purification of GFP-fusion proteins
directly from crude cell lysates in a high-throughput manner. The
method works well for both qualitative and quantitative measure-
ments and the immunoprecipitated GFP-fusions can then be
further tested in biochemical assays.
In vitro Histone-tail Peptide and DNA Binding Assay
In the next assay we determined whether this approach is also
feasible to quantify binding affinities between GFP-proteins and
peptides or DNA. First, we analyzed histone-tail peptide binding
specificities of the chromobox homolog 1, Cbx1, fused with a N-
terminal GFP-tag using the GFP-multiTrap. GFP-Cbx1 was
purified from mammalian cell lysate, as described above, and the
bound protein was incubated with TAMRA-labeled histone-tail
peptides. A set of 20 different histone-tail peptides (Table 1) was
used in technical triplicates in parallel and GFP served as negative
control (GFP data is not shown). After removal of unbound
substrate the amounts of protein and histone-tail peptide were
determined by fluorescence intensity measurements using a micro
plate reader. Binding ratios were calculated by dividing the
concentration of bound histone-tail peptide by the concentration
of GFP fusion (Figure 2A). GFP-Cbx1 preferentially binds
H3K9me3 and H3K9me2 histone-tail peptides consistent with
previous studies [11,12]. As expected, the phosphorylation of
serine 10 (S10p) next to the trimethylated lysine 9 leads prevents
binding of Cbx1, which is in accordance with previous reports
[13]. In addition to fluorescent quantification via a micro plate
reader, we scanned the TAMRA signals using a Typhoon scanner
(Figure 2B). Here, we detected TAMRA signals in the wells
corresponding to di- and trimethylated H3K9. Notably, we did
not detect differences in binding towards di-and trimethylated
H3K9 using a micro plate reader. However, we could detect
a preference for tri- over dimethylated H3K9 using a fluorescence
scanner. These differences could result from different sensitivities
of both methods. Furthermore, we performed a competition assay
to demonstrate the specificity of the histone-tail peptide-binding
assay. We incubated GFP-Cbx1 with TAMRA-labeled H3K9me3
in parallel with either biotinylated H3K9me3 or H3K9ac histone-
tail peptides. As expected, the addition of biotinylated H3K9me3
histone-tail peptide significantly decreased the binding of Cbx1 to
TAMRA-labeled H3K9me3, whereas the addition of biotinylated
H3K9ac did not alter the binding ratios (Figure 2C). In previous
studies [11,12], the binding affinities of the HP1b chromo domain,
the Drosophila homolog of mammalian Cbx1, for both di- and
trimethylated H3K9 peptides have been found to be 7 and
2.5 mM, respectively. In contrast, we could not detect a significant
difference in binding ratios between di- and trimethylated H3K9
histone tail peptides using a micro plate reader (Figure 2A). One
explanation could be the use of different expression systems. While
the binding ratios for the HP1b chromo domain were determined
using bacterially expressed protein we used a fluorescent fusion
protein derived from mammalian cells. In this context a recent
study revealed that recombinant HP1a prepared from mammalian
cultured cells exhibited a stronger binding affinity for K9-
Versatile Toolbox for In vitro Studies
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methylated histone H3 (H3K9me) in comparison to protein
produced in Escherichia coli [21]. Biochemical analyses revealed that
HP1a was multiply phosphorylated at N-terminal serine residues
(S11–14) in human and mouse cells and that this phosphorylation
enhanced the affinity of HP1a for H3K9me, displaying the
importance of post-translational modifications for binding affinities
[21]. To determine the binding affinity of GFP-Cbx1 to
H3K9me3, we varied the input amount of histone-tail peptide.
We plotted the amount of bound histone-tail peptide as a function
of total peptide and fitted the values using GraphPad Prism and
nonlinear regression (Figure 2D). The amount of bound
H3K9me3 histone-tail peptide increases linearly and saturates at
approximately 500 nM of input peptide. In contrast to H3K9me3,
we could not detect any binding of Cbx1 to H3 histone-tail
peptides. Notably, the exact determination of binding affinities was
not possible due to differences in the technical measurement of
input versus bound fractions. Here, the input amount of protein/
substrate was measured in solution, whereas the bound fraction
represents one value on the 96-well surface.
In addition to histone-tail peptide binding assays, we performed
DNA-binding assays. We purified the methyl-binding domain
(MBD) of MeCP2, fused with a C-terminal YFP tag, from cell
extracts as described and performed competition binding analysis
by incubating immobilized MBD-YFP with fluorescently labeled
un- and fully methylated DNA (Table 1). As a result we observed
a five-fold preference of MBD for fully methylated DNA over
unmethylated DNA (Figure 2E). In addition, we measured the
amount of bound DNA to MBD-YFP by varying the input amount
of DNA. We plotted the amount of bound un- and fully
methylated DNA as a function of total un-and fully methylated
DNA and fitted the values using GraphPad Prism and nonlinear
regression (Figure 2F). Similar to the relative binding ratios, MBD
binds preferentially to fully methylated DNA. These results are in
accordance with previous studies describing that MeCP2 interacts
specifically with methylated DNA mediated by the MBD domain.
In these studies, electrophoretic mobility shift assays (EMSA) using
the isolated MBD domain expressed in E. coli were performed and
dissociation constants of 14,7 and 1000 nM were calculated for
symmetrically methylated and unmethylated DNA, respectively
[14–16].
To assess the suitability of the in vitro histone-tail peptide and
DNA binding assay for high-throughput applications, the Z-factor
was calculated. For histone-tail peptide binding assays, we
calculated the Z-factor using the relative binding ratios of
H3K9me3 to GFP-Cbx1 as positive state and of H3K9me0 to
GFP-Cbx1 as negative state. For the DNA binding assay, we
calculated the Z-factor using the relative binding ratios of fully
methylated DNA to MBD-YFP as positive state and of
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Figure 1. One-step purification of GFP and GFP-fusion proteins. Purification of GFP and GFP-Cbx1 expressed in HEK293T cells. All GFP
concentrations were quantified via plate reader. (A) Purification of GFP and GFP-Cbx1 from HEK293T cell extracts, transciently transfected with the
GFP-fusions. Input (I), flow-through (FT) and bound (B) fractions were separated by SDS-PAGE and visualized by coomassie staining. (B) Different
amounts of GFP cell lysate were added into wells of a 96-well plate immobilized with the GFP-Trap (GFP-multiTrap).Shown are means6 SD from two
independent experiments. (C) Bound GFP fractions from both independent experiments (B) were eluted, seperated by SDS-PAGE and visualized by
immunoblot analysis using an anti-GFP mouse antibody (Roche, Germany). (D) Quantification of bound GFP fractions by immunoblotting. The mean
intensities of the GFP signals were measured using Image J.
doi:10.1371/journal.pone.0036967.g001
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unmethylated DNA to MBD-YFP as negative state (Table 2). The
Z-factors of 0.766 for the histone-tail peptide binding assay and
0.756 for the DNA binding assay strongly indicate that both assays
are robust, reproducible and suitable for high-throughput applica-
tions.
In vitro Protein-protein Binding Assay
In addition to the detection of substrate specificity (e.g. histone-
tail peptide) and DNA binding, analysis of the interaction with
other cellular components and factors is essential to understand
the function of proteins.
The use of fluorescence intensity read-out systems for the
quantification of protein-protein interactions in vitro provides a new
Table 1. Sequences of DNA oligonucleotides and histone-tail peptides.
DNA oligos
DNA substrate DNA sequence DNA labeling
CG-up 59- CTCAACAACTAACTACCATCCGGACCAGAAGAGTCATCATGG -39 No
MG-up 59- CTCAACAACTAACTACCATCMGGACCAGAAGAGTCATCATGG -39 No
um550 59- CCATGATGACTCTTCTGGTCCGGATGGTAGTTAGTTGTTGAG -39 ATTO550 at 59end
um700 59- CCATGATGACTCTTCTGGTCCGGATGGTAGTTAGTTGTTGAG -39 ATTO700 at 59end
mC700 59- CCATGATGACTCTTCTGGTCMGGATGGTAGTTAGTTGTTGAG -39 ATTO700 at 59end
DNA substrates
DNA substrate CpG site Label Oligo I Oligo II
UMB-550 unmethylated 550 CG-up um550
UMB-700 unmethylated 700 CG-up um700
FMB-700 Fully methylated 700 MG-up mC700
DNA sets
Binding set Control set
UMB-550 UMB-550
FMB-700 UMB-700
Histone-tail peptides
H3 (1–20) ART K QTARKSTGGKAPRKQLK TAMRA at C-terminus
H3K4me1 ART X1 QTARKSTGGKAPRKQLK
H3K4me2 ART X2 QTARKSTGGKAPRKQLK
H3K4me3 ART X3 QTARKSTGGKAPRKQLK
H3K4ac ART Z QTARKSTGGKAPRKQLK
H3K9me1 ARTKQTAR X1 S TGGKAPRKQLK
H3K9me2 ARTKQTAR X2 S TGGKAPRKQLK
H3K9me3 ARTKQTAR X3 S TGGKAPRKQLK
H3K9me3S10p ARTKQTAR X3 Z2 TGGKAPRKQLK
H3K9ac ARTKQTAR Z S TGGKAPRKQLK
H3 (17–36) RKQLATKAAR K SAPATGGVK TAMRA at N-terminus
H3K27me1 RKQLATKAAR X1 SAPATGGVK
H3K27me2 RKQLATKAAR X2 SAPATGGVK
H3K27me3 RKQLATKAAR X3 SAPATGGVK
H3K27ac RKQLATKAAR Z SAPATGGVK
H4 (10–29) LGKGGAKRHR K VLRDNIQGI
H4K20me1 LGKGGAKRHR X1 VLRDNIQGI
H4K20me2 LGKGGAKRHR X2 VLRDNIQGI
H4K20me3 LGKGGAKRHR X3 VLRDNIQGI
H4K20ac LGKGGAKRHR Z VLRDNIQGI
X1: monomethylated Lysine; X2: dimethylated Lysine; X3: trimethylated Lysine; Z: acetylated Lysine; Z2: phosphorylated Serine.
doi:10.1371/journal.pone.0036967.t001
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the binding ratios is indicated; **P,0.003. (D) Different amounts of TAMRA-labeled H3K9me3 and H3 histone-tail peptides were added to GFP-Cbx1.
Three or two independent experiments for H3K9me3 or H3 histone-tail peptides were performed, respectively. Shown are means 6 SD and the
amount of bound histone-tail peptide was plotted as a function of total histone-tail peptide. The curve was fitted using GraphPad Prism and
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and simple method avoiding laborious and inaccurate protein
detection using conventional immunoblotting systems.
To address the question if such interaction analysis can be
performed in a multi-well format we analyzed the interaction of
single GFP-fusions with RFP-fusion proteins expressed in mam-
malian cells. More precisely, we determined quantitative binding
ratios between nuclear located proteins involved in DNA-
replication (PCNA) [17,18], DNA-methylation (Dnmt1) [22] as
well as in DNA-repair (Xrcc1) [23]. As described, we immobilized
GFP-fusions on the GFP-multiTrap and incubated them with cell
lysate containing RFP-fusion proteins. After binding, we removed
unbound material, measured the concentrations of RFP and GFP
and calculated the molar binding ratios. Firstly, we determined the
binding ratios of the green fluorescent PCNA-binding domain of
Dnmt1 (GFP-PBD) to RFP-PCNA and used Dnmt1DPBD as
a negative control. By measuring the fluorescent signal intensities
we detected that RFP-PCNA binds to GFP-PBD in a molar ratio
of 1.4260.31 but not to Dnmt1DPBD (Figure 3A).
For a direct comparison we eluted the bound fractions,
separated them by SDS-PAGE and visualized the proteins by
immunoblotting (Figure 3B). Both, GFP-PBD and RFP-PCNA are
detected in the input and bound fractions whereas RFP is not
visible in the bound fraction of GFP-PBD (Figure 3B).
In addition, we measured the amount of bound RFP-fusion to
GFP-PBD with varying the input amount of RFP-fusion. We
plotted the amount of bound RFP-fusion as a function of total
RFP-fusion and fitted the values using GraphPad Prism and
nonlinear regression (Figure 3C). Similar to the relative binding
ratios, GFP-PBD binds to RFP-PCNA but not to RFP.
These results are in accordance with previous findings that
Dnmt1 associates with the replication machinery by directly
binding to PCNA, a homotrimeric ring which serves as loading
platform for replication factors, and that this binding depends on
the PCNA-binding domain in the very N-terminus of Dnmt1
[17,18]. In addition by determining the quantitative binding ratio
between both partner proteins our approach provides a more
detailed insight in the binding events occurring at the central
loading platform of the DNA replication.
Secondly, we determined the molar binding ratio of GFP-Ligase
III to RFP-Xrcc1. Xrcc1 binds in a molar ratio of 0.6160.14 to
Ligase III but did not bind to other proteins such as GFP-PBD,
GFP-Dnmt1DPBD or GFP. Previous studies demonstrated that
DNA Ligase III was recruited to DNA repair sites via its BRCT
domain mediated interaction with Xrcc1 [19,20].
For the protein-protein binding assays, we calculated the Z-
factor using the molar binding ratios of RFP-PCNA to GFP-PBD
as positive state and RFP to GFP-PBD as negative state (Table 2).
The Z-factor of 0.56 indicated that the protein-protein binding
assay is robust and reproducible.
In summary, we demonstrate a new quantitative and reliable
high-throughput method to analyze protein-protein interactions
using GFP- and RFP-fusion proteins.
Enzyme-linked Immunosorbent Assay (ELISA)
Next we examined endogenous protein-protein interactions
using an ELISA assay. For this purpose, we precipitated GFP-
fusion proteins in the 96 well format on the GFP-multiTrap and
cross-linked bound fractions with formaldehyde (CH2O) and/or
treated the bound fractions with methanol (MeOH). Using specific
antibodies against PCNA, we determined the binding of endog-
enous PCNA to GFP fusions of Dnmt1, Dnmt1DPBD, PCNA,
Fen1, which is a flap endonuclease and an essential DNA
replication protein [24]. We could detect endogenous PCNA
binding to Dnmt1 but not to Dnmt1DPBD similar to the results
obtained with the protein-protein interaction assay using RFP-
PCNA (Figure 4A). In addition, we detected binding of
endogenous PCNA to Fen1 but also to PCNA itself. These results
fit well to former studies showing that Fen1 or maturation factor 1
associates with PCNA in a stoichiometric complex of three Fen1
molecules per PCNA trimer [25,26]. In addition to 100 described
interacting partners, it is known that PCNA also interacts with
itself and forms a trimeric ring, which is confirmed by our ELISA
assay by giving a signal for endogenous PCNA binding to GFP-
PCNA (Figure 4A).
Next, we determined the binding of Cbx1 to endogenous
histone H3. Similar to PCNA, we precipitated GFP-Cbx1 and
GFP and detected endogenous H3 via an H3-antibody coupled to
HRP. In accordance with the experiments using TAMRA labeled
histone 3 peptides, we observed an H3 ELISA signal for binding to
Cbx1 but not to GFP. Using an H3K9me3-specific antibody, we
could not detect an ELISA signal (data not shown), due to the fact
that the tight binding of Cbx1 (Figure 2) to H3K9me3 most likely
nonlinear regression. All input and bound fractions were quantified via a plate reader. (E) DNA binding specificities of the MBD domain of MeCP2 to
un- and fully methylated DNA in direct competition. Shown are means 6 SD from three independent experiments. (F) Different amounts of Atto550-
labeled unmethylated and Atto700-labeled fully methylated DNA in direct competition were added to purified MBD-YFP. Shown are means 6 SD
from three independent experiments. The amount of bound DNA peptide was plotted as a function of total DNA. The curve was fitted using
GraphPad Prism and nonlinear regression. All input and bound fractions were quantified via a plate reader.
doi:10.1371/journal.pone.0036967.g002
Table 2. Overview of relative binding ratios and Z-factor values.
Relative binding ratios of Substrate/GFP- or YFP-fusion
Histone-tail peptide binding DNA binding Protein-protein binding
Fusion protein GFP-Cbx1 MBD-YFP GFP-PBD
Substrate H3K9me3 H3K9un Fully methylated DNA Unmethylated DNA RFP-PCNA RFP
Average ratio 0,5715 0,0772 0,0912 0,0223 1,487 0,005
Standard deviation 0,0150 0,0236 0.0037 0.0019 0,2111 0,006
Z-factor 0,766 0.756 0.560
Based on the average relative binding ratios and the standard deviations we calculated the Z-factor.
doi:10.1371/journal.pone.0036967.t002
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occludes the antibody epitope, as has been proposed for HP1
binding to H3K9me3. In this study, the histone H3 trimethyl-
lysine epitope is embedded in an aromatic cage blocking thereby
most likely the binding of any antibodies [27]. To further analyze
the bound fractions, we eluted GFP-Cbx1 and GFP, separated
them on an SDS-PAGE gel and visualized GFP and H3 by
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immunoblotting. Histone H3 was detectable in the input fractions
of both GFP and GFP-Cbx1 but as expected, only in the bound
fraction of GFP-Cbx1.
Comparative Analysis of Posttranslational Histone
Modifications
Histone posttranslational modifications play an important role
in the structural organization of chromatin and often correlate to
transcriptional activation or repression depending on their type
and location. Recently, it has been shown that nucleosomal
incorporation of histone variants can lead to alterations in
modification patterning and that such changes may complement
the properties brought by the variant itself [28].
In order to investigate the suitability of the GFP-multiTrap in
comparing such histone posttranslational modifications, we
isolated nucleosomes from HeLa cells expressing either GFP-
H2A or GFP-H2A.Z and precipitated them with the 96 well micro
plate. GFP levels were then recorded (data not shown) to ensure
equal loading of substrate per well. In addition, as a negative
control, the cytoplasmic supernatant fraction was also incubated
with the GFP-multiTrap. An ELISA approach was then used to
quantify differences in histone H3K4me2 levels between the two
different nucleosome compositions. Following cross-linking and
permeablization, bound nucleosomes were incubated with either
anti-H3, directly conjugated to HRP or anti-H3K4me2 (both
antibodies Abcam, UK). Histone H3K4me2 levels were then
normalized to the histone H3 signal. In accordance with published
data, H2A containing nucleosomes were depleted in H3K4me2
where as those containing H2A.Z showed a large enrichment for
this modification (Figure 5) [28].
Discussion
One challenge of the proteomic era is the effective integration of
proteomic, cell biological and biochemical data. Ideally, proteomic
data on tissue and cell cycle-specific expression of specific proteins
should be combined with subcellular localization and binding
dynamics of fluorescent proteins. Additionally, it is crucial to
determine cell biological and biochemical characteristics such as
interacting factors, enzymatic activity and substrate binding
specificities. The integration of all these different data has, in
part, been impeded by the simple fact that different protein tags
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are used for different applications. Here, we present a new
versatile, high-throughput method to determine in vitro binding
specificities and to detect endogenous interacting factors of GFP-
fusion proteins. We use 96-well micro plates with immobilized
GFP-Trap (GFP-multiTrap) for fast and efficient purification of
GFP-fusion proteins. We demonstrate the efficiency and purity of
the GFP immunoprecipitation (Figure 1), a prerequisite to obtain
reliable biochemical data on e.g. binding specificities. Moreover,
we measured histone-tail binding, DNA and protein-protein
binding ratios underlying the versatility of our approach (Figure 2
and 3 and Table 2). The suitability of the demonstrated assays for
high-throughput biochemical and functional studies was assessed
by calculating the Z-factors (Table 2). Therefore, our assay is
suitable to examine an initial high-throughput screening for
potential binding partners. Moreover, the assay can be used for
compound screening. Additionally, our method allows for de-
tection of endogenous interaction factors based on an ELISA assay
(Figure 4 and 5).
In contrast to other high-throughput techniques like conven-
tional microarrays, it does not require time-consuming recombi-
nant protein expression and purification but allows for the direct
biochemical analyses of GFP-fusion proteins expressed in mam-
malian cells. The versatile GFP-multiTrap combined with the
widespread use of fluorescent fusion proteins now enables a fast
and direct quantitative correlation of microscopic data concerning
the subcellular localization and mobility of fluorescent fusion
proteins with their enzymatic activity, interacting factors, and
DNA binding properties combining cell biology and biochemistry
with mutual benefits.
Materials and Methods
Expression Constructs, Cell Culture and Transfection
Mammalian expression constructs encoding GFP-Dnmt1, GFP-
Dnmt1DPBD, GFP-PBD, GFP-PCNA, RFP-PCNA, GFP-Ligase
III, mRFP, GFP, MBD-YFP, GFP-Fen1 and RFP-Xrcc1 were
described previously [7,20,29–37]. Note that all constructs encode
fusion proteins of GFP, RFP or yellow fluorescent protein (YFP).
The Cbx1 expression construct was derived by PCR from mouse
cDNA, cloned into pEGFP-C1 (Clontech, USA) and verified by
DNA sequencing. Throughout this study enhanced GFP (eGFP)
constructs were used and for simplicity referred to as GFP-fusions.
HEK293T cells [30] and HeLa Kyoto [29] were cultured in
DMEM supplemented with either 50 mg/ml gentamicin
(HEK293T) or 1% penicillin/streptomycin (HeLa Kyoto) and
10% fetal calf serum. For expression of GFP/RFP/YFP fusion
proteins, HEK293T cells were transfected with the corresponding
expression constructs using polyethylenimine (Sigma, USA). 2.
HeLa Kyoto cells were transfected using FuGene HD (Roche,
Germany) according to the manufacturer’s instructions. The
plasmid coding for GFP-H2A (H2A type 1, NP_003501.1) was
kindly provided by Emily Bernstein (Mount Sinai Hospital) and
the plasmid coding for GFP-Z-1 was a gift from Sachihiro
Matsunaga (University of Tokyo). Stable cell lines were selected
with 600 mg/ml G418 (PAA, Austria) and individual cell clones
sorted by using a FACSAria machine (Becton Dickinson,
Germany).
Histone-tail Peptides and DNA Substrate Preparation
Fluorescently labeled DNA substrates were prepared by mixing
two HPLC-purified DNA oligonucleotides (IBA GmbH, Germany
Table 1) in equimolar amounts, denaturation for 30 sec at 92uC
and slow cool-down to 25uC allowing hybridization. Histone-tail
peptides were purchased as TAMRA conjugates and/or biotiny-
lated (PSL, Germany) and are listed in Table 1.
Preparation of Protein Extracts
HEK293T cells were cultured and transfected as described [38].
For extract preparation 1 mg/ml DNaseI, 1 mM PMSF and
Protease Inhibitor cocktail (Roche, Germany) were included in the
lysis buffer (20 mM Tris-HCl pH 7.5, 150 mM NaCl, 2 mM
MgCl2, 0.5% NP40) or nuclear extract buffer (10 mM HEPES
pH 7.9, 10 mM KCl, 1.5 mMMgCl2, 0.34 M Sucrose, 10%Glyc-
erol, 1 mM b-mercapto-ethanol). Cells were lysed for 30 minutes
on ice followed by a centrifugation step (15`/12000 rpm/4uC).
Extracts from transfected 10 cm plates were diluted to 500 mL
with immunoprecipitation buffer (IP buffer; 20 mM Tris-HCl
pH 7.5, 150 mM NaCl, 0.5 mM EDTA) or dilution buffer
(20 mM HEPES pH 7.9, 150 mM KCl). An aliquot of 10 mL
(2%) were added to SDS-containing sample buffer (referred to as
Input (I)).
Purification and Elution of GFP/YFP/RFP- Fusions
For purification, 100 mL or 50 mL precleared cellular lysate
for full-area plates or half-area plates, respectively, was added
per well and incubated for 2 hours at 4uC on a GFP-multiTrap
plate by continuous shaking. After removing the supernatant,
wells were washed twice with 100 mL of washing buffer (WB;
20 mM Tris-HCl pH 7.5, 100–300 mM NaCl, 0.5 mM EDTA)
and 100 mL of IP or dilution buffer was added for measure-
ment. The amounts of bound protein were determined by
fluorescence intensity measurements with a Tecan Infinite
M1000 plate reader (Tecan, Austria). Wavelengths for excitation
and emission of GFP are 490610 nm and 511610 nm, for
RFP are 58665 nm and 608610 nm and for YFP 52565 nm
and 53865 nm, respectively. The concentration of proteins was
calculated using calibration curves that were determined by
measuring the fluorescence signal of known concentrations of
purified GFP, RFP and YFP. Notably, factors interfering with
H2A H2A.Z H2A H2A.Z
Supernatant Nucleosomes
0
0.2
0.4
0.6
0.8
1.0
1.2
D
et
ec
tio
n 
of
 e
nd
og
en
ou
s 
H
3K
4m
e2
GFP-fusion proteins
Figure 5. Comparative analysis of posttranslational histone
modifications. Cytoplasmic supernatant (SN) or mononucleosome
(MN) fractions prepared from HeLa cells expressing GFP-H2A or GFP-
H2A.Z were precipitated and the levels of H3 and H3K4me2 were
detected by ELISA (Absorbance at 450 nm). Shown are the H3K4me2
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fluorescence intensity measurements such as absorption of
excitation light by cell lysates, auto fluorescence of the samples
and/or scattering of the excitation/emission light by cell debris
are negligible (Figure S1). Bound proteins were eluted with
300 mM Glycin pH 2.5 and subsequently buffered with 1 M
Tris pH 7.5. Elution fractions were added to SDS-containing
sample buffer (referred to as Bound (B)). Bound proteins were
visualized by immunoblotting using the anti-GFP mouse mono-
clonal antibody (Roche, Germany).
In vitro Histone-tail Peptide Binding Assay
The in vitro histone-tail binding assay was performed as
described previously [10]. After one-step purification of GFP
fusion proteins the wells were blocked with 100 mL 3% milk
solved in TBS-T (0.075% Tween) for 30 minutes at 4uC on
a plate vortex, shaking gently. After blocking, the wells were
equilibrated in 50 mL IP buffer supplemented with 0.05%
Tween. TAMRA-labeled histone-tail peptides were added either
to a final concentration of 0.15 mM or of the indicated
concentrations and the binding reaction was performed at RT
for 20 min on a plate vortex, shaking gently. After removal of
unbound substrate the amounts of protein and histone-tail
peptide were determined by fluorescence intensity measurements.
The concentrations of bound TAMRA-labeled histone-tail
peptides were calculated using calibration curves that were
determined by measuring a serial dilution of TAMRA-labeled
peptides with known concentrations.
Binding ratios were calculated dividing the concentration of
bound histone-tail peptide by the concentration of GFP fusion.
Wavelengths for excitation and emission of TAMRA were
56065 nm and 58665 nm, respectively.
In vitro DNA Binding Assay
In vitro DNA binding assay was performed as described
previously [9,10] with the following modifications. GFP/YFP
fusions were purified from HEK293T extracts using the 96-well
GFP-binder plates and incubated with two differentially labeled
DNA substrates at a final concentration of either 100 nM or of the
indicated concentration for 60 min at RT in IP buffer supple-
mented with 2 mM DTT and 100 ng/mL BSA. After removal of
unbound substrate the amounts of protein and DNA were
determined by fluorescence intensity measurements. The concen-
tration of bound ATTO-labeled DNA substrates was calculated
using calibration curves that were determined by measuring a serial
dilution of DNA-coupled fluorophores with known concentrations.
Binding ratios were calculated dividing the concentration of bound
DNA substrate by the concentration of GFP/YFP fusion,
corrected by values from a control experiment using DNA
substrates of the same sequence but with different fluorescent
label, and normalized by the total amount of bound DNA.
Wavelengths for excitation and emission of ATTO550 were
54565 nm and 57565 nm and for ATTO700 700610 nm and
720610, respectively.
Protein-Protein Interaction
GFP fusions were purified from HEK293T extracts using the
96-well GFP multiTrap plates, blocked with 3% milk and
incubated with cellular extracts comprising the RFP fusions with
the indicated concentrations for 30 min at RT. After removal of
unbound RFP fusion (washing buffer) the amounts of proteins
were determined by fluorescence intensity measurements. Binding
ratios were calculated dividing the concentration of bound RFP
fusion by the concentration of GFP fusion. Wavelengths for
excitation and emission of RFP were 58665 nm and 608610 nm,
respectively. Bound proteins were eluted and separated by SDS-
PAGE and visualized by immunoblotting using the anti-GFP rat
monoclonal antibody; 3H9, and the anti-red rat monoclonal
antibody, 5F8 (both ChromoTek, Germany).
Enzyme-linked Immunosorbent Assay (ELISA)
GFP fusions were purified (from HEK293T extracts) using the
96-well GFP-multiTrap plates and were washed twice with
dilution buffer (for nucleosome experiments salt concentration
was adjusted to 300 mM). After washing bound fractions were
either cross-linked with 2% formaldehyde and/or additionally
permeabilized with 100% MeOH. After blocking with 3% milk
solved in TBS-T (0.075% Tween) the wells were incubated with
primary antibody (monoclonal rat anti-H3-HRP (Abcam, UK),
polyclonal rabbit anti-H3K4me2 (Abcam, UK) or monoclonal rat
anti-PCNA, 16D10 (ChromoTek, Germany) overnight at 4uC on
a plate vortex, shaking gently. The wells were washed three times
with 200 mL TBS-T and horseradish peroxidase-conjugated
secondary antibody (Sigma, USA) was incubated for 1 h at RT
for the detection of PCNA or H3K4me2. The wells were washed
again as described above. For PCNA experiments detection was
carried out by incubating each well with 100 mL TMB (3,39,5,59-
tetramethylbenzidine) for 10 minutes at RT. The reactions were
stopped with the addition of 100 mL 1 M H2SO4. For nucleosome
experiments, detection was carried out using OPD (Sigma, USA)
according to the manufacturers instructions. Bound histone H3,
PCNA or H3K4me2 levels were quantified by determination of
the absorbance at 450 nm using a Tecan Infinite M1000 plate
reader (Tecan, Austria).
Preparation of Mononucleosomes
261072106107HeLa cells, expressing eitherGFP-H2A orGFP-
H2A.Z, were incubated in PBS, 0.3% Triton X-100 and Protease
InhibitorCocktail (Roche,Germany) for 10 min at 4uC.Nuclei were
pelleted and supernatant (SN) transferred and retained. The pellet
was washed once in PBS, resuspended in EX100 buffer (10 mM
Hepes pH 7.6, 100 mM NaCl, 1.5 mM MgCl2, 0.5 mM EGTA,
10% (v/v) glycerol, 10 mM b-glycerol phosphate 1 mM DTT,
Protease Inhibitor Cocktail (Roche, Germany)) and CaCl2 concen-
tration adjusted to 2 mM. Resuspended nuclei were digested with
1.5 U MNase (Sigma, USA) for 20 min at 26uC. The reaction was
stopped by addition of EGTA to a final concentration of 10 mM
followed by centrifugation for 10 min at 1000 rcf, 4uC. Mono-
nucleosome containing supernatant (MN) was retained.
Calculation of the Z-factors
To assess the suitability of the assay for high-throughput
biochemical and functional studies, the Z-factor was calculated
using the equation Z~1{
3| spzsnð Þ
Dmp{mn D
[39]. In this equation, s is
the standard deviation of the positive (p) and the negative (n)
control; m is the mean value for the molar binding ratio (for
positive (mp) and negative (mn) controls). The values of three
independent experiments were used to calculate the Z-factor and
all values are listed in Table 2.
Supporting Information
Figure S1 Factors interfering the measured fluores-
cence intensities. (A) The concentrations of GFP and RFP
expressed in HEK293T cells were measured in serial dilutions of
crude cell extracts. Shown are means 6 SD from two independent
experiments. Fluorescence intensities were measured via a plate
reader and the GFP and RFP concentrations were determined as
described in the Material and Methods part. (B) Background GFP
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and RFP signals in cell lysates of untransfected HEK293T cells.
The fluorescence intensities (FI) were measured via a plate reader
and the concentrations were determined as described in the
Material and Methods part.
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Figure S1: Factors interfering the measured fluorescence intensities. (A) 
The concentrations of GFP and RFP expressed in HEK293T cells were 
measured in serial dilutions of crude cell extracts. Shown are means ± SD 
from two independent experiments. Fluorescence intensities were measured 
via a plate reader and the GFP and RFP concentrations were determined as 
described in the Material and Methods part. (B) Background GFP and RFP 
signals in cell lysates of untransfected HEK293T cells. The fluorescence 
intensities (FI) were measured via a plate reader and the concentrations were 
determined as described in the Material and Methods part.  
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ABSTRACT
DNA methylation and histone modifications play
a central role in the epigenetic regulation of gene
expression and cell differentiation. Recently, Np95
(also known as UHRF1 or ICBP90) has been found
to interact with Dnmt1 and to bind hemimethylated
DNA, indicating together with genetic studies a
central role in the maintenance of DNA methylation.
Using in vitro binding assays we observed a
weak preference of Np95 and its SRA (SET- and
Ring-associated) domain for hemimethylated CpG
sites. However, the binding kinetics of Np95 in
living cells was not affected by the complete loss
of genomic methylation. Investigating further links
with heterochromatin, we could show that Np95
preferentially binds histone H3 N-terminal tails
with trimethylated (H3K9me3) but not acetylated
lysine 9 via a tandem Tudor domain. This domain
contains three highly conserved aromatic amino
acids that form an aromatic cage similar to the
one binding H3K9me3 in the chromodomain of
HP1ß. Mutations targeting the aromatic cage of
the Np95 tandem Tudor domain (Y188A and Y191A)
abolished specific H3 histone tail binding. These
multiple interactions of the multi-domain protein
Np95 with hemimethylated DNA and repressive
histone marks as well as with DNA and histone
methyltransferases integrate the two major
epigenetic silencing pathways.
INTRODUCTION
DNA methylation and histone modiﬁcations are crucially
involved in the regulation of gene expression, inheritance
of chromatin states, genome stability and diﬀerentiation
(1–3). Although the biochemical networks controlling
these epigenetic marks have been the subject of intensive
investigation, their interconnection is still not well
resolved in mammals. DNA methylation patterns are
established by de novo DNA methyltransferases Dnmt3a
and 3b, while Dnmt1 is largely responsible for maintaining
genomic methylation after DNA replication (4,5). Dnmt1
possesses an intrinsic preference for hemimethylated
DNA substrates (6,7) and associates with proliferating
cell nuclear antigen (PCNA) at replication sites in vivo
(8–10). The transient interaction of Dnmt1 with PCNA
enhances methylation eﬃciency but is not strictly
required to maintain genomic methylation in human and
mouse cells (11,12).
Recently, Np95 has emerged as a central regulatory
factor for DNA methylation and interacts with all three
Dnmts (13). Np95 localizes at replication foci and its
genetic ablation leads to genomic hypomethylation and
developmental arrest (14–19). Np95 and its SET- and
Ring- associated (SRA) domain were shown to bind
hemimethylated DNA with higher aﬃnity than corre-
sponding symmetrically methylated or unmethylated
sequences both in vitro and in vivo (17,18,20–22). In
addition, crystal structures of the SRA domain com-
plexed with hemimethylated oligonucleotides revealed
ﬂipping of the 5-methylcytosine out of the DNA double
helix, a conﬁguration that would stabilize the SRA–DNA
interaction (20–22). Thus, recruitment of Dnmt1 to
hemimethylated CpG sites by Np95 has been proposed
as mechanism for the maintenance of genomic
methylation.
In addition to its role in controlling DNA methylation,
Np95 has been shown to take part in several other
chromatin transactions. Np95 or its human homolog
ICBP90/UHRF1 were reported to interact with the
histone deacetylase HDAC1 and the histone methyl-
transferase G9a and to mediate silencing of a viral
promoter, suggesting a role of Np95 in gene silencing
through histone modiﬁcation (13,23,24). Np95 binds
histone H3 and displays a Ring domain-mediated E3
ubiquitin ligase activity for core histones in vitro and
possibly histone H3 in vivo (25,26). The plant
*To whom correspondence should be addressed. Tel: +49 89 218074232; Fax: +49 89 218074236; Email: h.leonhardt@lmu.de
1796–1804 Nucleic Acids Research, 2010, Vol. 38, No. 6 Published online 21 December 2009
doi:10.1093/nar/gkp1152
 The Author(s) 2009. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
 at U
niversitaetsbibliothek M
uenchen on N
ovem
ber 22, 2011
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
homeodomain (PHD) of Np95 has been linked to
decondensation of replicating pericentric heterochromatin
(PH), but it is still unclear which domains recognize
speciﬁc histone modiﬁcations (16,26,27).
In this study we systematically analyzed the binding
properties of Np95 and its individual domains to DNA
and histone tails in vitro and their binding kinetics in living
cells. Our data reveal a multi-functional modular structure
of Np95 interconnecting DNA methylation and histone
modiﬁcation pathways.
MATERIALS AND METHODS
Expression constructs
Expression construct for GFP–Dnmt1 and RFP–PCNA
were described previously (10,28,29). All Np95 constructs
were derived by PCR from corresponding myc- and
His6-tagged Np95 constructs (25). To obtain GFP–
and Cherry-fusion constructs the Dnmt1 cDNA in the
pCAG–GFP–Dnmt1-IRESblast construct (11) or the
pCAG–Cherry–Dnmt1–IRESblast was replaced by Np95
encoding PCR fragments. The GFP–Np95Tudor
expression construct was derived from the GFP–Np95
construct by overlap extension PCR (30). The GFP–
Tudor mutant (Y188A, Y191A) was derived from the
GFP–Np95 construct by PCR-based mutagenesis (31).
All constructs were veriﬁed by DNA sequencing.
Throughout this study enhanced GFP (eGFP) or
monomeric Cherry (mCherry) constructs were used and
for simplicity referred to as GFP– or Cherry-fusions.
Cell culture, transfection and immunoﬂuorescence staining
HEK293T cells and embryonic stem cells (ESCs) were
cultured and transfected as described (11), with the excep-
tion that FuGENE HD (Roche) was used for transfection
of ESCs. The dnmt1/ J1 ESCs used in this study are
homozygous for the c allele (4). For immunoﬂuorescence
staining, TKO ESCs were grown on cover slips, ﬁxed with
3.7% formaldehyde in PBS for 10min and permeabilized
with 0.5% Triton X-100 for 5min. After blocking with 3%
BSA in PBS for 1 h endogenous Np95 was detected with a
polyclonal rabbit anti-Np95 serum (32). The secondary
antibody was conjugated to Alexa Fluor 568 (Molecular
Probes). Nuclear counterstaining was performed with
DAPI and cells were mounted in Vectashield (Vector
Laboratories). Images were obtained using a TCS SP5
AOBS confocal laser scanning microscope (Leica) using
a 63x/1.4NA Plan-Apochromat oil immersion objective.
Fluorophores were excited with 405 and 561 nm lasers.
In vitro DNA binding assay
The in vitro DNA binding assay was performed as
described previously (33) with the following modiﬁcations.
Two diﬀerent double-stranded DNA probes were labeled
with distinct ﬂuorophores and used in direct competition
(see Supplementary Figures S3 and S6 for details).
DNA oligos were controlled for CG methylation state
by digestion with either a CG methylation-sensitive
(HpaII) or -insensitive (MspI) enzyme (Supplementary
Figure S4). For extract preparation 2mM MgCl2 and
1mg/ml DNaseI were included in the lysis buﬀer.
Extracts from 1-3 transfected 10 cm plates were diluted
to 500-1000 ml with immunoprecipitation (IP) buﬀer and
1 mg of GFP–Trap (34) (ChromoTek, Germany) per ﬁnal
assay condition was added. After washing and equilibra-
tion beads were resuspended in 500ml of binding buﬀer
(20mM Tris-HCl pH 7.5, 150mM NaCl, 0.5mM
EDTA, 1mM DTT, 100 ng/ml BSA). Two oligonucleotide
substrates were added to a ﬁnal concentration of 50 nM
each and incubated at room temperature (RT) for 60min
with constant mixing. Fluorescence intensity measure-
ments were performed with a Tecan Inﬁnite M1000
plate reader using the following excitation/emission wave-
lengths: 490±10 nm/511±10nm for GFP, 550±15nm/
580±15nm for ATTO550 and 650±10nm/670±10 nm
for ATTO647N. Values were adjusted using standard
curves obtained with ATTO-dye coupled oligonucleotide
primers and puriﬁed GFP. Binding activity was expressed
as the ratio between the ﬂuorescent signals of bound
DNA probe and GFP fusion protein bound to the
beads, so that the signals from bound probes are
normalized to the amount of GFP fusion. Furthermore,
values were normalized using a control set of DNA probes
having identical sequences but distinct ﬂuorescent labels
(see Supplementary Figures S3 and S6 for details).
Peptide pull-down assay
Peptides were purchased as TAMRA conjugates (PSL,
Germany) and are listed in Supplementary Figure S7.
The peptide pull-down assay was performed analogously
to the DNA binding assay described above. After one-step
puriﬁcation of GFP fusion proteins with the GFP–Trap
(ChromoTek, Germany), the beads were equilibrated in
1ml IP buﬀer and resuspended in 500 ml binding buﬀer
supplemented with 100 ng/ml of BSA. Peptides were
added to a ﬁnal concentration of 0.74mM and the
binding reaction was performed at RT for 15min to
60min with constant mixing. The beads were washed
twice with 1ml of IP buﬀer and resuspended in 100 ml of
the same. Wavelengths for excitation and measurement of
TAMRA were 490±5nm and 511±5nm, respectively.
Fluorescence intensity measurements were adjusted using
standard curves from TAMRA coupled peptide and
puriﬁed GFP.
Live cell microscopy and ﬂuorescence recovery after
photobleaching analysis
Live cell imaging and ﬂuorescence recovery after photo-
bleaching (FRAP) analysis were performed as described
previously (11). For presentation, we used linear contrast
enhancement on entire images.
Statistical analysis
Results were expressed as mean±SEM. The diﬀerence
between two mean values was analyzed by Student’s
t-test and was considered to be statistically signiﬁcant in
case of P< 0.05 and highly signiﬁcant with P< 0.001.
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Electrophoretic mobility shift and supershift assays
Un- and hemimethylated DNA substrates (1 pmol
UMB550 and HMB647N, respectively) were incubated
with 0.6 pmol puriﬁed GFP–Np95 and 0.4 pmol
GFP–antibody (mouse monoclonal antibody, Roche).
Samples were subjected to a 3.5% non-denaturing
PAGE and analyzed with a ﬂuorescence scanner
(Typhoon Trio scanner; GE Healthcare) to detect
ATTO550 (unmethylated substrate), ATTO647N
(hemimethylated substrate) and green ﬂuorescence
(GFP–Np95).
RESULTS AND DISCUSSION
Np95 binding kinetics is largely independent of DNA
methylation levels in vivo
Recent studies showed Np95 bound to hemimethylated
DNA, suggesting that the essential function of Np95 in
the maintenance of DNA methylation consists of
substrate recognition and recruitment of Dnmt1. To inves-
tigate the dynamics of these interactions in vivo we
transiently transfected wild-type (wt) J1 ESCs with expres-
sion constructs for Cherry-Np95 and GFP–Dnmt1 and
monitored their subcellular distribution using live-cell
microscopy (Figure 1A and B). Np95 showed a nuclear
distribution with a cell cycle-dependent enrichment at
replicating PH, similar to Dnmt1. Consistent with earlier
observations (8,12,14–16) we detected co-localization of
Np95 and Dnmt1 at sites of DNA replication. We
investigated the dynamics of Np95 binding by quantitative
ﬂuorescence recovery after photobleaching (FRAP)
analysis (Figure 1B). As chromocenters (aggregates of
PH) are not homogeneously distributed in the nucleus,
we chose to bleach half nuclei to ensure that the
bleached region contains a representative number of
potential binding sites. We observed a relatively fast and
full recovery of relative GFP–Dnmt1 ﬂuorescence inten-
sity (Figure 1B), reﬂecting a transient and dynamic inter-
action as described before (11). In contrast, Cherry-Np95
showed a considerably slower and only partial (80%)
recovery within the same observation period. These
results indicated a relatively stable binding of Np95 to
chromatin and revealed an immobile protein fraction of
about 20%. These in vivo binding properties would be
consistent with tight binding of Np95 to hemimethylated
CpG sites and ﬂipping of the methylated cytosines out of
the DNA double helix as shown in recent co-crystal struc-
tures of the SRA domain of Np95 (20–22).
To directly test the contribution of DNA methylation
and the interaction with Dnmt1 to protein mobility, we
compared the binding kinetics of GFP–Np95 in wt ESCs
and ESCs lacking either Dnmt1 or all three major DNA
methyltransferases Dnmt1, 3a and 3b (triple knockout,
TKO). Surprisingly, Np95 binding to chromatin was not
aﬀected by either drastic reduction (dnmt1/) or even
complete loss (TKO) of genomic methylation and
showed in both cases remarkably similar FRAP kinetics
compared to wt J1 ESCs (Figure 1C). Similar results were
obtained with a C-terminal GFP fusion (Np95-GFP;
Supplementary Figure S1), arguing against conforma-
tional or sterical impairments of the N-terminal fusion
protein that could aﬀect the binding kinetics. Also, both,
the levels of endogenous Np95 and its degree of accumu-
lation at chromocenters were highly variable in TKO cells,
with chromocenter accumulation clearly visible in some
cells (Supplementary Figure S2). These results show that
DNA methylation and the three DNA methyltransferases
do not have a major eﬀect on the overall binding kinetics
of Np95 in living cells.
The SRA domain of Np95 is necessary and suﬃcient for
DNA binding in vitro
Next, we investigated the DNA binding activity of Np95
and the contribution of distinct Np95 domains by
generating a systematic set of individual domains and
deletion constructs fused to GFP (Figure 2A). To
directly compare the in vitro binding aﬃnity of Np95
regarding diﬀerent methylation states, we synthesized
double-stranded DNA-binding substrates with either one
or three un- or hemimethylated CpG sites and labeled
them with two distinct ﬂuorophores (Supplementary
Figure S3). DNA probes were controlled for CG
methylation state by digestion with either a CG
methylation-sensitive (HpaII) or -insensitive (MspI)
enzyme (Supplementary Figure S4). Performing conven-
tional electrophoretic mobility shift and supershift assays
we conﬁrmed the DNA binding activity of Np95 and
detected a preference for hemimethylated DNA substrates
(Figure 2B and Supplementary Figure S5).
As a second line of evidence and to quantify binding
preferences, we applied our recently developed non-
radioactive DNA binding assay (33) and tested
GFP–fused wt Np95 as well as a systematic set of individ-
ual domains and deletion constructs for their DNA-
binding properties in vitro (Figure 2C and Supplementary
Figure S6). This assay allows fast comparison of diﬀerent
potential binding substrates in direct competition as
well as the simultaneous quantiﬁcation of GFP–labeled
protein to calculate relative binding activity. The diﬀerent
GFP–Np95 fusion constructs were expressed in HEK293T
cells, puriﬁed with the GFP–Trap (34) and incubated with
the ﬂuorescently labeled DNA substrates. GFP–fusion
protein and bound DNA substrates were quantiﬁed with
a ﬂuorescence plate reader (Figure 2C and Supplementary
Figure S6). Furthermore, results were corrected for any
bias due to incorporation of diﬀerent ﬂuorescent labels
(Supplementary Figures. S3 and S6). Under these assay
conditions we observed an up to 2-fold preference
(factor 1.6–1.9) of Np95 for DNA substrates containing
one or three hemimethylated CpG sites (Supplementary
Figure S6). Deletion of the SRA domain completely abol-
ished the DNA-binding activity of Np95, whereas deletion
of either the PHD or the Tudor domain had no eﬀect
(Figure 2C). Consistently, the isolated PHD and Tudor
domains did not bind to DNA, while the SRA domain
alone showed similar binding strength and sequence pref-
erence as full-length Np95. Together, these results clearly
demonstrate that the SRA domain of Np95 preferentially
binds to hemimethylated CpG sites, although this
1798 Nucleic Acids Research, 2010, Vol. 38, No. 6
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Figure 1. Binding kinetics of Dnmt1 and Np95 in living cells. (A) Schematic representation of Np95 and Dnmt1 ﬂuorescent fusions. Ubl,
ubiquitin-like domain; Tudor, tandem Tudor domain; PHD, plant homeodomain; SRA, SET- and Ring-associated domain; Ring domain; PBD,
PCNA-binding domain; TS, targeting sequence; ZnF, zinc-ﬁnger; BAH, bromo adjacent homology domain; (KG)7, lysine-glycine repeat. (B) Dnmt1
and Np95 display diﬀerent kinetics. Representative images from FRAP experiments on wt J1 ESCs transiently co-transfected with Cherry-Np95 and
GFP–Dnmt1 constructs. Images show co-localization at chromocenters before (Pre) and at the indicated time points after (Pb) bleaching half of the
nucleus. Bleached areas are outlined. Corresponding FRAP curves are shown on the right. Bars, 5 mm. (C) FRAP kinetics of GFP–Np95 in J1 ESCs
with diﬀerent genetic backgrounds [wt, dnmt1–/– and dnmt1–/–, 3a–/–, 3b–/– (TKO)]. Kinetics of GFP–Dnmt1 is shown for comparison. Mobile and
immobile fractions are indicated on the right. Values represent mean±SEM.
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preference is only about 2-fold with puriﬁed proteins and
substrates in vitro.
The SRA domain dominates binding kinetics but not
localization of Np95
Next, we investigated the role of distinct Np95 domains
in nuclear interactions in vivo. To this aim, we expressed
the same GFP–Np95 constructs in np95/ ESCs and
tested their binding kinetics with FRAP experiments
(Figure 2D). Importantly, GFP–Np95 showed similar
FRAP kinetics in Np95 deﬁcient, wt or Dnmt-deﬁcient
ESCs (Figures 1C and 2D). Among all domains tested,
only the SRA domain showed similar kinetics as
full-length Np95, including the relatively slow recovery
and an immobile fraction of about 20%, while the
Tudor and PHD domain displayed the same high
mobility as GFP. Also, FRAP curves of the corresponding
deletion constructs indicated that the Tudor and the PHD
domains have only a minor contribution to in vivo binding
kinetics, while deletion of the SRA domain drastically
increased the mobility of Np95. These data indicate that
the SRA domain dominates the binding kinetics of Np95
in vivo. Curiously, the addition of the PHD to the SRA
domain (GFP–PHD-SRA) resulted in intermediate
kinetics and loss of the immobile fraction. This eﬀect
was, however, not observed in the context of the
full-length protein, suggesting that nuclear interactions
of Np95 are controlled by a complex interplay among
its domains. To directly study the role of the SRA
domain in controlling the subcellular localization of
Np95 we co-transfected np95/ ESCs with expression
constructs for Cherry-Np95 and either GFP–SRA or
GFP–Np95SRA (Figure 2E). This direct comparison
showed that the isolated SRA domain does not co-localize
with full-length Np95 at PH. Together, these results
indicate that the SRA domain of Np95 is necessary and
suﬃcient for DNA binding in vitro and also dominates the
binding kinetics in vivo, but is per se not suﬃcient for
proper subnuclear localization. The fact that the
Np95SRA construct co-localized with Np95 suggests
that other domains than the SRA control the subcellular
targeting of Np95.
Np95 binds to histone H3 via a tandem Tudor domain
Database searches showed that the sequence between the
Ubl and PHD domains of Np95 is highly conserved in
vertebrates and displays structural similarity to the
family of Tudor domains [(35); PDB 3db4; Figure 3A
and B]. The crystal structure revealed that the Tudor
domain is composed of two subdomains (tandem Tudor)
forming a hydrophobic pocket that accommodates a
histone H3 N-terminal tail trimethylated at K9
(H3K9me3) (PDB 3db3; Figure 3C). This hydrophobic-
binding pocket is created by three highly conserved
amino acids (Phe152, Tyr188, Tyr191) forming an
aromatic cage (Figure 3A and C). Interestingly, a very
similar hydrophobic cage structure has been described
for the chromodomain of the heterochromatin protein
1ß (HP1ß) (Supplementary Figure S7) that is known to
bind trimethylated lysine 9 of histone H3 and associates
with PH (36).
To further investigate the histone tail-binding properties
of Np95, we mutated two amino acids of the aromatic
cage (Y188A, Y191A) and tested the isolated tandem
Tudor domain and corresponding mutant in comparison
with Np95 using a peptide binding assay. GFP–Np95,
GFP–Tudor and GFP–Tudor (Y188A, Y191A) were
expressed in HEK293T cells, puriﬁed with the GFP–
Trap and incubated with TAMRA-labeled histone tail
peptides. The ﬂuorescence intensity of GFP fusion
proteins and bound peptides was quantiﬁed and the
relative binding activity calculated (Figure 3D and
Supplementary Figure S7). The tandem Tudor domain
showed a highly signiﬁcant preference for the trimethy-
lated (H3K9me3) peptide, while this eﬀect was less pro-
nounced in the full-length Np95. Interestingly, acetylation
of K9 (H3K9ac), a modiﬁcation largely underrepresented
in silent chromatin, prevented binding of the tandem
Tudor domain. Remarkably, point mutations targeting
aromatic cage residues within the tandem Tudor domain
completely abolished speciﬁc binding to N-terminal
histone H3 peptides.
Consistent with these binding data the tandem Tudor
domain also showed a weak enrichment at PH, while the
PHD domain, previously proposed as potential histone
H3-binding motif (26), did neither bind to H3K9
peptides in vitro nor to PH in vivo (Supplementary
Figure S8). These results indicate that the tandem Tudor
domain of Np95 features a peptide binding pocket with
structural and functional striking similarity to HP1ß and
confers selective binding to histone modiﬁcation states
associated with silent chromatin.
These multiple interactions of Np95 with heterochro-
matin components correlate well with functional data.
The depletion of Np95 in mouse cells resulted in increased
transcription of major satellite repeats (16). Also, an inter-
action of Np95 with G9a was described and both were
found to be essential for transcriptional regulation (24)
and epigenetic silencing of transgenes (13).
In summary, we showed that the SRA domain is neces-
sary and suﬃcient for DNA binding of Np95 in vitro.
Photobleaching experiments further indicated that the
SRA domain also dominates the binding kinetics of
Np95 in living cells which was however largely indepen-
dent of the DNA methylation level. These results suggest
that the SRA domain may also bind to unmethylated
DNA or undergo additional, still unidentiﬁed interactions
in vivo. While the essential role of Np95 in the mainte-
nance of DNA methylation is well established, it is still
unclear how a relatively weak preference for hemimethy-
lated DNA can be suﬃcient to maintain DNA methyla-
tion patterns over many cell division cycles for an entire
life time. We suggest that the multiple interactions of
the multi-domain protein Np95 with hemimethylated
DNA and H3K9 methylated histone tails as well as with
histone (G9a) and DNA (Dnmt1, 3a and 3b) methyl-
transferases may add up to the necessary speciﬁcity
in vivo. Clearly, these multiple interactions place Np95 at
the center of various epigenetic silencing mechanisms and
likely mediate epigenetic crosstalk.
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Figure 2. In vitro DNA binding and in vivo mobility of Np95 domains. (A) Schematic representation of the analyzed GFP–Np95 fusion constructs.
(B) Electrophoretic mobility shift and supershift assay. GFP–Np95 binding to hemimethylated DNA substrates is shown by the shifted
GFP–Np95:DNA complex. The addition of a GFP–antibody supershifted the GFP–Np95:DNA complex (supershift assay with unmethylated
DNA substrates in direct competition with hemimethylated DNA substrates is shown in Supplementary Figure S6). (C) In vitro DNA-binding
properties of Np95 constructs. Binding assays were performed using ﬂuorescently labeled double stranded oligonucleotide probes containing one
central hemimethylated CpG site. Shown are ﬂuorescence intensity ratios of bound probe/bound GFP fusion. Values represent means and SD of
three to six independent experiments. GFP was used as control. Further control experiments with either one or three central CpG sites and
alternating ﬂuorescent labels are shown in Supplementary Figure S3. (D) Kinetics of Np95 constructs in living np95–/– ESCs determined by half
nucleus FRAP analysis. GFP is shown as reference. Curves represent mean values from 6 to 15 nuclei. SEM (0.001–0.005) is not shown for clarity of
illustration. (E) Confocal mid-sections of living np95–/– ESCs transiently expressing the indicated Np95 fusion constructs (left and mid-panels).
Merged images are displayed on the right. Bar, 5 mm.
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Figure 3. Structure and H3 N-terminal tail binding of the tandem Tudor domain. (A) Schematic drawing of the multi-domain architecture of Np95
(top) and alignment of tandem Tudor domains from vertebrate Np95 homologs (bottom). Arrows show the end and start positions of the crystallized
tandem Tudor domain shown in (B). Residues forming the aromatic cage shown in (C) are indicated by arrowheads. Absolutely conserved residues of
the tandem Tudor domain are black shaded, while positions showing conservative substitutions are boxed with residues in bold face.
Secondary-structure elements were generated with EsPript (37) using the crystal structure of human UHRF1 (PDB 3db3 and 3db4) and are
shown above the amino acid sequence: a-helices (g), b-strands, strict alpha turns (TT) and strict beta turns (TTT). Accession numbers: Homo
sapiens Q96T88.1; Pan troglodytes XP_001139916.1; Bos Taurus AAI51672.1; Mus musculus Q8VDF2.2; Rattus norvergicus Q7TPK1.2; Dario rerio
NP_998242.1; Xenopus laevis ABY28114.1, Gallus gallus XP_418269.2. (B) Side view of the tandem Tudor domain as a cartoon model (left) and as
surface representation (right) in complex with a histone H3 N-terminal tail peptide trimethylated at lysine 9 (green stick model; only Arg8-Lys9-Ser10
of the H3 peptide are resolved). The image was generated with PyMOL (38). (C) An aromatic cage is formed by Phe152, Tyr188 and Tyr191 and
accommodates the trimethylated lysine 9 of H3 (H3K9me3). (D) Histone H3 N-terminal tail binding speciﬁcity of GFP–Np95, GFP–Tudor and
GFP–Tudor (Y188A Y191A) in vitro. Shown are ﬂuorescence intensity ratios of bound probe/bound GFP fusion. GFP was used as negative control.
Shown are means±SEM from four to ten independent experiments and two-sample t-tests were performed that do or do not assume equal
variances, respectively. Statistical signiﬁcance compared to the binding ratio of H3K9me3 is indicated: *P< 0.05, **P< 0.001.
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SUPPLEMENTARY INFORMATION 
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Supplementary Figure 1. Nuclear localization, FRAP kinetics and DNA binding specificity 
for an Np95 construct C-terminally fused to GFP (Np95-GFP, respectively). (A) Schematic 
drawing of Np95-GFP. Abbreviations are as in Fig. 1. (B) Representative images from FRAP 
experiments for Np95-GFP transiently expressed in wt, dnmt1-/- and TKO J1 ESCs as indicated 
on the left. Images show confocal mid-sections of nuclei before (Pre) and at the indicated time 
points after bleaching (Pb) half of the nucleus. Bleached areas are outlined. Arrowheads mark 
pericentric heterochromatin. Bars, 5 µm. (C) FRAP kinetics of Np95-GFP in J1 ESCs with 
different genetic backgrounds as shown in B and Fig. 1C. Kinetics of GFP-Dnmt1 is shown for 
comparison. Mobile and immobile fractions are indicated on the right. Values represent mean ± 
SEM. Note that the kinetics are similar to those shown for GFP-Np95 in Fig. 1C and that there is 
no significant difference in cells with different genetic backgrounds.  
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Supplementary Figure 2. Variable expression levels and localization of Np95 in TKO cells. 
TKO cells were stained with DAPI (A, B and C) and an anti-Np95 antibody (A’, B’ and C’). 
A-A’ and B-B’ show examples of cells with very low and high Np95 levels, respectively. In B’ 
accumulation of endogenous Np95 at chromocenters is evident. C and C’ show a field containing 
cells with very different Np95 levels and degrees of Np95 accumulation at chromocenters. Scale 
bars are 3 µm (A-B’) and 10 µm (C and C’). 
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Supplementary Figure 3. Oligo design for the in vitro DNA binding assay (A) DNA 
oligonucleotides used for the preparation of double stranded probes for in vitro DNA binding 
assays. M: 5-methyl-cytosine. (B) Description of double stranded probes used for in vitro DNA 
binding assays. Name, status of the central CpG site, fluorescent label, as well as DNA 
oligonucleotides and nature of the dCTP used in the primer extension reaction are specified. By 
using a control set of two probes with identical sequence but different fluorescent labels we 
observed effects due to probe preparation and/or unspecific binding of ATTO dyes (data not 
shown). The values obtained from the control set were used to normalize every probe / protein 
pair.  
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Supplementary Figure 4. Quality control of un- and hemi-methylated DNA substrates 
Unmethylated and hemimethylated DNA substrates (UMB550 and HMB647N, respectively) 
were digested with MspI or HpaII and analyzed by 15 % non-denaturing PAGE for CG 
methylation. DNA substrates were detected via their fluorescent ATTO label using the Typhoon 
Trio scanner. Note that the unmethylated DNA substrate is digested by both MspI and HpaII, 
whereas the hemimethylated substrate is cut by MspI, but not by the methylation sensitive HpaII. 
Sequences of the double stranded probes before (42mer) and after cut (21mer) as well as the 
unextended primer are displayed above. Enzyme recognition motifs are boxed and asterisks 
represent fluorescent ATTO label.  
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Supplementary Figure 5. Electrophoretic mobility shift and supershift assays with 
GFP-Np95. Un- and hemimethylated DNA substrates (1 pmol UMB550 and HMB647N, 
respectively) were incubated with 0.6 pmol purified GFP-Np95 and 0.4 pmol GFP-antibody. 
Samples were subjected to a 3.5 % non-denaturing PAGE and analyzed by the Typhoon Trio 
scanner to detect ATTO550 (unmethylated substrate), ATTO647N (hemimethylated substrate) 
and green fluorescence (GFP). Note that the DNA:GFP-Np95:GFP-antibody complex is shifting 
higher than the DNA:GFP-Np95 complex (arrows).  
 
 
Np95 connects two epigenetic pathways Rottach et al. 
7 
 
 
Supplementary Figure 6. DNA binding specificity of GFP-Np95 
The sequence specific DNA binding activity of Np95 was tested with an in vitro binding assays 
using GFP-Np95 with un- and hemimethylated substrates in direct competition. The DNA 
substrates included either one (left) or three (right) CG sites. Note that regardless of the attached 
fluorescent label (indicated by asterisks) and number of CG sites the hemimethylated DNA 
substrates are preferentially bound (1.6- to 1.9-fold). Shown are the means ± SEM from two 
(left) or four (right) independent experiments. 
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Supplementary Figure 7. Histone tail binding of Np95 and HP1ß (A) Amino acid sequences 
of TAMRA-labeled histone tail peptides used for the peptide binding assay. (B) Histone H3 and 
H4-tail binding specificity of GFP-Np95 in vitro. Ratios of bound TAMRA-labeled peptide over 
bound GFP fusion were determined and normalized to the ratio of H3K4/9un peptide over 
GFP-Np95. GFP was used as negative control. Shown are means ± SEM from six independent 
experiments. (C) Structural comparison of the H3K9me3-binding aromatic cages formed by the 
tandem Tudor domain of Np95 (left) and the chromodomain of HP1ß (right, PDB 1kne). In these 
structures, only Arg8-Lys9-Ser10 and Lys9-Ser10 from histone H3 are resolved peptides, 
respectively (green stick models). The image was generated with PyMOL (1).  
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Supplementary Figure 8. Histone tail binding and subcellular distribution of PHD and 
Tudor domain of Np95 (A) Histone H3 N-terminal tail binding specificity of GFP-Tudor, 
GFP-PHD and GFP in vitro. Shown are fluorescence intensity ratios of bound probe / bound 
GFP fusion. GFP was used as negative control. Shown are means ± SEM from four to six 
independent experiments. Only the tandem Tudor domain shows preferential binding of H3K9 
trimethylated histone tails. (B) Schematic representation of the analyzed Np95 constructs. All 
constructs were N-terminal GFP fusions (left panel). Confocal mid sections of living np95-/- 
ESCs transiently expressing the indicated Np95 fusion constructs and RFP-PCNA as S phase 
marker (left and mid panels). Merged images are displayed on the right. Bars, 5 µm. Only the 
GFP-Tudor fusion protein showed slight enrichment at pericentric heterochromatin.  
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ABSTRACT
Gene expression is regulated by DNA as well as histone modiﬁcations but the crosstalk and mechanistic link between these epigenetic signals
are still poorly understood. Here we investigate the multi-domain protein Uhrf2 that is similar to Uhrf1, an essential cofactor of maintenance
DNA methylation. Binding assays demonstrate a cooperative interplay of Uhrf2 domains that induces preference for hemimethylated DNA,
the substrate of maintenance methylation, and enhances binding to H3K9me3 heterochromatin marks. FRAP analyses revealed that
localization and binding dynamics of Uhrf2 in vivo require an intact tandem Tudor domain and depend on H3K9 trimethylation but not on
DNA methylation. Besides the cooperative DNA and histone binding that is characteristic for Uhrf2, we also found an opposite expression
pattern of uhrf1 and uhrf2 during differentiation. While uhrf1 is mainly expressed in pluripotent stem cells, uhrf2 is upregulated during
differentiation and highly expressed in differentiated mouse tissues. Ectopic expression of Uhrf2 in uhrf1/ embryonic stem cells did
not restore DNA methylation at major satellites indicating functional differences. We propose that the cooperative interplay of Uhrf2
domains may contribute to a tighter epigenetic control of gene expression in differentiated cells. J. Cell. Biochem. 112: 2585–2593,
2011.  2011 Wiley-Liss, Inc.
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D NA methylation and histone modiﬁcations are majorepigenetic marks involved in the regulation of gene
expression, inheritance of chromatin states, genome stability, and
cellular differentiation [Bird, 2002; Kouzarides, 2007; Reik, 2007].
Misregulation of epigenetic pathways, like erroneous DNA
methylation, may lead to cancer and other diseases [Jones and
Baylin, 2007]. Open questions concern the crosstalk andmechanistic
link between different epigenetic signals.
Genome-scale DNA methylation studies revealed a connection
between DNA methylation and histone modiﬁcations. Speciﬁcally,
DNA methylation correlates with the absence of H3K4 methylation
and presence of H3K9 methylation [Meissner et al., 2008]. This
correlation may in part be caused by DNA methyltransferases
speciﬁcally recognizing histone modiﬁcations. For instance, the de
novo DNA methyltransferase Dnmt3a and its cofactor Dnmt3L
speciﬁcally recognize unmethylated H3K4 mediated by the ATRX-
Dnmt3-Dnmt3L (ADD) domain [Ooi et al., 2007; Otani et al., 2009].
Dnmt1, which is involved in maintenance methylation during DNA
replication and DNA repair [Leonhardt et al., 1992; Mortusewicz
et al., 2005], speciﬁcally methylates hemimethylated DNA [Bestor
and Ingram, 1983; Pradhan et al., 1997] and associates with
constitutive heterochromatin via its targeting sequence (TS) domain
[Easwaran et al., 2004].
Recently, Uhrf1 (also known as Np95 or ICBP90) has been shown
to link DNA and histone modiﬁcations and has emerged as an
essential cofactor for the maintenance of genomic DNA methyla-
tion. Genetic ablation of uhrf1 leads to remarkable genomic
hypomethylation, a phenotype similar to dnmt1/ embryonic stem
cells (ESCs) [Bostick et al., 2007; Sharif et al., 2007]. Uhrf1 binds
hemimethylated DNA via a SET and RING associated domain (SRA)
domain and targets Dnmt1 to its substrate of maintenance DNA
methylation [Bostick et al., 2007; Sharif et al., 2007; Arita et al.,
2008; Avvakumov et al., 2008; Hashimoto et al., 2008; Qian et al.,
2008; Rottach et al., 2010]. This targeting activity of Uhrf1 is based
on speciﬁc binding to the heterochromatin mark H3K9me3 via a
tandem Tudor domain (TTD) [Karagianni et al., 2008; Rottach et al.,
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2010]. In addition, Uhrf1 interacts with Dnmt3a and Dnmt3b and
with histone modifying enzymes like HDAC1, G9a, and Tip60 [Unoki
et al., 2004; Achour et al., 2009; Kim et al., 2009; Meilinger et al.,
2009]. Finally, Uhrf1 displays E3 ubiquitin ligase activity for histone
H3 [Citterio et al., 2004] and is involved in large scale reorganization
of chromocenters [Papait et al., 2008].
Interestingly, a second member of the Uhrf family, Uhrf2, harbors
similar domains [Bronner et al., 2007]. Until now, the only
known function of Uhrf2 is a role in intranuclear degradation of
polyglutamine aggregates [Iwata et al., 2009]. In this study, we
systematically investigated the function and interplay of distinct
Uhrf2 domains in DNA and histone tail substrate recognition and
report ﬁrst hints on cell-type speciﬁc functions of Uhrf1 and Uhrf2.
MATERIALS AND METHODS
EXPRESSION CONSTRUCTS
Expression constructs for GFP, RFP-PCNA, Uhrf1-GFP, and GFP
constructs of Dnmt1 were described previously [Sporbert et al.,
2005; Fellinger et al., 2009; Meilinger et al., 2009]. All Uhrf2
expression constructs were derived by PCR from mouse uhrf2-myc
cDNA (MR210744, ORIGENE). To obtain GFP fusion constructs, the
uhrf1 cDNA [Rottach et al., 2010] was replaced by uhrf2 encoding
PCR fragments in the pCAG-uhrf1-GFP vector. The deletion and
point mutant expression constructs were derived from the
corresponding wild-type constructs by overlap extension PCR
[Ho et al., 1989] and PCR-based mutagenesis. The following start
and end amino acids were chosen: Uhrf2 tandem Tudor domain,
amino acids 118–312; Uhrf2 PHD domain, amino acids 325–395;
Uhrf2 tandem Tudor–PHD domain, amino acids 118–395; Uhrf1
tandem Tudor–PHD domain, amino acids 121–370. The linker
exchange constructs were derived by PCR using overlapping primers
that contained the partial linker sequence. Amino acid sequences of
the linkers: Uhrf1: KERRPLIASPSQPPA; Uhrf2: GAHPISFADGKF.
All constructs were veriﬁed by DNA sequencing. Throughout this
study enhanced GFP constructs were used and for simplicity referred
to as GFP fusions.
CELL CULTURE, TRANSFECTION, CELL SORTING, AND
DIFFERENTIATION
HEK293T cells, MEFs, and ESCs were cultured and transfected as
described [Schermelleh et al., 2007; Rottach et al., 2010] with the
exception that Lipofectamin (Invitrogen) was used for transfection
of MEFs. E14 uhrf1/ ESCs were transfected with Uhrf1-GFP and
Uhrf2-GFP expression constructs using FuGENE HD (Roche)
according to the manufacturer’s instructions. ESCs were sorted
for GFP positive cells 48 h after transfection with a FACS Aria II
instrument (Becton Dikinson). ESC strains wt E14, wt J1, and E14
uhrf1/ were cultured and differentiated to embryoid bodies as
described [Szwagierczak et al., 2010]. The ESC strain wt JM8A3.N1
(EUCOMM, Germany) was cultured in Knockout D-MEM (Gibco-
BRL, Grand-Island, NY) medium containing 10% fetal bovine serum
(PAA Laboratories GmbH, Austria), 0.1mM b-mercaptoethanol
(Gibco-BRL), 2mM L-glutamine, 100U/ml penicillin, 100mg/ml
streptomycin (PAA Laboratories GmbH). The medium was supple-
mented with 1,000U/ml recombinant mouse LIF (Millipore,
Temecula, CA).
RNA ISOLATION, CDNA SYNTHESIS, AND QUANTITATIVE
REAL-TIME PCR
RNA isolation and cDNA synthesis were performed as described
[Szwagierczak et al., 2010]. Equal amounts of cDNA were used for
Real-time PCR with TaqMan Gene Expression Master Mix (Applied
Biosystems) on the 7500 Fast Real-time PCR System (Applied
Biosystems) according to the manufacturer’s instructions. The
following TaqMan Gene expression assays were used: Gapdh (Assay
ID: Mm99999915_g1), uhrf1 (Assay ID: Mm00477865_m1) and
uhrf2 (Assay ID: Mm00520043_m1). Gene expression levels were
normalized to Gapdh and calculated using the comparative CT
Method (DDCT Method).
IN VITRO DNA BINDING AND HISTONE-TAIL PEPTIDE
BINDING ASSAY
The in vitro binding assays were performed as described previously
[Frauer and Leonhardt, 2009; Rottach et al., 2010]. NoCpG DNA
substrates were produced in a primer extension reaction [Frauer and
Leonhardt, 2009] others by hybridization of two DNA oligos
(Supplementary Fig. S7B–D). Histone-tail peptides were purchased
as TAMRA conjugates (PSL, Germany; Supplementary Fig. S7A).
Peptides were added in a molar ratio 1.5:1 (peptide/GFP fusion) and
the binding reaction was performed at RT for 15min with constant
mixing. For combined assays, samples were additionally incubated
with either H3K9me3 or H3K9ac histone-tail peptides in a molar
ratio 1.5:1 (peptide/GFP fusion) or increasing amount of DNA
substrate as indicated. The binding reaction was performed at RT for
60min with constant mixing.
IMMUNOFLOURESCENCE STAINING AND ANTIBODIES
For immunostaining, MEF cells and ESCs were grown on cover slips
and transiently transfected with Uhrf2-GFP (MEF cells), or co-
transfected with Uhrf2-GFP and RFP-PCNA (ESCs). Cells were ﬁxed
with 2.0% or 3.7% formaldehyde in PBS and permeabilized in PBS
containing 0.2% Triton X-100. The post-translational histone
modiﬁcation H3K9me3 was detected via a rabbit primary antibody
(Active Motif) and a secondary anti-rabbit antibody conjugated to
Alexa Fluor 594 (Molecular Probes, Eugene, OR). The antibodies
were diluted 1:1,000 or 1:500, respectively, in PBS containing
0.02% Tween-20 and 2% BSA. GFP-Binder (ChromoTek, Germany)
was used to boost GFP signals and was labeled with Alexa Fluor 488.
Cells were counterstained with DAPI and mounted in Vectashield
(Vector Laboratories, Burlingame, CA). Images of the cells were
obtained using a TCS SP5 AOBS confocal laser scanning microscope
(Leica, Wetzlar, Germany) with a 63x/1.4 NA Plan-Apochromat oil
immersion objective. GFP, Alexa Fluor 488, RFP, and Alexa Fluor
594 were excited with a 488-nm argon laser and a 561-nm diode
laser, respectively. Image series were recorded with a frame size of
512 512 pixels, a pixel size of 100 nm and with a detection pinhole
size of 1 Airy Unit.
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LIVE CELL MICROSCOPY AND FLUORESCENCE RECOVERY AFTER
PHOTOBLEACHING (FRAP) ANALYSIS
Live cell imaging and FRAP analyses were performed as described
[Schermelleh et al., 2007] with the exception that imported images
were intensity normalized, converted to 8-bit and Gauss-ﬁltered
(2 pixel radius). Data sets showing lateral movement were corrected
by image registration using the StackReg plug-in of ImageJ
[Abramoff et al., 2004] starting with a frame when approximately
half recovery was reached. Within the ﬁrst 30 s after bleaching,
images were taken every 150ms and then in intervals of 1 s.
DNA METHYLATION ANALYSIS
Genomic DNA was isolated with the QIAmp DNA Mini Kit (Qiagen)
and 1.5mg were bisulﬁte converted using the EZ DNA Methylation-
Gold Kit (Zymo research) according to the manufacturer’s
instructions. Primer sequences for major satellites were AAAAT-
GAGAAACATCCACTTG (forward primer) and CCATGATTTT-
CAGTTTTCTT (reverse primer). For ampliﬁcation we used Qiagen
Hot Start Polymerase in 1 Qiagen Hot Start Polymerase buffer
supplemented with 0.2mM dNTPs, 0.2mM forward primer, 0.2mM
reverse primer, 1.3mM betaine (Sigma) and 60mM tetramethy-
lammonium-chloride (TMAC, Sigma). Major satellites were ampli-
ﬁed in a single ampliﬁcation and pyrosequencing reactions were
carried out by Varionostic GmbH (Ulm, Germany).
STATISTICAL ANALYSIS
Results were expressed as means SD or means SEM. The
difference between two mean values was analyzed by Student’s
t-test and was considered as statistically signiﬁcant in case of
P< 0.05 () and highly signiﬁcant for P< 0.001 ().
RESULTS
OPPOSITE EXPRESSION PATTERN OF UHRF1 AND UHRF2 DURING
DIFFERENTIATION
Recently, Uhrf1 has emerged as an essential factor for the
maintenance of DNA methylation. Sequence analyses revealed
that Uhrf2 harbors ﬁve recognizable domains similar to Uhrf1
(Fig. 1A), but its role in the regulation of DNA methylation is still
unclear. We compared the expression pattern of uhrf1 and uhrf2 in
ESCs and somatic cells, during differentiation and in differentiated
mouse tissues (Fig. 1B–D and Supplementary Fig. S1). Interestingly,
both genes show opposite expression patterns; while uhrf1 is
expressed in ESCs and down regulated during differentiation, which
is consistent with previous reports [Muto et al., 1995; Fujimori et al.,
1998; Hopfner et al., 2000], uhrf2 is upregulated and highly
expressed in differentiated mouse tissues. The switch in the
expression pattern argues against a functional redundancy of
both genes and is consistent with the drastic loss of DNA
methylation in uhrf1/ ESCs despite the presence of intact
uhrf2 alleles. Therefore, the opposite expression pattern of both
genes suggests different functional roles of uhrf1 and uhrf2 in
development.
Fig. 1. Opposite expression pattern of uhrf1 and uhrf2 during differentia-
tion. A: Schematic outline of the multi-domain architecture of Uhrf1 in
comparison to Uhrf2. An N-terminal ubiquitin-like domain (Ubl) is followed
by a tandem Tudor domain (TTD), a plant homeodomain (PHD), a SET and RING
associated (SRA) domain and a C-terminal really interesting new gene (RING)
domain. Numbers indicate primary sequence similarities of single domains
determined by BlastP search [Altschul, 1991]. Expression analysis of uhrf1 and
uhrf2 by Real-time PCR in ESCs and somatic cells (B), during differentiation of
wt J1 ESCs (C) and in various adult mouse tissues in comparison to the
expression data in ESCs (D). Expression levels are relative to uhrf1 in wtJM8A
(B), day 0 of differentiation (C) and to kidney (D) (uhrf1 set to 1). Shown are
means SD of at least two independent experiments.
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COOPERATIVE BINDING OF REPRESSIVE EPIGENETIC MARKS
BY UHRF2
To investigate DNA and histone-tail binding preferences of Uhrf2 in
vitro, we used a versatile binding assay developed for GFP fusion
proteins [Rothbauer et al., 2008; Frauer and Leonhardt, 2009;
Rottach et al., 2010]. Similar to Uhrf1, histone-tail peptide binding
assays revealed that Uhrf2 preferentially binds to H3(1–20) and
H3K9me3 peptides (Fig. 2A). This binding activity of Uhrf2 is
mediated by the TTD but not the PHD domain (Fig. 2B). Consistently,
acetylation of H3K9, underrepresented in heterochromatin,
Fig. 2. Cooperative binding of repressive epigenetic marks by Uhrf2. In vitro binding ratios of ﬂuorescently labeled substrate over bound GFP fusion proteins were determined.
A: Histone H3- and H4-tail binding speciﬁcities of Uhrf2. Shown are means SD of biological duplicates. B: Histone H3 tail binding speciﬁcity of Uhrf2, its tandem Tudor
domain (TTD), its PHD domain and its TTD mutant (Y214A Y217A). Shown are means SEM of at least three independent experiments. C: DNA binding properties of Uhrf1,
Uhrf2 and of single (SRA, TTD) and combined Uhrf2 domains (TTD–PHD–SRA). Shown are means SEM of three independent experiments. D: DNA binding properties of Uhrf1,
Uhrf2 and Uhrf2 Y214A Y217A in combination with histone-tail peptide binding. Shown are means SD of three independent experiments (Uhrf1, Uhrf2) and of two
independent experiments (Uhrf2 Y214A Y217A). Values were normalized to the binding ratio of each GFP fusion for unmethylated DNA without histone-tail peptide. Statistical
signiﬁcance of differences between the binding ratios with un- and hemimethylated DNA is indicated; P< 0.05. Eþ F: H3K9me3 peptide binding by Uhrf1, Uhrf2, and
Uhrf1DSRA with increasing concentrations of DNA substrate containing either one central hemimethylated (E) or noCpG site (F). Shown are means SD of biological
duplicates. Values were normalized to the binding ratio of Uhrf1DSRA without DNA.
2588 COOPERATIVE DNA- AND HISTONE BINDING BY UHRF2 JOURNAL OF CELLULAR BIOCHEMISTRY
prevented the binding of Uhrf2 and its TTD. The binding of Uhrf1 to
H3K9me3 is mediated by an aromatic cage in the TTD [Rottach et al.,
2010]. Site-directed mutagenesis of Uhrf2 changing the two
conserved tyrosine residues to alanine (Y214A Y217A) (Supple-
mentary Fig. S2) abolished speciﬁc peptide binding (Fig. 2B) and
supports a function of the aromatic cage in H3K9me3 recognition.
Whereas Uhrf1 preferentially binds to hemimethylated DNA,
Uhrf2 failed to show a preference for hemi-over unmethylated DNA
(Fig. 2C). These differences in DNA binding preferences between
Uhrf1 and Uhrf2 were conﬁrmed by electrophoretic mobility shifts
(Supplementary Fig. S3). To further investigate the functional
interplay between DNA and histone binding we performed
combined binding assays (Fig. 2D). Interestingly, binding to
heterochromatin-speciﬁc H3K9me3 peptides induced a signiﬁcant
preference of Uhrf2 for hemi-over unmethylated DNA. Uhrf1
already on its own showed preference for hemimethylated DNA that
was further enhanced by binding to H3K9me3 peptides. To test the
speciﬁcity of this cooperativity we mutated the aromatic cage in
Uhrf2 that is necessary for H3K9me3 histone-tail peptide binding.
The mutated Uhrf2 (Y214A Y217A) showed comparable DNA
binding activity as the wild-type Uhrf2 but addition of heterochro-
matin-speciﬁc H3K9me3 peptides did not induce preference for
hemi-over unmethylated DNA (Fig. 2D).
In the reverse experiment, addition of DNA enhanced binding of
Uhrf1 and Uhrf2 to the H3K9me3 peptide (Fig. 2E,F). This was not
observed for the DNA binding mutant of Uhrf1 (Uhrf1DSRA) which
showed constant peptide binding with increasing DNA concentra-
tions. These ﬁndings suggest that single binding events of distinct
Uhrf2 domains lead to multivalent engagement of different
repressive epigenetic marks. In fact, multivalent engagement of
DNA and histone tail peptides via the SRA domain and the TTD,
respectively, results in afﬁnity enhancement and additional
speciﬁcity for hemimethylated DNA, the substrate of maintenance
methylation.
CELLULAR LOCALIZATION AND DYNAMICS OF UHRF2 DEPEND ON
HISTONE H3K9 METHYLATION
To monitor the subcellular localization of Uhrf2, we expressed
Uhrf2-GFP constructs in cells with different genetic backgrounds. In
wild type (wt) ESCs, Uhrf2 is localized in the nucleus and is enriched
at pericentric heterochromatin (PH) (Fig. 3A,B and Supplementary
Fig. S4A–C). To investigate which epigenetic marks at PH are
recognized by Uhrf2 we determined the localization of Uhrf2 in
genetically modiﬁed ESCs either lacking all three major DNA
methyltransferases Dnmt1, Dnmt3a, and Dnmt3b (TKO) [Tsumura
et al., 2006] or ESCs lacking the two major H3K9 methyltransferases
Suv39H1/H2 (Suv39h dn) [Lehnertz et al., 2003]. TKO cells are
practically devoid of genomic DNA methylation and Suv39h dn
ESCs show substantially reduced H3K9me3 levels. We found Uhrf2
localized at PH in TKO but not in Suv39h dn ESCs, indicating that
localization of Uhrf2 is dependent on H3K9 but not on DNA
methylation (Fig. 3A). Consistently, immunostaining of wt mouse
embryonic ﬁbroblasts (MEFs) showed co-localization of Uhrf2 and
H3K9me3 marks at PH, which was not observed in Suv39h dnMEFs
[Peters et al., 2001] (Fig. 3B). Also, mutations in the TTD (Uhrf2
Y214A Y217A) that abolished binding to H3K9me3 peptides in vitro
disrupted enrichment at PH in wt MEFs (Fig. 3B). The dependence of
Uhrf2 localization on H3K9me3 was also conﬁrmed by quantitative
correlation analysis (Supplementary Fig. S4D,E).
To investigate the effect of H3K9me3 on the dynamics of Uhrf2 in
living cells we performed quantitative ﬂuorescence recovery after
photobleaching (FRAP) analyses in wt and Suv39h dn MEFs. We
chose to bleach half nuclei to include a representative number of
Fig. 3. Cellular localization and dynamics of Uhrf2 depend on histone H3K9
methylation. A: Confocal mid sections of ﬁxed wt J1, TKO and Suv39h dn ESCs
transiently expressing Uhrf2-GFP and RFP-PCNA and counterstained with
DAPI, which preferentially highlights PH. Merged images are displayed on the
right side (GFP: green; DAPI: red). Scale bar 5mm. B: Confocal mid sections of
ﬁxed wt MEFs and Suv39h dn MEFs transiently expressing Uhrf2-GFP or Uhrf2
Y214A Y217A-GFP were immunostained for H3K9me3 and counterstained
with DAPI. Merged images are displayed on the right side (GFP: green; DAPI:
red). Scale bar 5mm. C: Dynamics of Uhrf2-GFP and Uhrf2 Y214A Y217A-GFP
in living MEFs determined by half nucleus FRAP analysis. GFP is shown as
reference. Curves represent means SEM from at least 8 nuclei.
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interactions from different nuclear domains and structures in
the bleached area [Rottach et al., 2010]. Recovery of Uhrf2-
GFP ﬂuorescence in Suv39h dn MEFs (half-time t1/2¼ 5.9 0.6 s)
and of the TTD mutant in wt MEFs (t1/2¼ 3.2 0.4 s) was
considerably faster than the recovery of Uhrf2-GFP in wt MEFs
(t1/2¼ 11.8 0.6 s) pointing to a crucial role of H3K9me3 in Uhrf2
dynamics in living cells (Fig. 3C). Taken together, these results
clearly demonstrate that the interaction of Uhrf2 with the
heterochromatin mark H3K9me3 is required for the localization
at PH and affects binding dynamics in living cells.
COOPERATIVE BINDING OF THE COMBINED UHRF2 TTD–PHD
DOMAIN
Recently, several studies showed multivalent binding to histone-tail
peptides [Ruthenburg et al., 2007]. In case of Uhrf1 and Uhrf2, the
TTD is followed by a second histone-tail binding domain, a PHD
domain (Fig. 1A). As the isolated PHD domains of Uhrf1 and Uhrf2
did not show binding to H3 histone-tail peptides (Fig. 2B) [Rottach
et al., 2010], we tested whether the combination of the PHD and the
TTD results in cooperative histone-tail binding. Surprisingly, the
combined TTD–PHD domain of Uhrf2 displayed a fourfold increased
binding to H3K9me2/me3 in comparison to the single TTD, which
was not observed for the corresponding construct of Uhrf1
(Figs. 2B and 4A).
Sequence alignments of the combined domains revealed two
striking differences between Uhrf1 and Uhrf2. Firstly, Uhrf2 harbors
an additional stretch of 33 highly conserved amino acids present in
the TTD (Supplementary Fig. S5A). Secondly, the linker region
between the TTD and PHD domain of Uhrf2 is highly conserved,
whereas this region is highly diverse in Uhrf1 (Supplementary
Fig. S5A). To test which sequence is responsible for the observed
cooperative interplay between PHD and TTD, we generated
and tested different hybrid and deletion constructs (Supplementary
Fig. S5B). Notably, replacement of the native linker in the Uhrf2
TTD–PHD construct by the Uhrf1 linker caused decreased relative
binding ratios to H3K9me2/3 comparable to the single Uhrf2 TTD
(Fig. 4B). Transferring the Uhrf2 linker to the Uhrf1 TTD–PHD
construct as well as deletion of the Uhrf2 stretch region did not affect
the binding to H3K9me3 peptides (Fig. 4B).
These results suggest that the cooperative interplay of different
Uhrf2 domains, which is responsible for the increased binding to
heterochromatin marks, is dependent on the highly conserved linker
region connecting the TTD and PHD domains. A similar functional
importance of linker sequences has been described for BPTF and
histone lysine demethylases [Li et al., 2006; Horton et al., 2010].
UHRF1 AND UHRF2 ARE NOT FUNCTIONALLY REDUNDANT IN ESCS
To investigate whether Uhrf1 and Uhrf2 are functionally redundant
we performed interaction and rescue assays. Like Uhrf1, also Uhrf2
interacts with Dnmts (Supplementary Fig. S6) suggesting a similar
function in DNA methylation. To test for such a functional role, we
ectopically expressed Uhrf2-GFP or Uhrf1-GFP in uhrf1/ ESCs
and determined DNA methylation levels at major satellites by
pyrosequencing. While ectopic expression of Uhrf1-GFP led to
signiﬁcant increase of DNA methylation levels at CpG sites of major
satellite DNA in uhrf1/ ESCs, Uhrf2-GFP did not restore DNA
methylation at these sites (Fig. 5). These results point to functional
differences between Uhrf1 and Uhrf2 in vivo.
DISCUSSION
Over the past decades many different histone modiﬁcations were
discovered that are involved in epigenetic gene regulation. A key
question is how these histone marks are linked to DNA methylation
pattern and how this complex epigenetic information is integrated
and translated into deﬁned chromatin structures and gene
expression levels. Epigenetic regulators that bind DNA and histone
marks are ideally suited to link these pathways and intramolecular
interactions between different binding domains may contribute to
Fig. 4. Cooperative binding of the combined tandem Tudor–PHD domain of
Uhrf2. A: Histone H3 N-terminal tail binding speciﬁcity of the TTD of Uhrf2
and of the combined TTD and PHD domain (TTD–PHD) of Uhrf1 and Uhrf2.
Shown are means SEM from at least six independent experiments. B: Histone
H3K9me3 binding of the combined TTD–PHD domains of Uhrf1 and Uhrf2,
hybrid proteins (L1 and L2 specify inserted linker sequences derived from Uhrf1
and Uhrf2, respectively) and a stretch deletion Uhrf2 construct. Shown are
means SEM from at least three independent experiments.
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substrate speciﬁcity and epigenetic regulation [Hashimoto et al.,
2009].
Recently, Uhrf1, an essential factor for the maintenance of DNA
methylation, has been shown to bind to repressive DNA and histone
modiﬁcations via an SRA and a tandem Tudor domain, respectively.
Here we provide the ﬁrst systematic characterization of the second
member of the Uhrf family, Uhrf2, and demonstrate that Uhrf2 binds
to the H3K9me3 heterochromatin mark via an aromatic cage of a
tandem Tudor domain (TTD). Mutations in the aromatic cage
abolished binding to H3K9me3 histone-tail peptides in vitro and
prevented enrichment of Uhrf2 at pericentric heterochromatin in
vivo. Interestingly, similar mutations in the aromatic cage of Uhrf1
prevented repression of p16INK4A [Nady et al., 2011] suggesting a
link between H3K9me3 binding and a function of Uhrf proteins in
gene repression.
Our results point to a complex regulation of substrate recognition
by Uhrf2 involving cooperative binding domains and critical linker
sequences. In contrast to Uhrf1, preferential binding of Uhrf2 to
hemimethylated DNA, the substrate of DNA maintenance methyla-
tion, was only induced upon simultaneous binding to H3K9me3
histone-tail peptides. Binding of Uhrf1 and Uhrf2 to DNA in turn
enhanced binding to H3K9me3 histone-tail peptides. Consistently,
SILAC-based proteomic analysis identiﬁed enrichment of UHRF1 at
nucleosomes containing repressive DNA and H3K9 methylation
marks [Bartke et al., 2010]. Together, these data demonstrate a
cooperative interplay between DNA and histone tail binding
domains of Uhrf1 and Uhrf2. A similar effect was reported for
MSL3 that speciﬁcally binds to H4K20me1 via a chromodomain
only in the presence of DNA [Kim et al., 2010].
An additional level of complexity was added by recent studies
showing multivalent binding of histone-tail peptides by mixed two-
effector modules [Ruthenburg et al., 2007]. Notably, the combined
TTD–PHD domain of Uhrf2, but not of Uhrf1, showed enhanced
binding to H3K9me3 histone-tail peptides. This cooperativity was
dependent on the highly conserved linker region connecting the TTD
and PHD domains. Similarly, an important role was attributed to
the linker sequence between the histone binding domain (PHD) and
the histone modifying domain of jumanji histone lysine demethy-
lases [Horton et al., 2010].
The dramatic loss of DNA methylation in uhrf1/ ESCs [Bostick
et al., 2007; Sharif et al., 2007] is remarkable, especially considering
the presence of the uhrf2 gene, which encodes a highly similar
protein as demonstrated in this study. As one possible explanation
for this lack of functional redundancy we found, in contrast to
uhrf1, relatively low uhrf2 mRNA levels in ESCs, which were not
affected by genetic uhrf1 ablation. Moreover, both genes also show
opposite expression patterns during differentiation. The failure of
ectopically expressed Uhrf2 to restore DNA methylation in uhrf1
deﬁcient cells clearly points to functional differences between both
proteins in vivo. However, more deﬁnitive insights into the speciﬁc
function(s) of Uhrf2 will require targeted mutations and subsequent
analyses of pluripotent as well as differentiated cells. Based on the
cooperative binding of Uhrf2 domains to repressive DNA and
histone marks we propose that Uhrf2 might contribute to a tighter
control of gene repression in differentiated cells as compared to a
less stringent control by Uhrf1 in pluripotent ESCs.
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Supplementary Figure S1. Opposite expression pattern of uhrf1 and uhrf2. Expression 
analyses of uhrf1 and uhrf2 by Real-time PCR during differentiation of ESCs with two 
different genetic backgrounds (wt E14 (A) and wt JM8A (B)). Transcript levels of uhrf1 at day 
0 of EB formation are used as reference point (set to 1). Shown are means ± SD from three 
technical replicates of one biological experiment. 
  
Supplementary Figure S2. Model of the tandem Tudor domain (TTD) of Uhrf2. (A) A model of 
the TTD of Uhrf2 was generated using SWISS Model [Arnold et al., 2006; Guex and Peitsch, 
1997] with the solved structure of the TTD of Uhrf1 (PDB: 3DB3) as template. Both 
structures, the Uhrf2 model in red and the Uhrf1 template in cyan, are superimposed in 
PyMOL [Schrodinger, 2010]. (B) H3K9me3 is embedded in an aromatic cage formed by 
three aromatic residues of Uhrf2. 
  
  
Supplementary Figure S3. Electrophoretic mobility shift of Uhrf1 and Uhrf2. (A) Un- and 
hemimethylated DNA substrates (1 pmol each in direct competition) were incubated with 
0.63 pmol purified Uhrf1-GFP or Uhrf2-GFP. Samples were subjected to 3.5% non-
denaturing PAGE and analyzed with a fluorescence scanner (Typhoon TRIO scanner, GE 
Healthcare) to detect ATTO550 (unmethylated substrate), ATTO647N (hemimethylated 
substrate) and GFP. (B) Band intensities were quantified with ImageJ [Abramoff, 2004]. To 
quantify bound DNA/protein ratios, grey values of unbound DNA bands were subtracted from 
the corresponding DNA input bands and subsequently normalized by the grey values of the 
GFP bands. All values were normalized to the relative binding ratio of Uhrf1 to unmethylated 
substrate. Shown are means ± SD from three independent experiments. Statistical 
significance between the binding ratios of un- and hemimethylated DNA is indicated; 
*P < 0.05. 
  
  
Supplementary Figure S4. Cell-cycle dependent localization of Uhrf2 in cells with different 
genetic backgrounds. Confocal mid sections of fixed wt J1 (A), TKO (B) and Suv39h dn 
ESCs (C), transiently expressing Uhrf2-GFP. Cells were co-transfected with a RFP-PCNA 
expression vector to distinguish S phase stages [Sporbert et al., 2005] and counterstained 
with DAPI. Merged images are displayed on the right. Scale bar 5 µm. In wt J1 and TKO 
ESCs the Uhrf2 fusion protein accumulates at pericentric heterochromatin independent of the 
cell-cycle stage and methylation levels (A) (B). In contrast, Uhrf2-GFP shows a fully 
dispersed nuclear distribution in Suv39h dn cells indicating the dependency on H3K9me3 
methylation for localization at PH in vivo (C). (D) and (E) Scatter blot of GFP-Uhrf2 and DAPI 
signals in wt MEFs and Suv39h dn MEFs. The corresponding Pearson correlation 
coefficients R ± SEM are calculated from ten analysed cells. The software Volocity (Perkin 
Elmer) was used for analysis, selecting the cell nucleus as region of interest. Note that 
Pearson correlation coefficients range from +1 to -1 for perfect to no co-localization. 
  
  
Supplementary Figure S5. Alignment and recombination of Uhrf1 and Uhrf2 domains. (A) 
Alignment of the tandem Tudor domain (TTD) and PHD domains from vertebrate Uhrf2 and 
Uhrf1 orthologs. Accession numbers for Uhrf2: Homo sapiens CAH74119.1; Bos taurus 
AAI48950.1; Mus musculus Q7TMI3; Rattus norvegicus NP_001101055.1; Pan troglodytes 
XP_528534.2; Xenopus laevis AAI28674.1. Accession numbers for Uhrf1: Homo sapiens 
Q96T88.1; Bos taurus AAI51672.1; Mus musculus Q8VDF2.2; Rattus norvegicus Q7TPK1.2; 
Dario rerio NP_998242.1; Xenopus laevis AAI28674.1, Gallus gallus XP_418269.2. Arrows 
show the start and end positions of the TTD and PHD domains. Absolutely conserved 
residues are black shaded, while positions showing conservative substitutions are boxed with 
residues in bold face. The additional stretch region found in the TTD of Uhrf2 and the linker 
region between TTD and PHD finger are boxed with dotted black lines. (B) Schematic outline 
of engineered constructs including the deletion of the stretch region and the swapping of 
linker sequences. 
  
  
Supplementary Figure S6. Uhrf2 interacts with Uhrf1, Dnmt1 and Dnmt3a/b. (A) Co- 
immunoprecipation of Uhrf2-myc and GFP-Uhrf1, GFP-Dnmt3a, GFP-Dnmt3b, GFP-HP1α, 
GFP-HP1β, GFP-HP1γ or GFP transiently co-expressed in HEK293T cells. Note that Uhrf2 
interacts with Uhrf1, Dnmt3a and Dnmt3b. (B) Co-immunoprecipation of Uhrf2-myc and 
GFP-Dnmt1 constructs transiently co-expressed in HEK293T cells: GFP-Dnmt1 (G-Dnmt1), 
GFP-fusions of the N-terminal and C-terminal part of Dnmt1 (G-D1-Nterm, G-D1-Cterm) and 
truncated Dnmt1 constructs (G-Dnmt1 1-309, G-TS 310-629, G-Dnmt1 630-1111). Note that 
Uhrf2 interacts with full-length Dnmt1, the N-terminal part and the targeting sequence (G-TS 
310-629). One percent of input (I) relative to bound fractions (B) was loaded. Co-
immunoprecipitation was performed using the GFP trap [Rothbauer et al., 2008]. Co-
precipitated myc-tagged proteins were detected using a mouse monoclonal primary anti-myc 
antibody (Invitrogen, Germany) and an HRP- or Cy5-conjugated secondary anti-mouse 
antibody (Sigma, Germany, or Jackson ImmunoResearch Laboratories, USA, respectively). 
 
  
  
Supplementary Figure S7. Histone-tail peptide and DNA sequences and quality control of 
DNA substrates. (A) Amino acid sequence of TAMRA-labelled peptides for in vitro histone-
tail peptide binding assays. Histone-tail peptides were purchased as TAMRA conjugates 
(PSL, Germany). (B) DNA oligos used for preparation of double-stranded probes for in vitro 
DNA binding assays. M: 5-methyl-cytosine. For hybridization, DNA oligos were mixed in 
equimolar amounts, heated to 92°C and cooled down to room temperature. DNA substrates 
for Figure 2F were completed in a primer extension reaction. By using a control set of DNA 
probes with identical sequence but different fluorescent labels we observed effects due to 
probe preparation and/or unspecific binding of ATTO dyes (data not shown). The values 
obtained from the control set were used to normalize every probe/protein pair. (C) Quality 
control of DNA substrates. Un- and hemimethylated DNA substrates (2 pmol; Atto647N 
labelled) were digested with 1 unit MspI or HpaII and analyzed by 15% non-denaturing 
PAGE for CpG methylation. Note that unmethylated DNA substrate is digested by both 
enzymes, whereas hemimethylated substrate is only cut by MspI. Enzyme recognition motifs 
are boxed and asterisks represent ATTO labels.  
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Introduction
Multicellular organisms contain a variety of highly specialized 
cells that despite their morphological and functional differences 
possess the same genetic information. During development, dif-
ferent sets of genes are activated and repressed to generate the cell 
type-specific functionality. It has become increasingly clear that 
cell type-specific gene expression patterns are established and 
maintained by a complex interplay of transcriptions factors and 
epigenetic regulators. In particular, DNA and histone modifica-
tions control the composition, structure and dynamics of chro-
matin and thereby regulate gene expression.1-3
DNA methylation was the first epigenetic modification to 
be identified and has been intensively studied for half a century. 
DNA methylation is the post-replicative addition of methyl 
groups to the C5 position of cytosines catalyzed by a family of 
DNA methyltransferases (Dnmts). All C5 Dnmts share the same 
conserved motifs involved in the complex molecular mechanism 
of methyl group transfer best studied in the prokaryotic Dnmt 
*Correspondence to: Heinrich Leonhardt; Email: h.leonhardt@lmu.de
Submitted: 07/01/11; Revised: 08/27/11; Accepted: 08/31/11
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DNA methylation plays a central role in the epigenetic 
regulation of gene expression during development and 
disease. remarkably, the complex and changing patterns of 
genomic DNA methylation are established and maintained by 
only three DNA methyltransferases. Here we focus on DNMT1, 
the major and ubiquitously expressed DNA methyltransferase 
in vertebrates, to outline possible regulatory mechanisms. 
A list of all protein interactions and post-translational 
modifications reported for DNMT1 clearly shows that DNMT1, 
and by extension also DNA methylation in general, are 
functionally linked with several other epigenetic pathways 
and cellular processes. General themes of these interactions 
and modifications include the activation, stabilization and 
recruitment of DNMT1 at specific sites and heterochromatin 
regions. For a comprehensive understanding of the regulation 
of DNA methylation it is now necessary to systematically 
quantify the interactions and modifications of DNMT1, to 
elucidate their function at the molecular level and to integrate 
these data at the cellular level.
Regulation of DNA methyltransferase 1  
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weihua Qin, Heinrich Leonhardt* and Garwin Pichler
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M.HhaI (Fig. 1A).6 This mechanism involves Dnmt binding to 
the DNA, flipping the target cytosine out of the DNA double 
helix, covalent bond formation between a conserved cysteine 
nucleophile and the cytosine C6, transfer of a methyl group from 
S-adenosyl-l-methionine to the activated cytosine C5 and Dnmt 
release by β-elimination.6,7
In vertebrates, there are five known members of the Dnmt fam-
ily that differ in structure and function and apart from DNMT2, 
all Dnmts comprise an N-terminal regulatory domain in addi-
tion to the C-terminal catalytic domain (Fig. 1A). The Dnmt3 
subfamily, comprising DNMT3a and DNMT3b, shows activity 
toward unmethylated DNA and establishes de novo DNA meth-
ylation patterns during gametogenesis and embryogenesis.8-10 The 
cofactor DNMT3L11 specifically recognizes unmethylated histone 
H3K4 12 and stimulates the activity of DNMT3a and DNMT3b,13 
but by itself lacks enzymatic activity.14 Established DNA methyla-
tion patterns are maintained during DNA replication and DNA 
repair by the ubiquitously expressed DNMT1,15,16 which displays 
a strong preference for hemimethylated CpG sites, the substrate of 
maintenance DNA methylation.17 The fifth member of the Dnmt 
family, DNMT2, shows very weak activity toward DNA and was 
instead shown to methylate cytoplasmic tRNAAsp.18,19
Despite their common catalytic mechanism, all three active 
eukaryotic Dnmts have distinct and non-redundant functions 
which are likely mediated by their diverse regulatory domains 
(Fig. 1A). In contrast to prokaryotic Dnmts, the tissue-specific 
de novo Dnmts, DNMT3a and DNMT3b, are only active 
on a subset of target CpG sites,20 reflecting a selective control 
imposed by the N-terminal regulatory domain. The ubiquitously 
expressed DNMT1 preferentially methylates hemimethylated 
CpG sites and thereby maintains DNA methylation patterns 
after DNA replication and DNA repair.15-17 Remarkably, the cat-
alytic domain of DNMT1—although possessing all conserved 
motifs—is not catalytically active by itself and requires alloste-
ric activation by the N-terminal regulatory domain.21-23 In this 
review we will focus on a detailed description of DNMT1 regula-
tion to illustrate the extremely complex and interconnected regu-
lation of DNA methylation.
Structure and Function of DNMT1
Bioinformatic analysis suggested that mammalian DNMT1 
evolved by fusion of at least three ancestral genes.22 The 
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repeats.24,25 The PBD domain has been shown to mediate the 
interaction with PCNA leading to the association of DNMT1 
with the replication machinery.15,26,27 The TS domain mediates 
association with heterochromatin and may lead to dimeriza-
tion of DNMT1.15,27,28 The CXXC domain of DNMT1 binds to 
N-terminal domain of DNMT1 harbors a proliferating cell 
nuclear antigen (PCNA) binding domain (PBD), a targeting 
sequence (TS domain), a zinc finger domain (CXXC) and two 
bromo-adjacent homology domains (BAH1/2) and is connected 
to the C-terminal catalytic domain by seven lysyl-glycyl dipeptide 
Figure 1. Structural insights into the DNA methyltransferase 1 (DNMT1). (A) Schematic outline of the domain architecture of mammalian Dnmts in 
comparison to the prokaryotic Dnmt, M.Hhai. All Dnmts harbor highly conserved motifs (i-X) in the C-terminal catalytic domain. in addition, DNMT1 
harbors a proliferating cell nuclear antigen (PCNA) binding domain (PBD) followed by the targeting sequence (TS domain), a zinc finger domain 
(CXXC), two bromo-adjacent homology domains (BAH1/2). DNMT3a and DNMT3b comprise a PwwP domain and a PHD domain that is also found in 
DNMT3L. (B) Crystal structure of the prokaryotic cytosine-(C5) methyltransferases M.Hhai in complex with hemimethylated DNA (PDB iD code 5mht).4 
(C) Crystal structure of the large fragment (291–1,620) of mouse DNMT1 (PDB iD code 3Av4) 5 in superimposition with the prokaryotic structure (B) 
showing the expected steric clash between the TS domain and DNA binding in the catalytic pocket. The single domains are color-coded as in (A).
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ring which serves as a common loading platform for replica-
tion factors.26,44-46 Binding of DNMT1 to PCNA enhances the 
methylation activity about 2-fold, but is not strictly required for 
maintaining DNA methylation in vivo.47,48 Thus, the transient 
association between DNMT1 and PCNA alone cannot bridge 
the gap between the slow in vitro kinetics of DNMT1 and the 
fast progression of the replication fork in vivo.
Although DNMT1 can bind hemimethlytated CpG sites 
by itself, it also interacts with methyl-CpG binding proteins 
like MeCP2,49 MBD2/3 50 and the UHRF family.25,51 MeCP2 
binds DNA, induces chromatin compaction52,53 and interacts 
with DNMT1 via its transcription repressor domain (TRD).49 
MeCP2 and MBD2, which specifically recognize fully methyl-
ated CpG sites,54 and MBD3 also form complexes with histone 
deactelyases HDAC1 and HDAC2 which in turn interact with 
DNMT1.49,55-58 This set of interactions can explain the correla-
tion between DNA hypermethylation and histone hypoacety-
lation at transcriptional inactive regions,59 suggesting a role in 
transcriptional repression.60 This complex may also comprise the 
DNMT1 association protein (DMAP1) 58,61 and the transcrip-
tional co-regulator Daxx62 mediating repression in an HDAC-
independent manner.58,61 In addition, the interaction with 
methyl-CpG binding proteins and HDACs may enrich DNMT1 
in highly methylated heterochromatic regions to increase local 
methylation efficiency and/or enhance heterochromatin forma-
tion at these highly methylated regions.
Recently, UHRF1 has emerged as an essential co-factor for 
maintenance DNA methylation. The genetic ablation of uhrf1 in 
embryonic stem cells (ESCs) leads to genomic hypomethylation 
similar to dnmt1-/- ESCs.63,64 UHRF1 co-localizes and interacts 
with DNMT1 throughout S-phase and preferentially binds to 
hemimethylated DNA via a SET and Ring associated (SRA) 
domain and to the H3K9me3 heterochromatin mark via a tan-
dem Tudor domain.65-69 The crystal structure of the SRA domain 
in complex with hemimethylated DNA revealed that the 5-meth-
ylcytosine is flipped out of the DNA double helix, a configuration 
that would stabilize the UHRF1-DNA interaction.65-69 These 
results suggest that DNMT1 does not directly bind its substrate, 
the hemimethylated DNA, but is rather recruited by UHRF1. 
Recently, the second member of the UHRF family, UHRF2, was 
also shown to interact with DNMT1 and repressive epigenetic 
marks.70 The slight differences in the structure and function of 
UHRF1 and UHRF2 and their opposite expression patterns sug-
gest non-redundant functions during development.70 In addition, 
UHRF1 and UHRF2, as well as DNMT1, bind to the de novo 
Dnmts DNMT3a and DNMT3b.70-75 These results demonstrate 
a complex interplay between methyl-CpG binding proteins and 
Dnmts in establishing genomic DNA methylation patterns.
Besides the interaction with methyl-CpG binding proteins, 
DNMT1 also associates with a number of proteins involved in 
the establishment and maintenance of heterochromatin struc-
ture. DNMT1 interacts with the major eukaryotic histone 
methyltransferases Suv39H1 76 and EHMT2 77-80 (also known 
as G9a), which are essential for H3K9 methylation.73,81 Genetic 
ablation of ehmt2 81,82 and suv39 h73 in mouse ESCs leads to DNA 
hypomethylation at specific loci in genomic DNA and altered 
unmethylated DNA but its deletion does not alter the activity and 
specificity of DNMT1.29 Interestingly, the isolated C-terminal 
catalytic domain of DNMT1, although harboring all conserved 
Dnmt motifs, requires an additional, large part of the N-terminal 
domain for enzymatic activity.21-23 Fusion of this N-terminal 
region of DNMT1 to the prokaryotic Dnmt, M.HhaI, induced 
a preference for hemimethylated DNA.30 Cleavage between the 
regulatory and the catalytic domain stimulated the initial veloc-
ity of methylation of unmethylated DNA without substantial 
change in the rate of methylation of hemimethylated DNA.31 
These findings illustrate the role of the N-terminal domain in 
the selective activation of the catalytic domain to ensure faithful 
maintenance of DNA methylation patterns.
First insights into the molecular mechanism of DNMT1 
regulation were provided by two recently published crystal struc-
tures comprising either a large fragment of mouse DNMT1 
(aa 291–1,620) (PDB ID code 3AV4) or a shorter fragment (aa 
650–1,602) in complex with unmethylated DNA (PDB ID code 
3PT6).5,32 Notably, the overall structure of the eukaryotic cata-
lytic domain is highly similar to the prokaryotic M.HhaI (PDB 
ID code 5mht) (Fig. 1B and C).4 In addition, both structures 
showed an interaction of the N-terminal regulatory domain with 
the C-terminal catalytic domain,5,32 which is consistent with 
prior genetic and biochemical studies.21,33 Remarkably, the TS 
domain was found deeply inserted into the catalytic pocket and 
would in this conformation prevent DNMT1 binding to hemi-
methylated DNA, the substrate for maintenance DNA methyla-
tion.5 These structural insights indicate that DNMT1 most likely 
undergoes several conformational changes during the methyla-
tion reaction. Activation of DNMT1 requires displacement of 
the TS domain from the DNA binding pocket to allow substrate 
binding. Indeed, deletion of the TS domain lowered the acti-
vation energy4 and addition of purified TS domains inhibited 
DNMT1 methylation activity in vitro,34 clearly pointing to an 
auto-inhibitory function of the TS domain. These findings sug-
gest that interacting proteins may modulate the interactions of 
the N-terminal domain with the catalytic domain and thereby 
regulate the activity of DNMT1 in vivo.
Regulation of DNMT1 Activity by Interacting Factors
Previously, it was proposed that nuclear processes like the repli-
cation of genetic and epigenetic information are regulated and 
coordinated by targeting participating proteins to functional 
subnuclear structures.35-37 Over the last two decades, a large vari-
ety of proteins were reported to interact with DNMT1, ranging 
from DNA methyltransferases, DNA binding proteins, chroma-
tin modifiers and chromatin binding proteins to tumor suppres-
sors, cell cycle regulators and transcriptional regulators (Fig. 2 
and Table 1).
The discrepancy between the high processivity of DNA rep-
lication (~0.035 sec per nucleotide) 42 and the low turnover rates 
(70–450 sec per methyl group) of recombinant DNMT1 43 in 
vitro suggests that additional mechanisms increase the activity of 
DNMT1 in vivo. Indeed, DNMT1 associates with the replica-
tion machinery15 by directly binding to PCNA, a homotrimeric 
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Figure 2. Overview of DNMT1 interacting proteins. (A) interacting proteins range from DNA methyltransferases, DNA binding proteins, chromatin 
modifiers and chromatin binding proteins to tumor suppressors, cell cycle regulators and transcriptional regulators. Proteins involved in the post-
translational modification of DNMT1 are highlighted in green. (B) Mapped interaction domains are indicated.
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Table 1. Overview of DNMT1 interacting proteins
Interacting Protein Function Method Organism References
Trancriptional regulator
DMAP1
involved in transcription repression and acti-
vation
Component of the NuA4 histone acetyltrans-
ferase (HAT) complex
Yeast 2-hybrid (Y2H)
Affinity Capture-western (AC/
wB)
reconstituted Complex
H. sapiens rountree, et al. 2000
PML-rAr
Transcriptional regulator of retinoic acid (rA) 
target genes; induces gene hypermethylation 
and silencing by recruiting Dnmt1
AC/wB H. sapiens Di Croce, et al. 2002
HeSX1
required for the normal development of the 
forebrain, eyes and other anterior structures; 
Possible transcriptional repressor
Y2H
AC/wB
H. sapiens Sajedi, et al. 2008
CXXC1 (CFP1)
Transcriptional activator that exhibits a 
unique DNA binding specificity for [AC]
CpG[AC] unmethylated CpG motifs
AC/wB H. sapiens Butler, et al. 2008
SP1 Transcription factor AC/wB H. sapiens esteve, et al. 2007
SP3 Transcription factor AC/wB H. sapiens esteve, et al. 2007
STAT3
Transcription factor that binds to the interleu-
kin-6 (iL-6)-responsive elements
AC/wB
Co-localization
H. sapiens Zhang, et al. 2005
wT1
Transcription factor that plays an important 
role in cellular development and cell survival
AC/wB H. sapiens Xu, et al. 2011
riP140
Modulates transcriptional activation and 
repression
AC/wB H. sapiens Kiskinis, et al. 2007
Chromatin modifier
HDAC1/2
Deacetylation of lysine residues on the 
N-terminal part of the core histones (H2A, 
H2B, H3 and H4)
AC/wB 
Co-fractionation
reconstituted Complex Y2H
H. sapiens
M. musculus
Fuks, et al. 2000; 
rountree, et al. 2000; 
Achour, et al. 2008; 
Kimura, et al. 2003; 
robertson, et al. 2000; 
Myant, et al. 2008;
KDM1A (AOF2; LSD1)
Histone demethylation of H3K4me and 
H3K9me; Demethylation of DNMT1
AC/wB M. musculus wang, et al. 2008
SUv39H1
Histone methyltransferase that specifically 
trimethylates H3K9
AC/wB H. sapiens
Fuks, et al. 2003; 
estève, et al. 2006
eHMT2 (G9a)
Histone methyltransferase that specifically 
mono- and dimethylates H3K9
AC/wB H. sapiens
estève, et al. 2006;  
Kim, et al. 2009; 
Tachibana, et al 2002; 
Peters, et al. 2003
eZH2
Polycomb group (PcG) protein. Catalytic sub-
unit of the PrC2/eeD-eZH2 complex
AC/wB 
reconstituted complex
H. sapiens
vire, et al. 2006;  
Xu, et al; 2011
eeD
Polycomb group (PcG) protein. Component 
of the PrC2/eeD-eZH2 complex
AC/wB 
Co-localization
H. sapiens vire, et al. 2006
SeTD7
Histone methyltransferase that specifically 
monomethylates H3K9
AC/wB 
Biochemical Activity
H. sapiens esteve, et al. 2009
KAT5 (TiP60)
Catalytic subunit of the NuA4 histone acetyl-
transferase complex
AC/wB H. sapiens Du, et al. 2010
LSH Chromatin remodeling AC/wB H. sapiens
Myant and Stancheva, 
2008
SMArCA5 (SNF2H)
Helicase that possesses intrinsic ATP-
dependent nucleosome-remodeling activity
AC/wB H. sapiens robertson, et al. 2004
The function of proteins is according to the UniProt database38,39 and the applied method is according to the BioGriD40 database apart from the 
fluorescent two-hybrid (F2H) assay.41 All protein names are according to the human nomenclature unless noted otherwise. Proteins involved in the 
post-translational modification of DNMT1 are highlighted in green.
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BAZ2A (TiP5)
essential component of the NorC (nucleolar 
remodeling complex) complex
reconstituted Complex H. sapiens Zhou, et al. 2005
(Methyl) CpG binding proteins
MeCP2 Methylated CpG binding protein
AC/wB 
reconstituted complex
R. norvegicus Kimura and Shiota, 2003
MBD2/MBD3 Methylated CpG binding protein AC/wB H. sapiens Tatematsu, et al. 2000
UHrF1
Hemimethylated CpG binding protein; essen-
tial for maintenance DNA methylation
Y2H
AC/wB 
reconstituted complex
Co-localization
H. sapiens
M. musculus
Bostick, et al. 2007 ; 
Sharif, et al. 2007; 
Arita, et al. 2008 ; 
Awakumov, et al. 2008; 
Qian, et al. 2008; 
Achour, et al. 2008; 
Meilinger, et al. 2009
UHrF2
e3 ubiquitin-protein ligase which mediates 
ubiquitination and subsequent proteasomal 
degradation of PCNP; Hemimethylated CpG 
binding protein
AC/wB M. musculus Pichler, et al. 2011
Tumor suppressor
p53 Tumor suppressor in many tumor types AC/wB H. sapiens esteve, et al. 2005
hNaa10p
Tumor suppressor
Stimulate Dnmt1 activity
AC/wB H. sapiens Lee, et al. 2010
DNA methyltransferase
DNMT3a
required for genome wide de novo methyla-
tion and is essential for the establishment of 
DNA methylation patterns during develop-
ment
AC/wB 
reconstituted Complex
H. sapiens
M. musculus
Fatemi, et al. 2002;  
Kim, et al. 2002
DNMT3b
required for genome wide de novo methyla-
tion and is essential for the establishment of 
DNA methylation patterns during develop-
ment
AC/wB 
reconstituted Complex
H. sapiens
rhee, et al. 2002;  
Kim, et al. 2002;  
Lehnertz, et al. 2003; 
Geiman 2004
Chromatin binding protein
HP1β recognizes and binds methylated H3K9 reconstituted Complex H. sapiens Fuks, et al. 2003
CBX5 recognizes and binds methylated H3K9 AC/wB H. sapiens Lehnertz, et al. 2003
Cell cycle regulator
PCNA Targeting Dnmt1 to replication foci
AC/wB 
reconstituted Complex
Co-localization
H.sapiens
Leonhardt, et al. 1992; 
Chuang, et al. 1997; 
rountree, et al. 2000
rB1 Cell cycle regulator
AC/wB 
reconstituted Complex 
Co-fractionation
H. sapiens
robertson, et al. 2000; 
Pradhan, et al. 2002
e2F1
Transcription factor
Play a role in controlling cell cycle entry
Co-fractionation H. sapiens robertson, et al. 2000
CHeK1 (CHK1)
checkpoint mediated cell cycle arrest in 
response to DNA damage or the presence of 
unreplicated DNA
AC/wB H. sapiens Palii, et al.  2008
Others
rGS6 regulator of G-protein signaling reconstituted Complex H. sapiens Liu, et al. 2004
USP7
Hydrolase that deubiquitinates target pro-
teins
AC/Mass Spectrometry
AC/wB 
F2H
H. sapiens
M. musculus
Sowa, et al. 2009; 
Qin, et al. 2010;  
Du, et al. 2010
The function of proteins is according to the UniProt database38,39 and the applied method is according to the BioGriD40 database apart from the 
fluorescent two-hybrid (F2H) assay.41 All protein names are according to the human nomenclature unless noted otherwise. Proteins involved in the 
post-translational modification of DNMT1 are highlighted in green.
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receptors, interacts with DNMT1 and DNMT3s in gene 
repression.93
Additional DNMT1 interactions have been reported with 
various tumor suppressor genes including WT1,84 Rb,57,94 p5395 
and hNaa10p.96 The Wilms tumor suppressor protein (WT1) 
recruits DNMT1 to the Pax2 promoter resulting in DNA 
hypermethylation.84 The retinoblastoma (Rb) tumor supressor 
gene product associates with DNMT1 and the transcription 
factor, E2F1, resulting in transcriptional repression of E2F1-
responsive promoters.57 The interaction with p53 stimulates 
DNMT1 activity leading to hypermethylation.95 In addition, 
studies showed that either deletion of p53 in the HCT116 
human colon carcinoma cell line or knockdown of p53 in 
human B-lymphoblast TK6 cells results in an increased level 
of DNMT1.97,98 Interestingly, clinical data from lung cancer 
patients indicated that p53 mutations were associated with over-
expression of DNMT1, providing a mechanistic link between 
the p53-DNMT1 interaction and cancerogenesis.99 Finally, the 
tumor suppressor, hNaa10p, recruits DNMT1 to promoters of 
tumor suppressor genes and increases the DNA binding affinity 
of DNMT1.96 Besides a role in normal gene regulation, con-
nections with deregulated gene expression in cancer were also 
reported. The leukemia-promoting PML-RAR fusion recruits 
DNMT1 to target promoters, inducing gene hypermethylation, 
an early step of carcinogenesis.100
For the sake of completeness, the following DNMT1 interact-
ing proteins should be mentioned even though the function of 
these interactions is still unclear. The first described interacting 
partners of DNMT1 were Annexin V101 and the molecular chap-
erone p23.102 The functional importance of DNMT1 interactions 
with RGS6, a protein that negatively regulates the heterotrimeric 
G protein signaling,103 with PARP-1 104,105 and with HESX1 106 
also remain elusive. The diversity of proteins reported to interact 
with DNMT1 provides a first insight into the complexity of the 
epigenetic network and illustrates the central role of DNMT1 in 
these regulatory pathways.
DNA methylation of pericentric satellite repeats, respectively. 
Interestingly, also the H3K9me3 binding heterochromatin pro-
tein HP1β was shown to interact with DNMT1,76 but localiza-
tion of DNMT1 at late replicating chromocenters seemed to be 
independent of SUV39H1/2 and HP1β.27 In addition, DNMT1 
interacts with Polycomb group (PcG) proteins EZH2 83,84 and 
EED,83 which are subunits of the PRC2/EED-EZH2 complex 
that methylates H3K27. EZH2 was shown to recruit DNMT1 
to target genes and thereby mediate promoter methylation.83 
A recent study showed that DNMT1 inhibition decreased the 
expression levels of PcG proteins and induced cellular senescence, 
providing a possible link between DNA methylation, mainte-
nance of stem cell self-renewal and multipotency.85
In addition to the histone modifying enzymes, also chroma-
tin remodeling ATPases like LSH are required for maintaining 
DNA methylation in mammals. LSH is related to the SNF2 fam-
ily of chromatin-remodeling ATPases and forms a complex with 
DNMT1, DNMT3b and HDACs, suggesting a role in transcrip-
tional repression.86,87 Similarly, BAZ2A (also known as TIP5), 
the large subunit of the nucleolar remodeling complex (NoRC), 
forms a complex with DNMT1, DNMT3s, HDACs and 
hSNF2H, mediating recruitment to rDNA.88 One component of 
this complex, the chromatin remodeler hSNF2H, increases the 
binding affinity of DNMT1 to mononucleosomes.89 The interac-
tion with these chromatin remodeling factors may help DNMT1 
to access substrate sites in heterochromatic regions.
Besides indirect connections to transcriptional regulation, 
also direct interactions of DNMT1 with transcription regula-
tors and factors have been described. CXXC1 (CFP1), a com-
ponent of the SetD1A/B methyltransferase complex, binds to 
DNMT1, and Cxxc1-deficient ESCs display reduced levels of 
global DNA methylation.90 Moreover, DNMT1 was shown to 
interact with the transcription factors SP1,91 SP3 91 and STAT3.92 
A STAT3-DNMT1-HDAC1 complex binds to the promoter of 
shp1, encoding a negative regulator of cell signaling, inducing 
cell transformation.92 Also RIP140, a co-repressor for nuclear 
Table 1. Overview of DNMT1 interacting proteins
UBC9 e2 ubiquitin-conjugating enzyme AC/wB H. sapiens Lee, et al. 2009
AKT1 rAC-alpha serine/threonine-protein kinase
AC/wB 
Co-localization
H. sapiens esteve, et al. 2011
PArP-1 Poly [ADP-ribose] polymerase 1
AC/wB 
reconstituted Complex
H. sapiens
reale, et al. 2005; 
Zampieri, et al. 2009
p23 Molecular chaperone AC/wB H. sapiens Zhang and verdine 1996
Daxx
Adapter protein in a MDM2-DAXX-USP7 
complex 
AC/wB 
Co-localization
H. sapiens Muromoto, et al. 2004
Annexin v Anticoagulant protein AC/wB R. norvegicus Ohsawa, et al. 1996
PKCs Protein kinase C
AC/wB 
Co-localization
H. sapiens Lavoie, et al. 2011
CK1 δ/ε Casein kinase 1δ/ε AC/wB M. musculus Sugiyama, et al. 2010
The function of proteins is according to the UniProt database38,39 and the applied method is according to the BioGriD40 database apart from the 
fluorescent two-hybrid (F2H) assay.41 All protein names are according to the human nomenclature unless noted otherwise. Proteins involved in the 
post-translational modification of DNMT1 are highlighted in green.
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physical interaction is required for the stabilization of DNMT1. 
Furthermore, the interaction of UHRF1 and DNMT1 increases 
during late S phase leading to destabilization of DNMT1.110
In fact, the first post-translational modification to be described 
was the phosphorylation of Dnmt1 at Ser515 (DNMT1 Ser509)112 
(Fig. 3A), which was suggested to modulate the interaction 
between the regulatory and catalytic domain.113 In addition, 
Dnmt1 is phosphorylated at Ser146 (in mice only) by the casein 
kinase 1δ/ε, decreasing the DNA binding affinity,114 and at sites 
in the regulatory domain, which have yet to be mapped, by mem-
bers of the PKC family.115 Notably, it has been reported that the 
phosphorylation of DNMT1 disrupts the DNMT1/PCNA/
UHRF1 interaction, promoting global DNA hypomethylation in 
human gliomas.116 Phosphorylation of Ser143 by AKT1 during 
early and mid-S phase has been described to stabilize DNMT1.117 
S143 phosphorylation in turn blocks methylation of the adjacent 
Lys142 by SETD7, which marks DNMT1 for proteolytic degra-
dation during late S phase and G
2
.117,118
Besides Lys142, SET7/9 can also methylate the Lys1096 
residue of Dnmt1 (Lys1094 of DNMT1), which destabilizes the 
enzyme. The corresponding demethylation by KDM1A (also 
Regulation of DNMT1 Activity by Modifications
While most of the interacting factors regulate DNMT1 activ-
ity by recruitment to specific DNA sequences and target genes, 
some of them have been described to modulate DNMT1 activity 
by post-translational modifications (Fig. 3). Recent publications 
have described several different post-translational modifications 
that influence the stability, abundance and activity of DNMT1.
DNMT1 was shown to undergo cell cycle-dependent changes 
in acetylation and ubiquitination.109-111 On the one hand, DNMT1 
is acetylated by KAT5 and subsequently ubiquitinated by the E3 
ubiquitin ligase, UHRF1, marking DNMT1 for proteolytic deg-
radation. The abundance of DNMT1 increases in early S phase 
and starts to decrease during late S or G
2
 phase, a pattern which 
inversely correlates with the abundance of KAT5, suggesting that 
KAT5-mediated DNMT1 acetylation triggers DNMT1 degrada-
tion.110 On the other hand, DNMT1 is deubiquitinated by USP7 
(also known as Herpes virus-associated ubiquitin-specific protease 
HAUSP) and deacetylated by HDAC1, protecting DNMT1 from 
proteolytic degradation.110,111 The interaction between DNMT1 
and USP7 is disrupted during mid-late S phase, showing that a 
Figure 3. regulation of DNMT1 by post-translational modifications. (A) Schematic outline of the domain architecture of DNMT1. The lysine residues 
K142 and K1094 are methylated and the serine residues S143 and S509 phosphorylated. in addition, the murine Dnmt1 is phosphorylated at S146. The 
conservation of known modified sites are shown in sequence logos by webLogo.107 The input to webLogo was a Clustalw108 alignment of DNMT1 from 
different species (Homo sapiens P26358.2; Bos Taurus DAA27999.1; Mus musculus P13864.5; Rattus norvegicus Q9Z330.2; Gallus gallus Q92072.1; Paracen-
trotus lividus Q27746.1 and Danio rerio AAi63894.1). (B) Crosstalk between DNMT1 and interacting proteins leading to post-translational modifications 
of DNMT1. The following abbreviations are used: Ac = Acetylation; Ub = Ubiquitination; SUMO = Sumoylation; p = Phosphorylation; Me = Methylation. 
The dotted line indicates a hypothetical dephosphorylation.
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at which stage of cellular differentiation, and finally which frac-
tions of the cellular DNMT1 protein pool are involved. Clearly, 
the availability of first structural data of DNMT1 helps to eluci-
date the function of these interactions and modifications in the 
regulation of DNMT1 at the molecular level.5,32,122 The biggest 
challenge however will be the integration of all these data to 
comprehend DNMT1 regulation in the context of living cells, 
taking into account the complexity and dynamics of its natural 
substrate, the chromatin, as well as the competition or coopera-
tion with countless other cellular proteins and processes.
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known as lysine-specific demethylase LSD1 and AOF2) in turn 
increases the stability of Dnmt1.119 Consistently, the genetic abla-
tion of kdm1a in ESCs led to a progressive loss of DNA methyla-
tion119 and caused cellular differentiation.120 Finally, DNMT1 is 
also sumoylated by the ubiquitin-conjugating enzyme, UBC9, 
leading to the increased catalytic activity of DNMT1 on genomic 
DNA in vitro.121 In summary, post-translational modifications 
influence the abundance and activity of DNMT1, and may thus 
play a role during normal development and disease.
Perspective
The ever-increasing list of interacting factors and post-transla-
tional modifications reported for Dnmt1 impressively illustrates 
the complexity of the regulation of DNA methylation in vivo. 
Many of these interactions and modifications were identified in 
different cells and species, using varied and mostly qualitative 
methods. It is now essential to systematically and quantitatively 
analyze the different combinations in which they occur, in which 
cell types they take place, during which phase of the cell cycle, 
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Cell Cycle-dependent Interactions of Dnmt1
Introduction and Aims
DNA methylation plays a central role in the epigenetic regulation of gene expres-
sion during development. Remarkably, the complex and changing patterns of ge-
nomic DNA methylation are established and maintained by only three DNA methyl-
transferases. In mammalian cells, Dnmt1 copies the DNA methylation pattern from
parental to daughter strand during DNA replication, thereby maintaining an impor-
tant epigenetic mark. Crucial for this process is not only the intrinsic preference of
Dnmt1 for hemimethylated DNA, the substrate of maintenance DNA methylation, but
also the interaction of Dnmt with a variety of different cellular structures and cofactors
at different cell cycle and developmental stages. Although, many interacting proteins
have been identified in the last two decades, the exact and dynamic regulation of
Dnmt1 is still poorly understood. Recent studies showed that interacting proteins could
have different impact on Dnmt1 depending on the cell cycle phase the interaction
occurs. One striking example for cell cycle-dependent regulation is the interaction
of Dnmt1 with Uhrf1. On one hand, Uhrf1 is an essential co-factor for maintenance
DNA methylation and its genetic ablation in ESCs leads to remarkable genomic hy-
pomethylation, a phenotype similar to dnmt1-/- ESCs (Bostick et al., 2007; Sharif et al.,
2007). Uhrf1 co-localizes and interacts with Dnmt1 throughout S-phase, preferentially
binds to hemimethylated DNA via a SET and Ring associated (SRA) domain and to
the H3K9me3 heterochromatin mark via a tandem Tudor domain, suggesting a role
in recruiting Dnmt1 to replication foci. On the other hand, Dnmt1 is ubiquitinated by
Uhrf1 triggered by Kat5-mediated acetylation of Dnmt1 (Qin et al., 2011a; Du et al.,
2010). Interestingly, the abundance of Dnmt1 increases in early S phase and starts
to decrease during late S and/or G2 phase, a pattern which inversely correlates with
the abundance of Kat5, suggesting that Kat5-mediated Dnmt1 acetylation triggers
Dnmt1 degradation. These data suggest, that Uhrf1 plays a dual role dependent on
the cell cycle phase. Uhrf1 either "activates" Dnmt1 by recruiting it to hemimethylated
CpG sites or "inactivates" Dnmt1 by triggering its proteosomal degradation by ubiq-
uitination. The ever-increasing list of interacting factors and post-translational modifi-
cations reported for Dnmt1 impressively illustrates the complexity of the regulation of
DNA methylation in vivo. For a comprehensive understanding of the regulation of DNA
methylation it is now necessary to systematically quantify the interactions and modifi-
cations of Dnmt1, to elucidate their function at the molecular level and to integrate
these data at the cellular level. It is now essential to analyze the different combinations
in which Dnmt1 interactions occur, in which cell types they take place, during which
phase of the cell cycle, at which stage of cellular differentiation, and finally which
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fractions of the cellular Dnmt1 protein pool are involved. In this study, we use a com-
bination of stable isotope labelling with amino acids in cell culture(SILAC) and mass
spectrometry to quantify cell cycle-specific interactions of Dnmt1.
Workow for quantitative analysis of Dnmt1 interactions
For a comprehensive understanding how Dnmt1 and DNA methylation is regulated
over the cell cycle it is crucial to quantify and analyze cell cycle-dependent interac-
tions of Dnmt1. Here, we use a combination of SILAC-based quantitative proteomics
(Ong et al., 2002) with immunoprecipitation of endogenous Dnmt1 from HeLa (derived
from cervical cancer cells taken from Henrietta Lacks) cells, synchronized at different
phases of the cell cycle. A standard workflow for SILAC-based analysis of protein inter-
action partners in pull-down experiments is summarized in (Figure 10).
In brief, HeLa cells are grown in either "light" media (containing 12C and 14N lysine
and arginine) or "heavy" media (containing 13C and 15N substituted lysine and argi-
nine). Cells grown in "light" or "heavy" media represent the non-labelled samples or the
SILAC standard, respectively. After culturing the cells for 12 days, which is sufficient for
complete labelling of the proteins, the cells are synchronized in G1 by adding 0.8 mM
mimosine to the media. It has been demonstrated, that the rare non- protein amino
acid mimosine induces a cell cycle arrest of human somatic cells in late G1 phase, be-
fore establishment of active DNA replication forks (Krude, 1999). After 24 h mimosine
treatment, the HeLa cells are released from G1 and harvested immediately (G1 phase)
or after 5 h (early S phase) and 10 h (late S phase). In this approach, SILAC is only used
to produce heavy labelled reference proteins or proteomes. these are added to the
proteomes under investigation after cell lysis and before protein digestion. The actual
experiment is therefore completely decoupled from the labeling procedure (Geiger
et al., 2011). In addition, the effective experimental variability, that inevitably occurs
when the samples are processed independently, reduces (Trinkle-Mulcahy et al., 2008).
The cells were lysed, protein concentrations were measured and equivalent amounts
of cell lysates were mixed. After a pre-clearing step, using not-functionalized beads,
endogenous Dnmt1 is immunoprecipitated using a Dnmt1 binding protein coupled to
agarose beads (DBP) provided by ChromoTek (Germany). The specific DBP was engi-
neered based on a 13-kDa Dnmt1 binding fragment derived from a llama single chain
antibody (Rothbauer et al., 2008). After washing four times with 150 mM NaCl, the
bound proteins were eluted by on-beads trypsination and analysed by high sensitivity
mass spectrometry in the Core Facility of the Max-Planck-Institute of Biochemistry.
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Figure 10: Workow of SILAC-based quantification of cell cycle-dependent interactions of Dnmt1
Firstly, HeLa cells are cultured for 12 days in SILAC media containing either "light" or "heavy" lysines and
arginines. Secondly, the HeLa cells are synchronized for 24 h with 0.8 mM mimosine, released and har-
vested either in G1, early S or late S of the cell cycle. HeLa cells labelled with "heavy" media and sychro-
nized in the corresponding cell cycle phases are mixed 1:1:1 and represent the SILAC standard. Thirdly,
the SILAC standard is mixed 1:1 with non-labelled HeLa cells synchronized either in G1, early S or late S
of the cell cycle. Endogenous Dnmt1 is immunoprecipitated with a specific Dnmt1 Binder coupled to
agarose-beads and the interactions are quantitatively determined by mass-spectrometry.
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Immunoprecipitation of endogenous Dnmt1 from crude cell extracts
As a first test, we determined the efficiency of the specific DBP to immunoprecipitate
endogenous Dnmt1. Initially, we tested 5 different DBP provided by ChromoTek (Ger-
many). These specific binding proteins are based on approximately 13-kDa Dnmt1
binding fragment derived from a llama single chain antibody. Previous studies demon-
strated, that specific binders such as the GFP-Trap (ChromoTek, Germany), a GFP-
binding protein coupled to agarose beads, has several decisive advantages over con-
ventional antibodies (Rothbauer et al., 2006; 2008). Firstly, typical high affinities of single
chain antibodies allow short (30-60 min) incubations to isolate endogenous proteins
and even transiently bound factors from different cellular compartments. Secondly, its
small size of about 13 kDa minimizes unspecific binding and entirely avoids contami-
nation by heavy and light chains of conventional antibodies (50 and 25 kDa) that nor-
mally interfere with subsequent analyses. Initially, we tested the influence of the DBP on
the catalytic activity of Dnmt1. We expressed GFP-Dnmt1 in human embryonic kidney
(HEK293T) cells and one-step purified GFP-Dnmt1 via the GFP-Trap (ChromoTek, Ger-
many) as described before (Frauer and Leonhardt, 2009). Briefly, cells were lysed, in-
cubated with the GFP-Trap (ChromoTek, Germany) and washed. Next, we incubated
the purified GFP-Dnmt1 with DNA trapping substrate containing the mechanism-based
inhibitor 5-aza-cytosine at a central hemi- (hemi) or unmethylated (un) CpG site with
different fluorescent labels (Frauer and Leonhardt, 2009). The immobilized GFP-Dnmt1
was incubated with trapping substrate, alone or in the presence of a 10-fold molar
excess of purified DBPs, and the catalytic activity of Dnmt1 was calculated. Those ini-
tial measurements did not reveal any inhibiting or activating effects of the DBP on the
catalytic activity of Dnmt1 (Figure 11A).
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Figure 11: Initial testing of different Dnmt1 binder
A) The catalytic activity of Dnmt1 on hemi- and unmethylated DNA was measured in direct competition
in the presence of a 10-fold molar excess of different Dnmt1 binder. The DNA binding and trapping activity
of Dnmt1 alone was measured as positive control. Shown are means ± SEM of at least three independent
experiments (except for Dnmt1 trapping). B) The catalytic activity was measured at different time points
for Dnmt1 with a 10-fold molar excess of Dnmt1 binder #569. Shown are means± SEM of two independent
experiments.
Next, we examined the influence of the DBP #569 on the enzyme kinetics of Dnmt1.
We performed the described trapping assay and measured the catalytic activity of
Dnmt1 at different time points. Samples containing a 10-fold molar excess of DBP #569
did not show an altered enzymatic kinetic in comparison to the positive control (Fig-
ure 11B). In addition, we tested the ability of the DBP to precipitate its antigen from
crude cell extracts and measured the catalytic activity of immunoprecipitated Dnmt1
(Figure 12). First, the DBP #569 was added to protein extracts of HEK293T cells express-
ing GFP-Dnmt1. Precipitated proteins were separated by SDS-PAGE and visualized by
Coomassie Blue or immunoblot analysis (Figure 12A). After precipitation with the DBP
the major protein band corresponded to GFP-Dnmt1. Next, we immunoprecipitated
endogenous Dnmt1 from HeLa cells or Dnmt1 from mouse embryonic fibroblast (MEF)
cells and determined the catalytic activity towards hemimethylated CpG sites with
the trapping assay (Figure 12B). We could detect catalytic activity in samples from
HeLa and MEF cells incubated with DBP coupled to agarose beads but not in samples
obtained with not-functionalized beads (Figure 12B).
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Figure 12: Immunoprecipitation of Dnmt1 with the Dnmt1 binder
A) Immunoprecipitation of GFP-Dnmt1 transiently expressed in HEK293T cells with DBP #569. Aliquots of
input (IP) flow trough (FT) and bound fraction were separated by SDS-PAGE and visualized either by
Coomassie staining (left) or by immunoblot analysis using a GFP-antibody (right). B) Endogenous Dnmt1
from HeLa or MEF cells was purified with the Dnmt1 binder. Purified Dnmt1 was incubated with hemimethy-
lated trapping substrate and the catalytic activity was measured after 90 minutes. Not-functionalized
beads were used as negative control. Shown are means ± SD of two independent experiments.
In summary, the DBP allows a fast and efficient (one-step) isolation of endogenous,
active Dnmt1 for biochemical analyses including DNA methyltransferase activity
Cell cycle synchronization of HeLa cells with mimosine
In this study, we wanted to quantify the interactions of Dnmt1 over the cell cycle. As
described above, interacting proteins can have different impacts on the activity of
Dnmt1 at different cell cycle stages. Here, we used mimosine to synchronize the HeLa
cells in G1. Mimosine, a plant-derived amino acid whose cellular target is still unclear,
blocks cells either in late G1 phase (Lalande, 1990) or at the G1/S boundary (Mosca et
al., 1992). Also, it has been shown, that mimosine can induce a cell cycle arrest before
establishment of active DNA replication forks (Krude, 1999). Mimosine is an effective
inhibitor of S-phase entry in mammalian fibroblastic cell lines and human leukemic cell
lines, and it inhibits DNA replication in Xenopus extracts (Gilbert et al., 1995). Mimosine
is a stable inhibitor of cell cycle progression and is a relatively non-toxic compared with
other chemical inhibitors, such as aphidicolin. To synchronize the cells, we cultured
them in media containing 0.8 mM mimosine for 24 h. After washing with PBS, the cells
were released and harvested at different time points (Figure 13). We stained the DNA
with propidium iodide and analysed the DNA content by flow cytometry.
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Figure 13: Cell cycle synchronization of HeLa cells using mimosine
HeLa cells were synchronized with 0.8 mM mimosine for 24 h, released and harvested after the indicated
time intervals (green: 0 h; blue: 5 h; red: 10 h). The cells were stained with propidium iodide (PI) and
analysed by flow cytometry.
The cells were efficiently synchronized in late G1 after 24 h incubation with mimosine
(Figure 13, green). After release in "light" media, we obtained a homogenous cell
fraction in early S ((Figure 13, blue) or mid-late S (Figure 13, red) after 5 h or 10 h,
respectively.
Identification of Dnmt1 interactions using the Dnmt1 binder
Then, we were interested whether we could detect known interaction partners of en-
dogenous Dnmt1 immunoprecipitated from HeLa or HEK293T cells using the DBP #569
coupled to beads. We, immunoprecipitated endogenous Dnmt1, washed the beads
four times with 150 mM NaCl and all proteins bound to the beads were digested with
trypsin. All mass spectrometry analyses were performed by the Core Facility of the
Max-Planck-Institute of Biochemistry.
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Protein( Description( Uniprot(
Accession(
Cell(Type( Unique(Peptides(
HEK293T/HeLa(
Transcription(and(Development(Regulation(
PSIP1% Transcriptional%co1activator%involved%in%neuroepithelial%
stem%cell%differentiation%and%neurogenesis%
O75475% Both% 6/4%
KAP1% Mediates%gene%silencing% Q13263% HEK293T% 5/0%
TRIM25% Ubiquitin%E3%ligase% Q14258% HeLa% 0/2%
FXR1% RNA1binding%protein%required%for%embryonic%and%
postnatal%development%of%muscle%tissue.%
P51114% Both% 3/2%
Histones(
Histone%H1.3% Linker%Histone% P16402% Both% 8/3%
Histone%H2B%
type%
Core%Component%of%nucleosome% Q16778% Both% 5/2%
Histone%H4% Core%Component%of%nucleosome% P62805% Both% 8/6%
ChromatinDassociated(
HDAC6% Histone%deacetylase% Q6NT75% Both% 7/14%
HDAC10% Histone%deacetylase% Q969S8% HeLa% 0/3%
HDAC2% Histone%deacetylase% Q92769% Both% 2/0%
SMARCA5% Helicase%that%possesses%intrinsic%ATP1dependent%
nucleosome1remodelling%activity%
O60264% HEK293T% 5/0%
CHD4% Component%of%the%histone%deacetylase%NuRD%complex.% Q14839% HEK293T% 2/0%
CBX1% Recognizes%and%binds%methylated%H3K9% Q6IBN6% HEK293T% 2/0%
DNA(damage(
XRCC5% Single%stranded%DNA1dependent%ATP1dependent%
helicase.%
P13010% Both% 3/4%
XRCC6% Single%stranded%DNA1dependent%ATP1dependent%
helicase.%
P12956% Both% 7/7%
DDB1% Required%for%DNA%repair.% Q16531% Both% 2/2%
PARP1% Poly%[ADP1ribose]%polymerase%1% P09874% HEK293T% 18/0%
ZC3HAV1L% Phosphorylated%upon%DNA%damage.% Q96H79% Both% 2/2%
DNA(methylation(
DNMT1% Maintenance%DNA%methylation% P26358% Both% 3/3%
Cell(cycle(regulator(
PCNA% Targeting%DNMT1%to%replication%foci% P12004% Both% 13/7%
Others(
PRMT1% Protein%arginine%methyltransferase% Q99873% Both% 4/3%
USP7% Hydrolase%that%deubiquitinates%target%proteins% A6NMY8% Both% 2/6%
SET% Multitasking%protein,%involved%in%transcription,%
nucleosome%assembly%and%histone%binding%
Q01105% Both% 2/4%
Annexin% Calcium1regulated%membrane1binding%protein% P07355% HeLa% 0/4%
%
Table 1: Interaction partners of Dnmt1
Endogenous Dnmt1 was purified from HeLa or HEK293T cells using the Dnmt1 Binder and interaction part-
ners were determined by mass spectrometry
We summarized the interaction partner of Dnmt1 in Table 1. Notably, we found pro-
teins that are known to interact with Dnmt1 such as HDAC2 (Rountree et al., 2000;
Robertson et al., 2000), Smarca5 (Robertson et al., 2004), Cbx1 (Fuks et al., 2003), Parp1
(Reale et al., 2005; Zampieri et al., 2009), Usp7 (Du et al., 2010; Qin et al., 2011a), An-
nexin (Ohsawa et al., 1996) and Kap1 (Quenneville et al., 2011), demonstrating the
reliability of our approach. Besides known interactions, we could identify proteins in-
volved in DNA damage repair such as Xrcc5, Xrcc6 and Ddb1 (Table 1). It has been
shown, that Dnmt1 and PCNA accumulate at DNA damage sites, whereas recruit-
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ment of Dnmt3a or b was not observed (Mortusewicz et al., 2005), indicating a direct
role of Dnmt1 in the restoration of epigenetic information. In addition, Dnmt1 inter-
acts with Mbd4, a mismatch-specific DNA N-glycosylase, further supporting a role of
Dnmt1 in DNA damage repair (Ruzov et al., 2009). Also, Dnmt1 interacts with differ-
ent chromatin-associated proteins like HDAC6 and HDAC10, which are both class IIb
histone deacetylases. Notably, only the interactions with HDAC1 and 2 have been
described so far (Robertson et al., 2000; Rountree et al., 2000). In summary, we could
detect known interactions and could discover several new interactions, demonstrating
the reliability and usefulness of our approach.
SILAC-based quantification of cell cycle-dependent interactions
The samples were prepared as described in Figure 10 and the mass spectrometry
data was analysed by MaxQuant (Cox and Mann, 2008). A false discovery rate (FDR)
of 0.01 for proteins and peptides and a minimum peptide length of 6 amino acids
were required. MS/MS spectra were searched by Andromeda against the IPI human
database (version 3.68) combined with 262 common contaminants and concate-
nated with the reversed versions of all sequences. For the Andromeda search trypsin
allowing for cleavage N-terminal to Arginine and Lysine was chosen as enzyme speci-
ficity. MaxQuant was used for scoring of the peptides for identification. It also de-
termined the SILAC state of peptides by the mass differences between SILAC peptide
pairs and this information was used to perform searches with fixed Arg10 and Lys8 mod-
ifications as appropriate. Maximally two missed cleavages and three labelled amino
acids were allowed. Initial mass deviation of precursor ion was up to 7 ppm, mass de-
viation for fragment ions was 0.5 units on the m/z scale. Protein identification required
two peptides one of which had to be unique to the protein group. Data analysis plots
were performed in the MaxQuant environment (Perseus). We created a heat map of
the SILAC pull-down ratios and performed a one-way hierarchical clustering.
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Figure 14: Dynamic Dnmt1 interactome visualized by a heat map and one-way hierarchical clustering
The columns represent ratios of either late S to early S, late S to G1 or early S to G1. Green values represents
a negative ratio, red values represent a positive ratio. Shown are the median of three independent
experiments. Only nuclear proteins with at least two SILAC ratio in each group are plotted. All ratio
intensities are shown in log2 scale.
We found 44 nuclear proteins and our Dnmt1 interactome includes well-know binders
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such as PCNA and different histone proteins.
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Figure 15: SILAC ratios for Dnmt1, PCNA and H2A
SILAC ratios taken from (Figure 14) between different cell cycle phases of Dnmt1, PCNAand Histone H2A.
Notably, the SILAC ratio of Dnmt1 is constant, demonstrating a non-varying Dnmt1
protein concentration over the cell cycle (Figure 15). Interestingly, PCNA interacts pre-
dominantly during early S phase with Dnmt1 while several histones interact with Dnmt1
in late S (Figure 15). Consistently, it is known that Dnmt1 interacts with PCNA in early
to mid S phase (Schermelleh et al., 2007) and with histones at late replicating chromo-
centers in late S phase (Easwaran et al., 2004), demonstrating changing interactions of
Dnmt1 during S phase of the cell cycle. In summary, we have described a streamlined
interaction screen, which accurately discover and characterize dynamic interactions
of endogenous Dnmt1 in the same experiment.
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4 Discussion
Epigenetic modifications such as DNA methylation, histone modifications and nucle-
osome positioning play a role in the regulation of gene expression. However, the
crosstalk and mechanistic links between these epigenetic signals are still poorly un-
derstood.
Over the past decade, a large variety of different interacting factors and post-
translational modifications were reported for the eukaryotic DNA methyltransferase,
Dnmt1, illustrating the complexity of DNA methylation in vivo. In this PhD thesis, I investi-
gated the role of Dnmt1 interacting factors such as Uhrf1 and Uhrf2 and examined their
role in connecting different epigenetic pathways. To gain further insights into the func-
tion of these proteins, I established a high-throughput histone-tail peptide, DNA and
protein-protein binding assay. Applying this method, I provided further insights into
the crosstalk of DNA methylation and histone modifications. I could show that Uhrf1
and Uhrf2 specifically bind to the predominant heterochromatin mark H3K9me3, me-
diated by highly conserved aromatic amino acids forming an aromatic cage structure.
Moreover, binding assays demonstrated a cooperative interplay of Uhrf2 domains that
induces preference for hemimethylated DNA, the substrate of maintenance methyla-
tion, and enhances binding to H3K9me3 heterochromatin marks. Furthermore, I estab-
lished and applied protocols to quantify and discover interactions of Dnmt1 over the
cell cycle.
4.1 Versatile Toolbox for High-Throughput Biochemical and Func-
tional Studies with Fluorescent Proteins
In the past, a variety of different in vivo and in vitro assays have been developed to
determine protein binding specificities and affinities to different substrates like DNA, hi-
stones and proteins. These include the yeast two-hybrid assay (Fields and Song, 1989;
Chien et al., 1991), the protein complementation assay (Johnsson and Varshavsky,
1994), peptide phage display (Smith, 1985), microarrays, isothermal titration calorime-
try (ITC) (Ababou and Ladbury, 2007), surface plasmon resonance (SPR) (Aslan et al.,
2005) and conventional pull-down experiments with mass spectrometry (Gavin et al.,
2002; Ho et al., 2002) or immunoblot analyses. All these techniques are powerful tools
to quantify and identify binding events but have certain disadvantages. On the one
hand, techniques like ITC and SPR need large amounts of proteins. To gain large
amounts, those proteins have to be expressed and purified from bacterial systems (e.g.
E.coli) or lower eukaryotes such as yeast (e.g. S. cerevisiae). Thus, the recombinant
proteins might lack essential post-translational modifications or are not folded properly
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which could lead to different binding properties and inaccurate results. The expression
of proteins in higher eukaryotes like insects ensures post-translational modifications but
is very time-consuming and expensive. In addition SPR and ITC measurements one
can only determine the binding affinity to one substrate, which does not reflect the in
vivo situation where most proteins have the choice between many different binding
substrates inparallel. On the other hand, conventional methods like pull-downs require
proteins fused to a small epitope tag such as FLAG or c-Myc. In contrast, in vivo data
are acquired using fluorosescent tags like GFP and RFP. The integration of these in vitro
data with in vivo data obtained with fluorescently labelled proteins has in part been
impeded by the simple fact that different protein tags are used for different applica-
tions. In Chapter 3.1, we provide protocols for two specific GFP- and RFP- binding
proteins based on antibody fragments derived from llama single chain antibodies. The
binding proteins can be produced in bacteria and coupled to monovalent matrixes
generating so-called Nanotraps. We provide protocols for precipitation of fluorescent
fusion proteins from crude cell extracts to identify and map protein-protein interac-
tions as well as specific histone-tail peptide binding in an easy and reliable manner.
Furthermore, we expanded the presented assays to 96-well micro plates to generate
a versatile toolbox for high throughput biochemical and functional studies with fluores-
cent fusion proteins (Chapter 3.2 and Figure 16).
GFP
Protein X
DNA
Proteins
Peptides
Figure 16: Schematic drawing of the GFP-multiTrap
A specific GFP-binding protein is immobilized in the wells. Purified GFP-fusions can be tested for histone-tail
peptide, DNA and protein binding.
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Using a new system based on 96-well micro plates comprising an immobilized GFP-
binding protein (GFP-Trap, GFP-multiTrap), we performed fast and efficient one-step
purification of different GFP- and YFP-fusion proteins from crude cell lysate. After im-
mobilization we determined highly reproducible binding ratios of the cellular expressed
GFP-fusion proteins to histone-tail peptides, DNA or RFP-fusion proteins. Briefly, after ex-
pression of GFP-fusion proteins, we generated crude cell extracts by cell lysis and cen-
trifugation and transferred the soluble supernatant to single wells of the GFP-multiTrap.
After binding, the single wells were subjected to several washing steps and incubated
with fluorescently labelled substrates such as histone-tail peptides and DNA substrates
or with RFP-fusion proteins (Figure 16). After removal of unbound substrate, the abso-
lute amounts and molar ratios of GFP-fusion proteins and bound substrates were de-
termined by fluorescence measurements. As proof of principle, we tested histone-tail
peptide binding specificities of Cbx1, the DNA binding specificities of the MBD domain
of MeCP2 and the protein-protein interactions of different epigenetic regulators. We
found that Cbx1 preferentially binds to di- and trimethylated H3K9 histone-tail pep-
tides and this specific binding is abolished by phosphorylation of the adjacent serine.
Notably, previous studies (Jacobs et al., 2001) measured binding affinities of 7 and
2.5 µM for H3K9me2 and H3K9me3 for the HP1b chromo domain, the Drosophila ho-
molog of mammalian Cbx1. These measurements indicated a clear preference for
trimethylated H3K9. However, we could not detect a preference for H3K9me3. One
explanation could be the use of different expression systems. While the binding ratios
for the HP1b chromo domain were determined using bacterial expressed protein we
used a fluorescent fusion protein derived from mammalian cells. In this context a re-
cent study revealed that recombinant HP1b prepared from mammalian cultured cells
exhibited a stronger binding affinity for K9-methylated histone H3 (H3K9me) in compar-
ison to protein produced in E.coli due to multiple post-translational phosphorylation at
N-terminal serine residues (Hiragami-Hamada et al., 2011). This demonstrates the im-
pact of post-translational modifications on biochemical properties of specific proteins
and emphasizes the advantage of using GFP-fusion proteins expressed in mammalian
systems. Furthermore, we could measure a preference of the isolated MBD domain
of MeCP2 for symmetrically methylated over unmethylated DNA, consistent to pre-
vious studies (Nan et al., 1993; Free et al., 2001) using conventional electrophoretic
mobility shift assays (EMSA). In addition to the detection of substrate specificity, the
analysis of the interaction with other cellular components and factors is essential to
understand the function of proteins. The use of fluorescently labelled fusion proteins
to study protein-protein interactions in vitro, provides a new and simple method since
binding events can be detected by measuring the fluorescence, avoiding laborious
and inaccurate protein detection using conventional immunoblotting systems. Using
our new assay, we determined quantitative binding ratios between nuclear located
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proteins involved in DNA replication, DNA methylation as well as in DNA repair. In par-
ticular, we could show that the PBD domain of Dnmt1 binds to PCNA and that deletion
of this domain abolishes binding of full-length Dnmt1 to PCNA. In parallel, we used an
ELISA-based assay to detect endogenous interaction factors bound to immunoprecip-
itated GFP-fusion proteins. Notably, using this appraoch, we found endogenous PCNA
bound to Dnmt1, Fen1 and PCNA itself but not binding to Dnmt1 lacking the PBD do-
main. Also, we could detect endogenous Histone H3 bound on Cbx1. Remarkably, we
quantified the level of H3 and H3K4me2 at nucleosomes comprising different histone
variants. In particular, we found higher levels of H3K4me2 at nucleosomes comprising
H2A.Z in comparison to H2A.
In summary, we established a new versatile medium/high-throughput approach to
analyse binding specificities of fluorescently labelled fusion proteins and to detect en-
dogenous interacting factors in a fast and reliable manner.
4.2 Uhrf proteins connect different pathways
4.2.1 Uhrf1 coordinates repressive epigenetic pathways
As described in Chapter 1.2.2, Dnmt1 interacts with a large variety of different proteins
including chromatin binding and modifying proteins. It is known, that DNA and H3K9
methylation correlate and form a complex regulatory network contributing to gene
repression (Cedar and Bergman, 2009; Esteve et al., 2006). These two repressive epige-
netic modifications seem to mutually influence each other in vivo. On the one hand,
the knockdown of the DNA methyltransferase Dnmt1 results in decreased levels in H3K9
di-and trimethylation (Espada et al., 2004; Ikegami et al., 2007; Dong et al., 2008). On
the other hand, the knockdown of the histone methyltransferase Suv39H1/H2 or G9a,
that are both known to interact with Dnmt1, leads to decreased DNA methylation in
mammals (Lehnertz et al., 2003; Tachibana et al., 2002). However, how histone marks
are linked to DNA methylation pattern and how this complex epigenetic information is
integrated and translated into defined chromatin structures and gene expression lev-
els still remains elusive. In this context, multi-domain proteins that bind DNA and histone
marks are ideally suited to link epigenetic pathways and intra-molecular interactions
between different binding domains may contribute to substrate specificity and epige-
netic regulation (Hashimoto et al., 2009).
The multi-domain protein Uhrf1 has recently emerged as key factor to connect two
repressive epigenetic pathways by binding to hemimethylated DNA and to histones
(Citterio et al., 2004; Avvakumov et al., 2008; Arita et al., 2008). Moreover, Uhrf1 inter-
acts with both DNA and H3K9 methyltransferases including Dnmt1 and G9a (Kim et al.,
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2009; Meilinger et al., 2009; Unoki et al., 2004; Achour et al., 2009) and genetic ablation
in ESCs leads to genome- wide hypomethylation, a phenotype similar to dnmt1-/- ESCs
(Bostick et al., 2007; Sharif et al., 2007). Based on these data, Uhrf1 was suggested to re-
cruit Dnmt1 to hemimethylated CpG sites at replication forks. The SRA domain of Uhrf1
is sufficient to recognize hemimethylated DNA but it was still unclear which domain
or combination of domains is binding to histones and which specific histone modifi-
cations are recognized. Using in vitro DNA and histone-tail peptide binding assays in
combination with in vivo fluorescence recovery after photobleaching (FRAP) studies in
ESCs, we characterized the various interactions mediated by Uhrf1 and the single Uhrf1
domains (Chapter 3.3). We found that Uhrf1 binds to hemi- over unmethylated DNA
substrates with only an about two-fold preference. Consistently, we found that com-
plete loss of genomic DNA methylation does not affect binding kinetics of Uhrf1 in vivo.
Moreover, the isolated SRA domain is sufficient for DNA binding of Uhrf1 in vitro. How-
ever, the subcellular localization of the isolated SRA domain is different in comparison
to the full-length Uhrf1, pointing to an additional role of other domains in the proper
subcellular localization. Using ourin vitro histone-tail peptide-binding assay, we could
demonstrate that Uhrf1 preferentially binds to the predominant heterochromatin mark
H3K9me3. Interestingly, the specific recognition is mediated by three highly conserved
aromatic amino acids in the tandem Tudor domain forming an aromatic cage struc-
ture. Together, our data support the hypothesis that Uhrf1 possess a multi-functional
modular structure connecting DNA methylation and histone modification pathways.
4.2.2 Uhrf2 coordinates repressive epigenetic pathways
Interestingly, a second member of the Uhrf family, Uhrf2, harbours similar domains (Bron-
ner et al., 2007). Until now, Uhrf2 has been described to play a role in intranuclear
degradation of polyglutamine aggregates (Iwata et al., 2009) and cell cycle control
(Mori et al., 2002; Li et al., 2004; Mori et al., 2011). However, a potential function of
Uhrf2 in maintenance DNA methylation has not been reported. We systematically in-
vestigated the function and interplay of distinct Uhrf2 domains in DNA and histone tail
substrate recognition and reported first data on cell-type specific functions of Uhrf1
and Uhrf2 (Chapter 3.4). Firstly, we compared the expression pattern of uhrf1 and
uhrf2 in ESCs and somatic cells, during differentiation and in differentiated mouse tis-
sues and found opposite expression patterns; while uhrf1 is expressed in ESCs and down
regulated during differentiation, which is consistent with previous reports (Fujimori et
al., 1998; Hopfner et al., 2000), uhrf2 is up regulated and highly expressed in differen-
tiated mouse tissues. Using our in vitro binding assays, we investigated the DNA and
histone-tail peptide binding preferences of Uhrf2. Similar to Uhrf1, Uhrf2 preferentially
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binds to unmodified histone H3 and H3K9me3 mediated by an aromatic cage in the
tandem Tudor domain. Consistently, acetylation of H3K9, underrepresented in hete-
rochromatin, prevented the binding of Uhrf2. Notably, in contrast to recent publica-
tions, we could not detect any histone binding for the isolated PHD domains of Uhrf1
and Uhrf2 in vitro. It was shown, that the PHD domain, which is located adjacent to the
tandem Tudor domain, binds to histone H3 unmodified arginine 2 (H3R2) (Rajakumara
et al., 2011; Xie et al., 2011; Wang et al., 2011; Hu et al., 2011). The binding of the PHD
domain to H3 is abolished by methylation of H3R2 but not by H3K4 and H3K9 methy-
lation. ChIP studies demonstrated that Uhrf1’s ability to repress its direct target gene
expression is dependent on PHD binding to unmodified H3R2, thereby demonstrating
the functional importance of this recognition event and supporting the potential for
crosstalk between histone arginine methylation and Uhrf1 function (Rajakumara et al.,
2011). In general, arginine methylation is catalysed by the PRMT family of proteins and
physiological roles for protein arginine methylation have been established in several bi-
ological processes like signal transduction, mRNA splicing, transcriptional control, DNA
repair and protein translocation (Bedford and Clarke, 2009). However, little is known
about how histone arginine residues are recognized and to what extent protein argi-
nine methylation and demethylation occurs. Interestingly, we could demonstrate that
the combination of the PHD and the tandem Tudor domain of Uhrf2 displayed an
increased binding to H3K9me2/me3 in comparison to the single TTD, which was not
observed for the corresponding construct of Uhrf1. The increased binding depends
on the highly conserved linker region between the tandem Tudor and PHD domain of
Uhrf2, suggesting a cooperative interplay of different Uhrf2 domains. A similar func-
tional importance of linker sequences has been described for BPTF and histone lysine
demethylases (Li et al., 2006; Horton et al., 2010). In case of BPTF, the largest sub-
unit of the ATP-dependent chromatin-remodelling complex, NURF, a PHD and a bromo
domain are connected via a a-helical linker (Li et al., 2006). Both investigated his-
tone demethylases harbour a PHD that binds H3K4me3 and a jumonji domain that
demethylates either H3K9me2 or H3K27me2 and the substrate specificity is controlled
by the linker connecting both functional domains (Horton et al., 2010). These data
demonstrate an additional level of complexity involving multivalent binding of histone-
tail peptides by mixed two- effector modules (Ruthenburg et al., 2007).
In contrast to Uhrf1, Uhrf2 did not show a DNA binding preference for hemimethylated
DNA. However, binding to heterochromatin-specific H3K9me3 peptides induced a sig-
nificant preference of Uhrf2 for hemi- over unmethylated DNA. Vice versa, binding
to DNA enhanced binding of Uhrf1 and Uhrf2 to the H3K9me3 peptide. Consistently,
SILAC-based proteomic analysis identified enrichment of Uhrf1 at nucleosomes con-
taining repressive DNA and H3K9 methylation marks (Bartke et al., 2010). A similar ef-
fect was reported for MSL3 that specifically binds to H4K20me1 via a chromodomain
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only in the presence of DNA (Kim et al., 2010).
Similar to Uhrf1, the subcellular localization and binding dynamics of Uhrf2 in vivo are
dependent on histone H3K9 methylation but not on DNA methylation. Consistently,
mutant Uhrf1 protein deficient for H3K4me0/K9me3 binding fails to reduce the expres-
sion of a target gene, p16INK4A, when overexpressed (Nady et al., 2011). Remarkably,
transient expression of Uhrf2 in uhrf1-/- ESCs did not restore the DNA methylation pattern
at major satellites, pointing to functional differences between Uhrf1 and Uhrf2 in vivo.
Notably, a recent publication reveals that Uhrf fails to recruit Dnmt1 to replication foci
during S phase of the cell cycle, demonstrating that the cell cycle-dependent inter-
action between Uhrf1 and Dnmt1 is a key regulatory mechanism for DNA methylation
(Zhang et al., 2011). Also, the opposite expression pattern argues against a functional
redundancy of both genes and explain the drastic loss of DNA methylation in uhrf1-/-
ESCs despite the presence of intact uhrf2 alleles.
4.2.3 Diverse function of Uhrf proteins
As illustrated in Figure 9, Uhrf proteins harbour several distinct functional domains, sug-
gesting diverse functional roles in different cellular pathways. It was suggested, that
Uhrf1 binds to hemimethylated DNA, flips the base out of the DNA helix and recruits
Dnmt1 to its substrate. However, conventional in vitro DNA methyltransferase activity
assays argue against that simple model. Dnmt1 is active on hemimethylated naked
DNA and less active on DNA wrapped around mononucleosomes (Figure 17). Re-
markably, the addition of Uhrf1 abolished the catalytic activity of Dnmt1, suggesting
a tight binding of Uhrf1 to hemimethylated DNA that occludes the DNA from Dnmt1.
These data indicate that the base flipping mediated by Uhrf1 does not facilitate the
DNA methylation reaction by Dnmt1. Likely, Uhrf1 recruit other proteins to ensure main-
tenance DNA methylation by Dnmt1.
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Figure 17: Radioactive in vitro DNA methyltransferase assay
Dnmt1 and Uhrf1 were expressed recombinantly in insect cells. Un- or hemimethylated DNA substrates,
either naked or wrapped around mononucleosomes, were incubated with Dnmt1 alone or with Dnmt1
and Uhrf1 in molar ratio of 1:2. All reactions were performed in the presence of S-Adenosyl-L-Methionine
(SAM [3H]) at 37°. Reactions were stopped after 0.5, 1 or 1.5 h, precipitated in TCA and counts per minute
(cpm) were measured. Carina Frauer purified Dnmt1 from insect cells and Henrike Klinker (Becker lab)
prepared the mononucleosomes.
Indeed, interactomics of both Uhrf proteins discovered a broad range of proteins with
different functions (Table 2) that are involved in many different pathways (Table 3).
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Protein( Description( Uniprot(
Accesion(
Bait( Unique( Peptides(
Uhrf1/Uhrf2(
Transcription(Regulation(
DMAP1& Involved&in&transcription&repression&and&activation& Q9NPF5& Uhrf2& 0/3&
PRDM10& May&be&involved&in&transcriptional&regulation& Q17R90& Uhrf2& 0/2&
ZNF618& May&be&involved&in&transcriptional&regulation.& Q5T7W0& Uhrf2& 0/2&
PSIP1& Transcriptional&coNactivator&& O75475& Both& 6/8&
ADNP& Potential&transcription&factor.& Q9H2P0& Uhrf2& 0/9&
MTA2& May& be& involved& in& the& regulation& of& gene& expression& as& repressor&
and&activator&
O94776& Uhrf1& 2/0&
Cell(Cycle(Regulation(
ANP32A& Implicated&in&a&number&of&cellular&processes,& P39687& Both& 2/6&
ANP32B& Implicated&in&a&number&of&cellular&processes,& P39687& Both& 2/6&
Histones(
Histone&H4& Core&Component&of&nucleosome& P62805& Both& 11/13&
HIST2H2BE& Core&Component&of&nucleosome& Q16778& Uhrf2& 0/5&
HIST1H2BN& Core&Component&of&nucleosome& Q99877& Uhrf1& 3/0&
H2A.Z& Histone&variant& P0C0S5& Uhrf1& 4/4&
macroNH2A.2& Histone&variant& Q9P0M6& Uhrf2& 0/8&
ChromatinAassociated((
SMARCA5& Helicase& that& possesses& intrinsic& ATPNdependent& nucleosomeN
remodelling&activity&
O60264& Both& 16/17&
RSF1& Required& for& assembly& of& regular& nucleosome& arrays& by& the& RSF&
chromatinNremodelling&complex.&
Q96T23& Both& 9/4&
BAZ1A& Component&of&the&ACF&complex& Q9NRL2& Both& 5/5&
BAZ1B& Atypical&tyrosineNprotein&kinase&& Q9UIG0& Uhrf1& 2/0&
HDAC1& Histone&deacetylase& Q13547& Uhrf1& 2/3&
RNF2& E3&ubiquitinNprotein&ligase&& Q99496& Uhrf2& 0/4&
CBX8& Component&of&a&Polycomb&group&(PcG)& Q9HC52& Uhrf2& 0/4&
CBX3& Recognizes&and&binds&methylated&H3K9& Q13185& Both& 2/3&
RCC1& Binds&both&to&the&nucleosomes&and&doubleNstranded&DNA.& Q16269& Uhrf1& 7/0&
PBRM1& Involved& in& transcriptional& activation&and& repression&of& select&genes&
by&chromatin&remodelling&
Q86U86& Uhrf1& 3/0&
CHD4& Component&of&the&histone&deacetylase&NuRD&complex& Q14839& Uhrf2& 0/10&
DNA(binding(
UHRF2& E3&ubiquitinNprotein&ligase&& Q96PU4& Uhrf2& 0/24&
UHRF1& Hemimethylated&CpG&binding&protein& A8K024& Both& 10/4&
DNMT1& Maintenance&DNA&methylation& P26358& Uhrf1& 2/0&
DNA(damage(
PARP1& Poly&[ADPNribose]&polymerase&1& P09874& Both& 39/47&
PARP2& Involved&in&the&base&excision&repair&(BER)&pathway& Q9UGN5& Uhrf1& 6/0&
XRCC1& Corrects& defective& DNA& strandNbreak& repair& and& sister& chromatid&
exchange&
P18887& Uhrf1& 3/0&
XRCC5& Single&stranded&DNANdependent&ATPNdependent&helicase.& P13010& Uhrf1& 6/0&
XRCC6& Single&stranded&DNANdependent&ATPNdependent&helicase.& P12956& Uhrf1& 4/0&
MSH6& Component&of&the&postNreplicative&DNA&mismatch&repair&system& P52701& Uhrf1& 9/0&
DDB1( Required&for&DNA&repair.& Q16531& Both& 4/17&
RFC5& Elongation&of&primed&DNA&templates&by&DNA&polymerase&delta& P40937& Uhrf1& 2/0&
MPG& Hydrolysis&of&the&deoxyribose&NNglycosidic&bond&for&base&excision& P29372& Uhrf2& 0/2&
Ligase&III& Corrects& defective& DNA& strandNbreak& repair& and& sister& chromatid&
exchange&
P49916& Uhrf1& 2/0&
RAD23B& Multiubiquitin&chain&receptor&involved&in&modulation&of&proteosomal&
degradation.&
P54727& Uhrf2& 0/2&
Others(
USP7& Hydrolase&that&deubiquitinates&target&proteins& A6NMY8& Both& 30/28&
SET& Multitasking&protein,&involved&& Q01105& Uhrf2& 0/11&
&
Table 2: Interaction partners of Uhrf1-GFP and Uhrf2-GFP
GFP-fusions were expressed in HEK293T cells and purified via GFP-Trap. Interaction partner were deter-
mined by mass spectrometry.
As mentioned, Uhrf1 and Uhrf2 have been shown to interact with DNA methyltrans-
ferases (Dnmt1, Dnmt3a and b) and histone methyltransferases (G9a), demonstrating
their role in connecting different epigenetic pathways. Uhrf1 forms a repressive com-
plex with G9a/GLP in euchromatic regions to regulate transcription of p21 and p16INK4A
(Nady et al., 2011; Kim et al., 2009) and Suv39H1/H2-mediated H3K9 methylation has
been demonstrated to be essential for proper localization of Uhrf proteins (Pichler et
al., 2011; Karagianni et al., 2008). Notably, the major H3K9 methyltransferases Suv39H1,
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G9a, GLP and SetDB1 have recently been demonstrated to coexist in a multimeric
complex, and these enzymes cooperate to mediate H3K9 methylation in both eu-
and heterochromatin (Fritsch et al., 2010).
Uhrf1& Uhrf2&
KEGG&pathways& Count& Percentage& KEGG&pathways& Count& Percentage&
Spliceosome* 5* 7.69* Spliceosome* 24* 17.27*
SLE* 4* 6.15* SLE* 7* 5.04*
Base*excision*repair* 4* 6.15* RNA*transport* 7* 5.04*
Nucleotide*excision*repair* 3* 4.62* Ribosome* 7* 5.04*
NHEJ* 3* 4.62* mRNA*surveillance* 4* 2.88*
Mismatch*repair* 3* 4.62* Ribosome*biogenesis* 3* 2.16*
Wnt*signaling*pathway* 2* 3.08* Cancer*pathway* 3* 2.16*
UbOmediated*proteolysis* 2* 3.08* Nucleotide*excision*repair* 3* 2.16*
RNA*transport* 2* 3.08* Base*excision*repair* 3* 2.16*
Ribosome*biogenesis** 2* 3.08* Wnt*signaling*pathway* 2* 1.44*
Ribosome* 2* 3.08* UbOmediated*proteolysis* 2* 1.44*
DNA*replication* 2* 3.08* Protein*processing* 2* 1.44*
& * * Mismatch*repair* 2* 1.44*
& * * Colorectal*cancer* 2* 1.44*
& * * Cell*cycle* 2* 1.44*
*
Table 3: Uhrf proteins associate with a broad range of proteins
The immunoprecipitated proteins were grouped and counted according to the KEGG pathways. Rows
indicate the KEGG pathway and how many proteins in relation to the total number of immunoprecipi-
tated proteins are annotated in this particular pathway. Following abbreviations were used: SLE: Systemic
lupus erythematosus; NHEJ: Non-homologous end joining; Ub: Ubiquitin. Notably, histone proteins are
involved in the SLE KEGG pathway.
Both, Uhrf1 and Uhrf2 bind to methylated H3K9, generated by H3K9 methyltransferases
through the tandem Tudor domain and PHD finger module, which may recruit H3K9
methyltransferases to methylate the adjacent H3K9 of neighbouring nucleosomes. That
may help to establish and maintain H3K9me3 states on both heterochromatic and cer-
tain silenced euchromatic regions (Barski et al., 2007; Bilodeau et al., 2009). Therefore,
it is highly possible that the propagation of DNA methylation and H3K9me3 mutually
reinforce each other to ensure the stability of heterochromatic states through Uhrf1-
and Uhrf2- associated repressive complex (Hashimoto et al., 2009; Xie et al., 2011). In
addition, our interactomics data identified Cbx3 binding to both Uhrf proteins (Table
2). Cbx3 binds to trimethylated H3K9 (Kaustov et al., 2010) and may help to maintain
heterochromatin similar to HP1b (Maison and Almouzni, 2004). Notably, we could also
detect proteins involved in ATP-dependent chromatin remodelling such as Smarca5,
Baz1a and Baz1b (Table 2). These interaction data suggest that Uhrf proteins bind to
histones and DNA and recruit chromatin remodeller that may "open" the chromatin to
facilitate the maintenance of DNA methylation. Interestingly, Dnmt1 also interacts with
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Smarca5 that increases the binding affinity of Dnmt1 to mononucleosomes that may
help Dnmt1 to access substrate sites in heterochromatic regions. (Robertson et al.,
2004). Indeed, Smarca5, also known as Snf5h, is the catalytic subunit of ACF complex
that regulates spacing of nucleosomes using ATP to generate evenly spaced nucleo-
somes along the chromatin. It was shown that Snf2h becomes specifically enriched in
replicating pericentric heterochromatin and in vivo depletion of Snf2h slows the pro-
gression of DNA replication, demonstrating a role in enabling DNA replication through
highly condensed regions of chromatin (Collins et al., 2002).
In addition, Uhrf proteins harbour a Ring domain, which possesses ubiquitin E3 ligase
activity and might function in modulating chromatin structure through its ubiquitin ac-
tivity. In vitro, H2A, H2B and H3 were identified as substrates of Uhrf1 with similar ef-
ficiency (Citterio et al., 2004) and we could detect several core histones interacting
with both Uhrf proteins (Table 2). Compared to acetylation, methylation, and phos-
phorylation, very little is known about the function of histone ubiquitylation. Recently,
the histone H3 and H4 ubiquitin ligase complex, CUL4-DDB-ROC1, has been charac-
terized. Biochemical studies indicate that CUL4-DDB-ROC1-mediated histone ubiqui-
tylation weakens the interaction between histones and DNA and facilitates the recruit-
ment of repair proteins to damaged DNA (Wang et al., 2006). Also, we could show
(Qin et al.; unpublished data,), that ubiquitination activity of Uhrf1 was required for
maintenance of DNA methylation by Dnmt1. These data suggest, that besides the role
of Uhrf proteins in propagating histone methylation they control the overall structure of
nucleosomes by ubiquitination.
In addition, Uhrf1 and Uhrf2 associate with the deubiquitinase Usp7, which also bind
to Dnmt1, suggesting a dynamic complex including Dnmt1, Uhrf1 and Usp7 in mam-
malian cells (Qin et al., 2011a). Notably, genetic ablation of usp7 in human tumor cell
lines did not affect global DNA methylation but led to a 65 % decreased DNA methy-
lation level at the imprinted gene H19 (Du et al., 2010). Consistently, Usp7 and Uhrf1
were reported to modulate Dnmt1 stability by ubiquitination and deubiquitination (Qin
et al., 2011a; Du et al., 2010), and in addition Usp7 stimulates both the maintenance
and de novo methylation activity of Dnmt1 in vitro (Felle et al., 2011).
As mentioned, ubiquitination of H3 and H4 participates in the cellular response to DNA
damage (Wang et al., 2006) and Uhrf proteins were suggested to ubiquitinate histones.
Consistently, the loss of Uhrf1 increases the sensitivity of cells to DNA damage (Tien et
al., 2011). It was shown, that Uhrf1-depleted cells exhibit increased sensitivity to g-
irradiation and that these cells show impaired cell cycle arrest and an impaired accu-
mulation of histone H2A.X phosphorylation (gH2A.X) in response to g-irradiation (Mistry
et al., 2010). Notably, several proteins involved in DNA damage repair such as Parp1/2,
Xrcc1 and 6 and Ddb1 interact with both Uhrf proteins.
Taken together, Uhrf proteins may function in the propagation of repressive chromatin
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states, gene expression/repression, protein and histone ubiquitination, cell cycle regu-
lation and DNA damage response (Figure 18).
U
hrf1/2
U
hrf1/2
U
hrf1/2
U
hrf1/2
H3K9MT
TTD
PHD
ATPase
TTD
PHD
Uhrf1/2
Ub
Ub
DNA 
repairUb
Ub
Ub
Ub
Usp7
Dnmt1
genotoxic 
stress
CG
TTD
CG
CG
CG
CGCG
CG
CG
Me
Me
CG CG CG
CGCGCG
Me Me
MeMe
CG CG CG
CGCGCG
Me Me
MeMe
maintenance
methylation
hemimethylated
CpG site
PC
NA
Dnmt1
PHD SRA
RING
Uhrf1/2
DNA
replication
A
B C
D E
SRA RING
Figure 18: Diverse functions of Uhrf proteins
A) Uhrf proteins bind to repressive epigenetic modifications and Uhrf1 recruits Dnmt1 to replication foci.
B) Uhrf proteins bind to H3K9me3 and recruit H3K9 methyltransferases (H3K9MT), propagating heterochro-
matic regions. C) Uhrf proteins bind to ATP-dependent chromatin remodeller. D) Uhrf proteins harbour an
E3 ubiquitin ligase, RING, domain, that ubiquitinates proteins like Dnmt1 and histones. E) Uhrf proteins play
a role in DNA damage repair and interact with proteins involved in DNA repair.
128
DISCUSSION
4.3 Dynamic interactions of Dnmt1
Over the past decade, a large variety of different interacting factors and post-
translational modifications were reported for the eukaryotic DNA methyltransferase
Dnmt1. The ever-increasing list impressively illustrates the complexity of Dnmt1 regu-
lation. Furthermore, some of these interactions are highly dynamic over the cell cycle,
illustrating an additional level of regulation. One example of cell cycle-dependent
regulation is described in Chapter 1.2.3. During early S to mid S phase, Dnmt1 inter-
acts with PCNA and is localized at replication foci. In addition, Dnmt1 is stabilized by
Akt1-mediated phosphorylation (Esteve et al., 2011) to guarantee a necessary level of
active Dnmt1. Whereas in late S phase, Dnmt1 is localized at late replication chromo-
centers and Uhrf1-dependent ubiquitination destabilizes Dnmt1 (Easwaran et al., 2004;
Du et al., 2010). These examples illustrate the interplay of specific interactions recruit-
ing Dnmt1 to specific foci and/or mediating post-translational modifications.
However, many of the known interactions and modifications were identified in different
cells and species regardless of the cell cycle phase using varied and mostly qualitative
methods. To gain further insights into the complexity of Dnmt1 regulation, it is essential
to systematically and quantitatively analyse the different interactions dependent on
the cell cycle phase.
We used a quantitative SILAC-based mass spectrometry approach to discover and
characterize dynamic interactions of endogenous Dnmt1 in the same experiment.
Consistent to in vivo data, we could show that Dnmt1 interacts with PCNA predom-
inantly in early S phase and binds to core histones during late S phase of the cell
cycle. However, we could not quantify the interactions such as with the chromatin
remodeller Smarca5 or with transcriptional regulator such as Kap1. we initially found
with convential mass spectrometry (Table 1). Further experiments with other synchro-
nization techniques like Thymidin treatment and using different SILAC standards such
as HEK293T cells and/or only unsynchcronized cells may be necessary to detect and
quantifiy additional interactions.
The biggest challenge however will be the integration of all these data to comprehend
Dnmt1 regulation in the context of living cells, taking into account the complexity and
dynamics of its natural substrate, the chromatin, as well as the competition or cooper-
ation with countless other cellular proteins and processes We are convinced that the
combination of future quantitative interaction and in vivo studies will provide valuable
insights into the epigenetic regulation of gene expression
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5.2 Abbreviations
5caC: 5-carboxylcytosine
5fc: 5-formylcytosine
5hmC: 5-hydroxymethylcytosine
5mC: 5-methylcytosine
aa: amino acid
Ac: acetylation
ADD: ATRX-Dnmt-Dnmt3L
ATP: adenosine-5’-triphosphate
BAH: Bromo Adjacent Homology domain
BER: base excision repair
bp: base pair
BRCT: BRCA1 C Terminus
CMT: Chromomethylase
CpG: cytosine-phosphatidyl-guanine
cpm: counts per minute
CTD: catalytic domain
Da: Dalton
DBP: Dnmt1 binding protein
DMAP: Dnmt1 association protein
DNA: deoxyribonucleic acid
Dnmt: DNA methyltransferase
ELISA: enzyme linked immunosorbent assay
ESC: embryonic stem cell
FDR: false discovery rate
FRAP: fluorescence recovery after photobleaching
G phase: gap phase
GFP: green fluorescent protein
h: hours
H3K9MT:H3K9 methyltransferases
HDAC: histone deacetylase
HEK293T: human embryonic kidney cells
HeLa: cervical cancer cells taken from Henrietta Lacks
HP1: heterochromatin-associated protein 1
ICBP90: inverted CCAAT box binding protein of 90 kDa
ITC: isothermal titration calorimetry
MBD: methyl-CpG binding domain protein
MBT: malignant brain tumor
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MDS: myelodysplastic syndrome
Me: methylation
MEF: mouse embryonic fibroblast
MET: methyltransferase
min: minutes
NFR: nucleosome free region
NHEJ: non-homologous end joining
nm: nanometre
Np95: nuclear protein of 95 kDa
NURF: nucleosomal remodelling factor
p: phosphorylation
P/CAF: p300/CBP-associated factor
PBD: PCNA binding domain
PBS: phosphate buffered saline
PcG: polycomb group
PCNA: proliferating cell nuclear antigen
PCNP: PEST-containing nuclear protein
PDB: protein data bank
PHD: Plant Homeo Domain
PI: propidium iodide
Prc: polycomb repressive complex
PWWP: proline-tryptophan-proline motif
RFP: red fluorescent protein
Ring: really interesting new gene
S phase: synthesis phase
SAM: S-Adenosyl-L-Methionine
SD: standard deviation
SEM: standard error of the mean
SILAC: stable isotope labelling with amino acids in cell culture
SLE: systemic lupus erythematosus
SPR: surface plasmon resonance
SRA: SET and Ring associated
SUMO: sumoylation
TCA: trichloroacetic acid
TDG: thymidine deglycosylase
TRD: transcription repression domain
trxG: trithorax group
TS: targeting sequence
TSS: transcription start site
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Ub: ubiquitination
Ubl: ubiquitin-like
Uhrf: Ubiquitin-like-containing PHD and RING finger domains protein
wt: wild type
ZnF: zinc finger
mm: micrometre
mM: micromolar
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